Exhibit 12

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 1 of 330 PageID:

43590
 IN THE UNITED STATES DISTRICT COURT

 FOR THE DISTRICT OF NEW JERSEY

 - - -

KIMBERLEE WILLIAMS, : CIVIL ACTION

et al., :

 Plaintiffs, :

 :

 vs. :

 :

BASF CATALYSTS, LLC, :

et al., :

 Defendants : NO. 2:11-CV-1754

 - - -

 MONDAY, MAY 14, 2018

 - - -

 Videotaped deposition of

ARTHUR DORNBUSCH, was held at the law offices

of Littleton, Park, Joyce, Ughetta & Kelly,

141 West Front Street, Suite 120, Red Bank,

New Jersey, commencing at 9:06 a.m., on the

above date, before Deborah A. Brazukas, a

Registered Professional Reporter, Certified

Shorthand Reporter of New Jersey, License No.

XI 01938, and Notary Public.

 MAGNA LEGAL SERVICES

 (866) 624-6221

 www.MagnaLS.com

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 2 of 330 PageID:

43591
Page 2

1 APPEARANCES:

2 COHEN, PLACITELLA & ROTH, P.C.

 BY: CHRISTOPHER M. PLACITELLA, ESQUIRE

3 MICHAEL COREN, ESQUIRE

 127 Maple Avenue

4 Red Bank, New Jersey 07701

 732.747.9003

5 cplacitella@cprlaw.com

 mcoren@cprlaw.com

6 Counsel for Plaintiffs

7

8 KIRKLAND & ELLIS, LLP

 BY: PETER FARRELL, ESQUIRE

9 655 Fifteenth Street, N.W.

 Washington, D.C. 20005

10 202.879.5959

 peter.farrell@kirkland.com

11 Counsel for BASF Catalysts, LLC

12

13 PEPPER HAMILTON, LLP

 BY: BARRY BOISE, ESQUIRE

14 3000 Two Logan Square

 18th and Arch Streets

15 Philadelphia, Pennsylvania 19103

 215.981.4591

16 boiseb@pepperlaw.com

 Counsel for Cahill, Gordon; Peter

17 Sloane; Ira Dembrow

18

19 MARINO, TORTORELLA & BOYLE, P.C.

 BY: KEVIN MARINO, ESQUIRE

20 JOHN BOYLE, ESQUIRE

 437 Southern Boulevard

21 Chatham Township, New Jersey 07928

 973.824.9300

22 khmarino@khmarino.com

 jboyle@khmarino.com

23 Counsel for Arthur Dornbusch

24

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 3 of 330 PageID:

43592
Page 3

1 APPEARANCES (Continued):

2

3 HEROLD LAW, P.A.

 BY: ERIC TUNIS, ESQUIRE

4 25 Independence Boulevard

 Warren, New Jersey 07059

5 908.484.1153

 etunis@herold.com

6 Counsel for Thomas Halket

7 ALSO PRESENT:

8 Sneha Desai, Esquire

 Robert Pratter, Esquire (via telephone)

9 Lea Callahan

 Ray Moore, The Videographer

10

11

12

13

14

15

16

17

18

19

20

21

22

23

24

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 4 of 330 PageID:

43593
Page 4

1 INDEX

2 - - -

3 TESTIMONY OF: PAGE

4 ARTHUR DORNBUSCH

5 BY MR. PLACITELLA 11

6

7 - - -

8 EXHIBITS

9 - - -

10 NO. DESCRIPTION PAGE

11 Dornbusch1 United States Securities

 and Exchange Commission,

12 Washington, D.C.,

 Schedule 14A *

13

Dornbusch2 Excerpt from BASF Privilege

14 Log - Dornbusch *

15 Dornbusch3 Excerpt from BASF Privilege

 Log - O'Shaughnessy Ashton

16 Entries *

17 1 Cahill Collection of Testing

 Document (Excluding

18 Privileged Documents) *

19 3 Transcript of deposition of

 Glenn Hemstock, March 16,

20 1983, Re: Westfall vs.

 Whittaker, Clark & Daniels,

21 et al. *

22

23

24

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 5 of 330 PageID:

43594
Page 5

1 EXHIBITS (Continued):

2 - - -

3 NO. DESCRIPTION PAGE

4 4 Transcript of deposition of

 Peter Gale, April 26, 1983,

5 Re: Westfall vs. Wittacker,

 Clark & Daniels, et al. *

6

 5 Affidavit of William H.

7 Ashton *

8 6 Affidavit of Charles D.

 Carter *

9

 13 Excerpt of transcript of

10 deposition of Daniel

 Steinmetz, July 18, 2017,

11 Re: Sampson vs. 3M Company,

 et al. *

12

 14 Summary of Activities

13 Related to Servives Rendered

 for Decof & Grimm in the case

14 of David H. Westfall vs.

 Whittaker, Clark & Daniels,

15 et al. *

16 15 Inter-Department Memorandum,

 Minerals & Chemical Division,

17 Document Retrieval -

 Discontinued Operations,

18 March 7, 1984 *

19 41 Answers of BASF Catalysts

 LLC ton Interrogatories

20 Propounded by the Plaintiffs,

 Re: Williams, et al. vs.

21 BASF Catalysts, LLC, et al. *

22

23

24

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 6 of 330 PageID:

43595
Page 6

1 EXHIBITS (Continued)

2 - - -

3 NO. DESCRIPTION PAGE

4

 50 Answers, Objections and

5 Responses of Pita Realty

 Limited, Formerly Known as

6 Eastern Magnesia Talc Company,

 and Engelhard Corporation to

7 Owens-Corning Fiberglas

 Corporation's Interrogatories

8 and Request for Production,

 Re: Asbestos Products

9 Liability Litigation *

10 57 Responses by Engelhard

 Corporation to Plaintiffs'

11 First Standard Set of

 Liability Interrogatories,

12 Re: Chernick vs. ABB Lummus

 Global, Inc., et al. *

13

 108 Letter from Eric S. Sarner

14 to Mr. Hobson, January 22,

 1990 *

15

 121 Letter from Eric S. Sarner

16 to Dear Jim, April 23, 1990 *

17 123 Letter from Sarner to Dear

 Peter, April 24, 1990 *

18

 148 Letter from Francis Patrick

19 Newell to Signe O'Brien

 Rudberg, Esquire, November

20 18, 2003 *

21 176 BASF Catalysts LLC's

 Responses and Objections to

22 Plaintiffs' First Request for

 Admissions, Re: Williams,

23 et al. vs. BASF Catalysts,

 LLC, et al. *

24

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 7 of 330 PageID:

43596
Page 7

1 EXHIBITS (Continued):

2 - - -

3 NO. DESCRIPTION PAGE

4 203 Defendant Arthur A. Dornbusch

 II's Disclosures Under Rule

5 26(a)(1), Re: Williams, et

 al. vs. BASF Catalysts, LLC,

6 et al. *

7 210 Letter from Eric S. Sarner

 to Dear David, July 16, 1991 *

8

 214 "Englehard Corp. William

9 Salling" with attachments *

10 215 Letter from Harriet

 Vasilopoulos to Ms. Nancy

11 Remundo, January 24, 1985,

 with attachment *

12

13 (* Exhibit marked prior to start of

14 deposition.)

15

16

17

18

19

20

21

22

23

24

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 8 of 330 PageID:

43597
Page 8

1 - - -

2 DEPOSITION SUPPORT INDEX

3 - - -

4 Direction to Witness Not to Answer

5 Page Line Page Line Page Line Page Line

6 16 14 118 2 238 9 267 19

7 35 5 121 23 239 15 272 20

8 35 11 125 1 242 9 274 20

9 35 17 126 16 245 6 275 3

10 36 1 127 2 246 5 276 10

11 36 14 127 15 246 13 278 3

12 41 12 130 17 250 11 280 7

13 42 12 132 1 252 18 286 17

14 43 14 132 6 253 3 287 6

15 45 2 146 22 253 12 288 9

16 46 6 191 2 256 12 289 1

17 51 24 207 1 257 7

18 55 17 208 4 257 17

19 56 22 219 13 258 10

20 114 10 228 6 258 20

21 116 10 230 11 259 5

22 117 10 237 21 263 7

23

24

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 9 of 330 PageID:

43598
Page 9

1 DEPOSITION SUPPORT INDEX (Continued):

2 - -

3

4 Request for Production of Document

5 Page Line

6 None

7

8 Stipulations

9 Page Line

10 None

11

12 Question Marked

13 Page Line

14 None

15

16

17

18

19

20

21

22

23

24

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 10 of 330 PageID:

43599
Page 10

1 THE VIDEOGRAPHER: We are now

2 on the record. This begins DVD No. 1 in

3 the deposition of Arthur Dornbusch in the

4 matter of Kimberlee Williams, et al.

5 versus BASF Catalysts, LLC, et al., in

6 the United States District Court for the

7 District of New Jersey, Civil Action No.

8 2:11-cv-1754.

9 Today is May 14th, 2018, and

10 the time is 9:06 a.m. This deposition

11 is being taken at 141 West Front Street,

12 Red Bank, New Jersey, at the request of

13 Cohen, Placitella and Roth.

14 The videographer is Ray Moore

15 of Magna Legal Services and the court

16 reporter is Debbie Brazukas of Magna

17 Legal Services. Counsel will be noted

18 on the stenographic record.

19 Will the court reporter please

20 swear in the witness.

21 - - -

22 ARTHUR DORNBUSCH, after having

23 been duly sworn, was examined and

24 testified as follows:

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 11 of 330 PageID:

43600
Page 11

1 - - -

2 EXAMINATION

3 - - -

4 BY MR. PLACITELLA:

5 Q. Good morning, Mr. Dornbusch. How

6 are you?

7 A. Good morning.

8 Q. I can make you a promise before

9 we start. This will be a lot shorter than

10 the last time we were together.

11 A. That would be good.

12 Q. As you know, I'm Chris

13 Placitella, and I'm here to get your

14 testimony today.

15 You currently reside where?

16 A. Six Harbor Drive in Rumson, New

17 Jersey.

18 Q. And you went to Yale to get your

19 bachelor of arts?

20 A. I did.

21 Q. And then University of

22 Pennsylvania Law School?

23 A. Yes.

24 Q. All right. Did you ever sit for

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 12 of 330 PageID:

43601
Page 12

1 any -- the New Jersey bar?

2 A. No.

3 Q. Okay. Am I correct that your --

4 that you started with Engelhard in 1976?

5 A. Yes, December '96.

6 Q. And your first job was

7 assistant --

8 A. '76.

9 Q. -- general counsel?

10 A. Yes.

11 Q. Okay. At that time, what were

12 your job responsibilities?

13 A. I was responsible for the general

14 legal support of certain of the business --

15 sub business groups. I don't recall

16 specifically which ones. I know that one of

17 them was the systems, air -- air and systems

18 water group located in Union, New Jersey.

19 And there were other groups too, but at that

20 time, I'm not sure what they were.

21 Q. Okay. And am I -- in 1980, you

22 became the vice president and general counsel

23 of Minerals and Chemicals --

24 A. Yes.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 13 of 330 PageID:

43602
Page 13

1 Q. -- is that fair?

2 And what were your

3 responsibilities as vice president and

4 general counsel for Mineral and Chemicals?

5 A. I was responsible for all of the

6 legal affairs of that division. That was one

7 of three divisions of Engelhard, Minerals and

8 Chemicals Corporation.

9 Q. Okay. In that capacity, did you

10 do work on the talc litigation?

11 MR. FARRELL: Objection to

12 form.

13 THE WITNESS: Yes. I'm not

14 sure at what point talc litigation

15 ensued, but yes.

16 BY MR. PLACITELLA:

17 Q. Okay. And in 1984, did you

18 become the corporate secretary for Engelhard?

19 A. Yes.

20 Q. All right. And as corporate

21 secretary, did you attend board meetings?

22 A. Yes, I did.

23 Q. Okay. In 1984, did you become

24 vice president and general counsel for the

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 14 of 330 PageID:

43603
Page 14

1 entire Engelhard Corporation?

2 A. Yes.

3 Q. Okay. In 1984, did you become

4 responsible for the legal affairs of the

5 company?

6 A. Yes.

7 Q. Okay. Did that include reviewing

8 financial disclosures?

9 A. Yes.

10 Q. Were you considered an officer of

11 the corporation at that point?

12 A. Yes.

13 Q. From -- when -- in 1984, were you

14 in charge of supervising litigation relate --

15 related to Engelhard?

16 A. Yes.

17 Q. Okay. And did that include the

18 Emtal talc litigation?

19 MR. FARRELL: Objection to

20 form.

21 THE WITNESS: Yes.

22 BY MR. PLACITELLA:

23 Q. Okay. Did you keep that title

24 into 2006, when you retired?

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 15 of 330 PageID:

43604
Page 15

1 A. Yes.

2 Q. Okay. And did your

3 responsibilities change at all from 1984 to

4 2006, when you retired?

5 A. No.

6 Q. Okay. So, you know, we're here

7 to talk about the -- the talc litigation, so

8 I want to just ask you some questions.

9 When is the first time that

10 you learned there were reports indicating

11 that there was asbestos in Emtal talc?

12 MR. MARINO: Objection to form.

13 BY MR. PLACITELLA:

14 Q. You can answer.

15 A. It was probably in 1981.

16 Q. And what were the circumstances?

17 MR. FARRELL: Objection to

18 form.

19 THE WITNESS: The person who

20 preceded me in that position, Joe Brush,

21 was going over some of the items that

22 were of current interest. And I recall

23 him saying -- tell -- telling me --

24 MR. FARRELL: Mr. --

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 16 of 330 PageID:

43605
Page 16

1 Mr. Dornbusch --

2 THE WITNESS: Yes.

3 MR. FARRELL: -- one moment.

4 When it comes to a conversation between

5 you and Mr. Brush, who, as I understand

6 it, was also a lawyer for the company --

7 THE WITNESS: Yes.

8 MR. FARRELL: -- I would

9 caution you on the disclosure of

10 information or communications that would

11 be covered by the attorney-client

12 privilege or, depending on the time

13 period, the work product doctrine.

14 So I didn't mean to interrupt

15 your answer, but it sounded like you

16 were heading in that direction. I would

17 instruct you not to answer questions or

18 to disclose information covered by

19 privilege or work product.

20 If you can continue your

21 answer without disclosing such

22 information, that's fine. But if you're

23 about to disclose the substance of a

24 communication with Mr. Brush, I'd

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 17 of 330 PageID:

43606
Page 17

1 instruct you not to do so and would

2 object to the question on that basis.

3 MR. MARINO: Could I have the

4 question back, please.

5 (Whereupon, the court reporter

6 read back the record as requested.)

7 MR. PLACITELLA: The first

8 question is when is the first time that

9 you learned there were reports indicating

10 there was asbestos in Ental talc. And

11 the second -- next question was, what

12 were the circumstances.

13 MR. FARRELL: The question --

14 MR. MARINO: That -- that --

15 that question does not call for the

16 disclosure of any statements --

17 THE WITNESS: Yeah.

18 MR. MARINO: -- made to you by

19 anyone. I -- I think Mr. Farrell's

20 objection was because you began to

21 volunteer such testimony.

22 THE WITNESS: Yes, I spoke to

23 my predecessor.

24 BY MR. PLACITELLA:

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 18 of 330 PageID:

43607
Page 18

1 Q. Okay. And that was information

2 already in his possession?

3 MR. FARRELL: Objection to

4 form.

5 MR. MARINO: Same objection.

6 THE WITNESS: Well, I assume it

7 was. He knew.

8 BY MR. PLACITELLA:

9 Q. Okay. When is the first time

10 that you learned there was testing data

11 concerning the asbestos content of Emtal

12 talc?

13 A. I don't recall.

14 Q. Okay. When is the first time you

15 learned there was testing data -- that

16 testing data existed indicating there was

17 asbestos in Emtal talc?

18 MR. FARRELL: Objection to

19 form; foundation.

20 THE WITNESS: I don't recall.

21 BY MR. PLACITELLA:

22 Q. Okay. When is the first time, if

23 ever, that you learned that consultants hired

24 by Engelhard found asbestos in Emtal talc?

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 19 of 330 PageID:

43608
Page 19

1 MR. FARRELL: Objection to

2 form.

3 THE WITNESS: I don't recall.

4 BY MR. PLACITELLA:

5 Q. When is the first time that you

6 learned that Em -- that Engelhard scientists

7 testified under oath about the testing of

8 Emtal talc for asbestos?

9 MR. MARINO: I just object to

10 the form of the question and ask if you

11 could ask the question -- the

12 foundational question first, please.

13 BY MR. PLACITELLA:

14 Q. Can you answer my question?

15 A. I'm not sure what it was.

16 Q. Did you ever -- did you ever

17 learn that Engelhard scientists testified

18 under oath concerning the testing of Emtal

19 talc for asbestos?

20 A. Yes.

21 Q. And when was the first time you

22 learned that?

23 A. I don't know.

24 Q. Okay. Did you, at some point,

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 20 of 330 PageID:

43609
Page 20

1 learn that Engelhard scientists testified

2 under oath that there were testing results

3 indicating that there was, in fact, asbestos

4 in Emtal talc?

5 MR. FARRELL: Objection to form

6 and foundation.

7 THE WITNESS: Was this a when

8 question, or did?

9 BY MR. PLACITELLA:

10 Q. Did. Did first?

11 A. What was the question, did I...

12 Q. Did there come a time when you

13 learned that Engelhard scientists testified

14 under oath that there were testing results

15 indicating that there was asbestos in Emtal

16 talc?

17 MR. FARRELL: Objection to form

18 and foundation.

19 BY MR. PLACITELLA:

20 Q. You can answer it.

21 A. I believe there -- I believe

22 there was such a time, yes.

23 Q. And when was that?

24 A. I don't recall.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 21 of 330 PageID:

43610
Page 21

1 Q. Do you not remember? Was it in

2 the early '80s, the late '80s, the '90s?

3 MR. FARRELL: Objection to

4 form.

5 BY MR. PLACITELLA:

6 Q. Do you have an estimate?

7 A. Not -- no, I don't.

8 Q. Okay. Do you know who David Hyde

9 is or was?

10 A. Yes.

11 Q. And who was he?

12 A. He was a senior partner at Cahill

13 Gordon and Reindel.

14 Q. All right. And what -- what

15 was -- did you have dealings with him in your

16 capacity as general counsel?

17 A. I did, yes.

18 Q. And what was the nature of those

19 dealings?

20 A. Well, he represented Engelhard in

21 a number of matters. And in support of the

22 litigation, I talked to him frequently.

23 Q. Okay. And do you recall when --

24 if there was a time when he supplied you with

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 22 of 330 PageID:

43611
Page 22

1 a memo related to the testing of Emtal talc?

2 MR. FARRELL: Objection to

3 form.

4 MR. MARINO: Is the question

5 did he ever provide Mr. Dornbusch with --

6 MR. PLACITELLA: Right.

7 MR. MARINO: -- with such a

8 memo?

9 MR. PLACITELLA: Yeah.

10 THE WITNESS: Yes.

11 BY MR. PLACITELLA:

12 Q. Okay. And do you remember the

13 context of when and why you got that memo?

14 MR. FARRELL: Objection to

15 form.

16 THE WITNESS: No, I -- I had

17 completely forgotten until our previous

18 depositions revealed it.

19 BY MR. PLACITELLA:

20 Q. Okay. What recollection do you

21 have about getting that memo?

22 MR. FARRELL: Objection to form

23 and foundation; attorney-client privilege

24 to the extent it actually gets into the

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 23 of 330 PageID:

43612
Page 23

1 substance of the memo, the substance of

2 your commun -- the question is a bit

3 broad. So if it's a circumstances or

4 subject matter answer, that's acceptable.

5 But if it gets into the content of

6 communications between you and Mr. Hyde

7 or anybody at Cahill or the substance of

8 the memo itself, I would object on

9 privilege grounds.

10 MR. MARINO: And for clarity of

11 the record, that's a continuing objection

12 and continuing direction.

13 MR. PLACITELLA: Okay.

14 THE WITNESS: My recollection

15 of the -- my earliest recollection of

16 seeing it is when you showed it to me at

17 a previous deposition in the state

18 matter.

19 BY MR. PLACITELLA:

20 Q. Okay. And do you recall that --

21 have you seen it since then?

22 A. No.

23 Q. Okay. Do you -- do you remember

24 the circumstances under which you received

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 24 of 330 PageID:

43613
Page 24

1 that memo?

2 A. You mean originally?

3 Q. Yes.

4 A. No, I don't.

5 MR. PLACITELLA: Okay. Can you

6 give me P-1.

7 MR. FARRELL: While

8 Mr. Placitella is pulling that out,

9 Mr. Dornbusch, I would just remind you

10 that the deposition in the state matter

11 that you alluded to is protected by a

12 sealing order, which I think you

13 understand.

14 THE WITNESS: Uh-huh.

15 MR. FARRELL: So I just caution

16 you about speaking about the contents of

17 that deposition and the substance of it.

18 It is all under seal and cannot be

19 disclosed here, or anywhere else for that

20 matter. So I would just remind you of

21 the fact that your prior testimony is

22 covered by that sealing order.

23 MR. MARINO: Do you wish to

24 place on the record a statement

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 25 of 330 PageID:

43614
Page 25

1 indicating that to the extent there is

2 any disclosure during this deposition of

3 materials that would be covered by that

4 sealing order that they should be subject

5 to the sealing order?

6 MR. FARRELL: Yes. And I -- I

7 would hope we would not even go down that

8 road and that it would be inadvertent,

9 and that was part of why I thought it

10 would be useful just to remind everybody

11 of the ground rules.

12 BY MR. PLACITELLA:

13 Q. I put in front of you what's P --

14 been marked previous -- at previous

15 depositions as Exhibit 1, which is a copy of

16 a compilation that's represented to be what

17 was attached to the memo from Mr. Hyde to

18 yourself, minus the documents that are being

19 withheld on grounds of privilege. I ask if

20 you can just look at that for a second.

21 A. Okay.

22 Q. Does any of that look familiar to

23 you?

24 A. It looks familiar as -- as what

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 26 of 330 PageID:

43615
Page 26

1 you -- what I previously saw, yes.

2 Q. Okay. It was --

3 MR. TUNIS: Excuse me,

4 Mr. Dornbusch, could you keep your voice

5 up just a little bit.

6 THE WITNESS: Oh, I'm sorry.

7 Yes.

8 BY MR. PLACITELLA:

9 Q. Do you know how that memo was

10 constructed?

11 MR. FARRELL: Objection to

12 form.

13 BY MR. PLACITELLA:

14 Q. The circumstances under which it

15 was constructed?

16 A. I do not, no.

17 Q. All right. Do you know whether

18 someone from Cahill Gordon came to Engelhard

19 and looked at the records or whether the

20 records were sent to Cahill Gordon that are

21 the subject of that memo?

22 MR. FARRELL: Objection to

23 form.

24 THE WITNESS: I don't know.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 27 of 330 PageID:

43616
Page 27

1 BY MR. PLACITELLA:

2 Q. Okay. Do you know whether, when

3 you received that memo, it contained all of

4 the asbestos testing records or some of the

5 records?

6 MR. FARRELL: Objection to the

7 form.

8 THE WITNESS: I don't know.

9 BY MR. PLACITELLA:

10 Q. Okay. Do you -- do you know who

11 requested that that memo be prepared?

12 A. No.

13 Q. Was it requested by you? Do you

14 recall?

15 A. I don't recall.

16 Q. Okay. It's been represented from

17 the representative of BASF that that full

18 memo was found in your files.

19 Do you have any recollection

20 of that memo being in your files?

21 MR. MARINO: Objection to the

22 question. Can you show him what you're

23 talking about, please.

24 MR. PLACITELLA: Sure.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 28 of 330 PageID:

43617
Page 28

1 MR. FARRELL: Object to form

2 and foundation.

3 MR. PLACITELLA: Give me

4 Exhibit 13.

5 This is Exhibit 13, excerpts

6 from the deposition of Daniel Steinmetz.

7 MR. FARRELL: Do you have the

8 full testimony?

9 MR. PLACITELLA: No.

10 BY MR. PLACITELLA:

11 Q. And I'm going to refer you to

12 page 130 of the deposition.

13 A. 130?

14 Q. Yeah.

15 A. Mine -- mine just goes to

16 page 93.

17 Q. That's not good.

18 All right. Let's go to

19 page 82 then. It's the same thing.

20 On page 82, I asked a

21 corporate representative of BASF, Daniel

22 Steinmetz, about this document. And I -- and

23 I said, "That was found in -- when I say the

24 original version, the one you say you found

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 29 of 330 PageID:

43618
Page 29

1 in Mr. Dornbusch's file, correct?"

2 Answer: "Yes."

3 "Do you know the source of the

4 documents that are located in the original

5 version of P-15?"

6 Answer: "And by source, you

7 mean what?"

8 "Where they got the documents

9 from."

10 Answer: "Where Cahill

11 obtained the documents?"

12 Answer: "Yes."

13 "It was put together 40 years

14 ago. I don't know exactly what the source of

15 those documents were. I might" -- "I might

16 be able to tell you whether it was an

17 original document or a copy of an original or

18 what. I just don't know in every case."

19 Do you recall that document

20 being placed in your file at any point in

21 time?

22 MR. FARRELL: Objection to form

23 and foundation.

24 THE WITNESS: No.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 30 of 330 PageID:

43619
Page 30

1 BY MR. PLACITELLA:

2 Q. Okay. If you had that document

3 in your file, where would you keep it?

4 MR. FARRELL: Objection to

5 form; foundation.

6 THE WITNESS: Well, I -- it

7 would depend. If I -- if it was

8 something that I anticipated having an

9 ongoing need to refer to it, I would keep

10 it in my office files. I probably -- I

11 might write something in the upper corner

12 to indicate to my secretary what I

13 intended to call it. Or she might. I

14 might just give it to her -- I had a very

15 capable secretary -- and tell her that

16 I'm going to need this from time to time;

17 put it some place where you can find it.

18 BY MR. PLACITELLA:

19 Q. Well, what was her name?

20 A. Her name was Terry, Terry

21 Richards.

22 Q. Okay. Now, do you know -- so you

23 -- as you sit here today, you don't have a

24 present recollection of what you did with

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 31 of 330 PageID:

43620
Page 31

1 this memo when you received it; is that fair?

2 A. Correct. Yes.

3 MR. FARRELL: Objection to

4 form.

5 MR. MARINO: Objection to the

6 form of the question.

7 BY MR. PLACITELLA:

8 Q. Would that memo have been

9 transferred to BASF at the time that you

10 stopped working for Engelhard and went to

11 work for BASF?

12 MR. MARINO: Objection to

13 "would that." Is the question was it?

14 MR. FARRELL: Objection.

15 MR. PLACITELLA: You can

16 answer.

17 MR. FARRELL: Objection to form

18 and foundation.

19 THE WITNESS: I can't see any

20 reason why it wouldn't have been. I --

21 all -- all of the -- the intent was, they

22 -- they bought the company, they were

23 entitled to all of its files.

24 MR. PLACITELLA: Okay. Can you

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 32 of 330 PageID:

43621
Page 32

1 give me Exhibit 203.

2 MR. MARINO: Thank you.

3 MR. FARRELL: Thank you.

4 BY MR. PLACITELLA:

5 Q. I'm giving you Exhibit 203.

6 These are your disclosures in this case for

7 what you deem to be discoverable information.

8 And in your disclosures, you list Vernon

9 Hurst, and you -- and you say that his area

10 of knowledge is tests and inspections of the

11 mine in Johnson, Vermont; asbestos tests

12 and/or studies of Engelhard/BASF talc.

13 Do you see that?

14 A. I don't see what you just quoted

15 but --

16 Q. It's on page 8.

17 A. Oh.

18 Q. And I put it up there. Just...

19 A. Oh, yes, I see, Vernon Hurst.

20 Q. Okay. Now, this was supplied to

21 us by your counsel. Who was Vernon Hurst?

22 A. Vernon Hurst was the head of the

23 department of geology at the University of

24 Georgia. In fact, I believe he founded the

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 33 of 330 PageID:

43622
Page 33

1 department. And we had retained his services

2 as an expert witness in a patent litigation.

3 And so I knew -- I knew him and knew that he

4 had credentials as an expert in the area.

5 Q. Okay. And you say that he was

6 knowledgeable about tests and inspections of

7 the mine in Johnson, Vermont.

8 Did he make an inspection of

9 the Johnson, Vermont mine, to your knowledge?

10 A. Yes.

11 Q. Okay. And when was that?

12 A. I don't recall.

13 Q. Do you remember what -- what

14 decade it was? Was it the '80s, the '90s?

15 A. Not even that. I -- I really

16 don't know. I'd be guessing.

17 Q. Okay. And do you -- and it

18 further says, his -- I guess his tests and

19 inspections were about asbestos tests and/or

20 studies.

21 Do you know whether he ran any

22 tests related to the Johnson mine concerning

23 asbestos?

24 A. I don't know.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 34 of 330 PageID:

43623
Page 34

1 MR. FARRELL: Objection to --

2 objection to form. It was an, I don't

3 know?

4 MR. MARINO: If you could just

5 -- I'm sorry. If you could just leave a

6 little space after Mr. Placitella's

7 question to give counsel and --

8 THE WITNESS: Right.

9 MR. MARINO: -- myself an

10 opportunity to object.

11 THE WITNESS: Sorry.

12 MR. MARINO: It's all right.

13 THE WITNESS: I'm accustomed to

14 the previous deposition where there was

15 no privilege.

16 MR. FARRELL: Not a -- not a

17 problem.

18 BY MR. PLACITELLA:

19 Q. Okay. Do you know --

20 MR. FARRELL: And the answer

21 was "I don't know;" is that correct?

22 BY MR. PLACITELLA:

23 Q. Do you know whether Vernon Hurst

24 ever found that the Johnson mine was

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 35 of 330 PageID:

43624
Page 35

1 contaminated with asbestos?

2 MR. FARRELL: Objection to

3 form; foundation; privilege; work

4 product.

5 Mr. Dornbusch, I instruct you

6 not to answer the question.

7 BY MR. PLACITELLA:

8 Q. Could you answer that question,

9 sir, but for your instruction not to answer

10 it?

11 MR. MARINO: That's an improper

12 question. He's been instructed not to

13 answer. Next question.

14 BY MR. PLACITELLA:

15 Q. Okay. Could you answer that

16 question, sir?

17 MR. MARINO: Direction not to

18 answer that question.

19 BY MR. PLACITELLA:

20 Q. Sir, you've listed Mr. Hurst as

21 somebody with discoverable information

22 concerning asbestos tests.

23 What discoverable information

24 are you referring to?

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 36 of 330 PageID:

43625
Page 36

1 MR. MARINO: Mr. Dornbusch has

2 been directed not to answer the question

3 on the grounds of attorney-client

4 privilege.

5 He's now respecting that

6 direction.

7 BY MR. PLACITELLA:

8 Q. Different question. You've

9 listed in your Rule 26 disclosure the fact

10 that Vernon Hurst was knowledgeable about

11 asbestos testing.

12 What -- what was the -- what

13 was his knowledge?

14 MR. FARRELL: Objection to

15 form; foundation. Same instruction on

16 privilege and work product.

17 MR. PLACITELLA: How is it

18 privileged?

19 MR. FARRELL: You just asked

20 the witness what Vernon Hurst's knowledge

21 was regarding the testing of talc for

22 asbestos. That's the same question I

23 just instructed him to answer (sic) 30

24 seconds ago.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 37 of 330 PageID:

43626
Page 37

1 MR. PLACITELLA: How is that

2 privileged?

3 MR. FARRELL: Because he would

4 need to disclose the answer to the

5 question that I instructed him not to

6 answer.

7 MR. PLACITELLA: How is --

8 how's -- how is that? What's the basis

9 for that assertion?

10 MR. MARINO: He's being asked

11 to disclose information that exists by

12 virtue of the attorney-client

13 relationship. It's a confidential

14 relationship. You understand the

15 direction not to answer the question.

16 MR. PLACITELLA: No. I'm

17 asking Mr. Farrell what is the basis for

18 your assertion that that information is

19 privileged, given the fact that it was

20 disclosed as discoverable information by

21 Mr. Dornbusch in his Rule 26 disclosure.

22 MR. FARRELL: Well, first of

23 all, Mr. Dornbusch doesn't control this

24 privilege. BASF controls the privilege.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 38 of 330 PageID:

43627
Page 38

1 And BASF has not waived the privilege

2 over the substance of Mr. Hurst's work or

3 his communications with anybody at

4 Engelhard or Cahill regarding the

5 analysis he did.

6 So I can't speak to why

7 Mr. Dornbusch listed Mr. Hurst in his

8 initial disclosure. I can tell you he's

9 not capable of waiving that privilege.

10 He didn't waive the privilege. I've

11 asserted privilege over the substance of

12 Mr. Hurst's work and his communications

13 with Engelhard and Cahill.

14 I've instructed the witness

15 not to answer the question. So if you

16 have another question for the witness,

17 we can move to that question. But I

18 think I've addressed this issue.

19 MR. PLACITELLA: No. I want to

20 tease this out, because I need to go to

21 the Court.

22 BY MR. PLACITELLA:

23 Q. Can you show me where on your

24 privilege log Mr. Hurst is mentioned

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 39 of 330 PageID:

43628
Page 39

1 anywhere, because I couldn't find it.

2 MR. FARRELL: I don't have our

3 privilege log here today, Mr. Placitella.

4 Do you have a question for

5 Mr. Dornbusch?

6 MR. PLACITELLA: No. I want to

7 flesh this out, because this is an

8 important area.

9 MR. FARRELL: I'm not here to

10 flesh it out for you, sir. I've

11 explained the basis for my privilege

12 objection.

13 MR. PLACITELLA: No, I don't

14 really --

15 MR. FARRELL: Did you have a

16 question for the witness?

17 MR. PLACITELLA: No. I have a

18 question for you. What is the basis for

19 your asserting privilege over what

20 Mr. Hurst found about asbestos in the

21 Johnson mine?

22 MR. FARRELL: I've just

23 explained it to you.

24 MR. PLACITELLA: What's that?

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 40 of 330 PageID:

43629
Page 40

1 MR. FARRELL: I've just

2 explained it to you. Do you have a

3 question for the witness?

4 MR. PLACITELLA: No, you didn't

5 explain it.

6 What is the basis for your

7 privilege?

8 MR. FARRELL: I've explained it

9 to you. Do you have a question for the

10 witness. I'm not the witness. Do you

11 have a question for Mr. Dornbusch?

12 BY MR. PLACITELLA:

13 Q. Mr. Dornbusch, was Dr. Hurst --

14 he is -- it was Dr. Hurst, correct?

15 A. Yes.

16 Q. Okay. And he was one of the

17 foremost authorities in the world in this

18 area of asbestos testing and geology?

19 A. I don't know that.

20 Q. Okay.

21 A. I -- I had retained him

22 originally for something very different.

23 Q. And what was the purpose of your

24 retainer of Dr. Hurst as related to Johnson

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 41 of 330 PageID:

43630
Page 41

1 mine?

2 MR. FARRELL: Objection to form

3 and foundation.

4 Are -- are you able to answer

5 that question, Mr. Dornbusch, without

6 getting into the substance of

7 communications between you and

8 Mr. Hurst -- anybody at Engelhard and

9 Mr. Hurst for that matter -- or Cahill

10 and Mr. Hurst?

11 THE WITNESS: No.

12 MR. FARRELL: Then I instruct

13 you not to answer the question on

14 privilege grounds.

15 BY MR. PLACITELLA:

16 Q. Was he retained as -- in

17 connection with litigation?

18 MR. FARRELL: Objection to form

19 and foundation.

20 THE WITNESS: I believe so.

21 BY MR. PLACITELLA:

22 Q. Okay. And when was that?

23 A. I don't recall.

24 MR. MARINO: Speak up a little

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 42 of 330 PageID:

43631
Page 42

1 bit, please.

2 THE WITNESS: I don't recall.

3 MR. MARINO: Thank you.

4 BY MR. PLACITELLA:

5 Q. And do you know why --

6 MR. FARRELL: Objection to --

7 BY MR. PLACITELLA:

8 Q. -- he was retained?

9 MR. FARRELL: Objection to

10 form; foundation; privilege; work

11 product.

12 I instruct you not to answer

13 the question.

14 MR. MARINO: It's a continuing

15 instruction not to answer questions that

16 would disclose confidential

17 communications between attorney and

18 client.

19 BY MR. PLACITELLA:

20 Q. Okay. Let me just go to the

21 record. Can you go to the first page of the

22 disclosure -- actually, page 2, under

23 identity of witnesses it says, "Pursuant to

24 Rule 26(a)(1)(A)(i) of the Federal Rules of

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 43 of 330 PageID:

43632
Page 43

1 Civil Procedure, subject to and without

2 waiving the limitations set forth above,

3 Dornbusch is presently aware of the

4 individuals set forth below who may have

5 discoverable information that he may use to

6 support his defenses in this lawsuit."

7 Do you see that?

8 A. I do.

9 Q. Do you know, after you submitted

10 this in this case, whether BASF ever took the

11 position before today that any of the

12 information that you were disclosing was

13 privileged?

14 MR. MARINO: Please do not

15 answer the question.

16 If you will, in drawing the

17 witness's attention to specified

18 information as you have highlighted on

19 the screen, if you could just scroll up

20 a little bit --

21 MR. PLACITELLA: Well --

22 MR. MARINO: -- and show him

23 the information that begins at the

24 paragraph immediately preceding. These

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 44 of 330 PageID:

43633
Page 44

1 disclosures are made subject to the

2 reservation of all privileges and

3 protections. Dornbusch's initial

4 disclosures are made without, in any way,

5 waiving the right to object to any

6 discovery request or to the admissibility

7 of any evidence on the grounds of

8 privilege, work product, et cetera, et

9 cetera.

10 BY MR. PLACITELLA:

11 Q. Okay. My question to you was,

12 before today, were you ever notified by BASF

13 that your disclosure of Dr. Hurst implicates

14 any kind of privilege.

15 MR. FARRELL: Objection.

16 MR. MARINO: How would -- how

17 would he learn that information? Do you

18 think he is in direct contact with BASF,

19 or do you think that would have been

20 information that he would have learned

21 from counsel.

22 BY MR. PLACITELLA:

23 Q. You can answer the question.

24 MR. MARINO: He cannot answer

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 45 of 330 PageID:

43634
Page 45

1 the question.

2 I direct you not to answer the

3 question.

4 MR. PLACITELLA: Okay.

5 MR. MARINO: That question

6 seeks the disclosure of information

7 between Mr. Dornbusch and myself. That

8 is a privilege that he controls. And

9 that is -- this is, based upon that

10 privilege, a direction not to answer that

11 inquiry.

12 BY MR. PLACITELLA:

13 Q. Okay. Where did the information

14 come from that you listed Vernon Hurst for on

15 page 8?

16 MR. FARRELL: Objection to form

17 and foundation.

18 Are you asking for the

19 identity of a person?

20 MR. PLACITELLA: No.

21 BY MR. PLACITELLA:

22 Q. What was the source of this? Is

23 this from your personal knowledge?

24 A. I -- I don't -- I don't know.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 46 of 330 PageID:

43635
Page 46

1 Q. Okay. Do you know why you

2 disclosed Mr. Hurst as somebody with

3 discoverable information?

4 MR. FARRELL: Objection to form

5 and foundation.

6 MR. MARINO: Again, when -- in

7 my experience, Mr. Placitella, when

8 initial disclosures are made pursuant to

9 the Federal Rules of Civil Procedure,

10 they are typically made subject to the

11 applicable privileges. Probing

12 Mr. Dornbusch with respect to the source

13 of this information threatens to invade

14 that privilege. And he's directed not to

15 answer.

16 BY MR. PLACITELLA:

17 Q. Do you have personal -- did this

18 information come from your personal

19 knowledge?

20 MR. FARRELL: Objection to form

21 and foundation.

22 MR. MARINO: Can you clarify

23 what you mean by "this information,"

24 please.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 47 of 330 PageID:

43636
Page 47

1 BY MR. PLACITELLA:

2 Q. The information listed Vernon

3 Hurst knows about testing and/or inspections

4 of the mine in Johnson, Vermont, asbestos

5 tests and/or studies of Engelhard/BASF's

6 talc.

7 MR. MARINO: Mr. Dornbusch has

8 disclosed his knowledge that Mr. Hurst

9 may be knowledgeable -- and I highlight

10 the words "may be knowledgeable" -- as to

11 tests and/or inspections of the mine in

12 Johnson, Vermont, asbestos tests and/or

13 studies of Engelhard/BASF's talc.

14 I don't want to burden the

15 record with this sort of back and forth.

16 But I think we know the purpose of Rule

17 26 disclosures. Mr. Dornbusch has

18 disclosed this information so that you

19 can take discovery with respect to

20 Mr. Hurst if you wish to do so; not so

21 that you can probe Mr. Dornbusch on

22 attorney-client privileged information.

23 BY MR. PLACITELLA:

24 Q. Do you know if Mr. Hurst --

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 48 of 330 PageID:

43637
Page 48

1 Dr. Hurst is still alive?

2 A. I don't know.

3 Q. No.

4 And if Dr. Hurst is, in fact,

5 dead, the only person who would have the

6 information would be yourself, correct?

7 MR. FARRELL: Objection to form

8 and foundation.

9 MR. MARINO: Same objection.

10 THE WITNESS: I don't know that

11 either.

12 BY MR. PLACITELLA:

13 Q. Do you know whether Dr. Hurst

14 authored any reports related to the

15 inspection of the Johnson mine or asbestos

16 testing?

17 MR. FARRELL: Objection to

18 form.

19 THE WITNESS: I'm not aware of

20 any, no.

21 BY MR. PLACITELLA:

22 Q. So whatever conversations you had

23 with Dr. Hurst were verbal?

24 MR. FARRELL: Objection to form

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 49 of 330 PageID:

43638
Page 49

1 and foundation.

2 THE WITNESS: Yes.

3 BY MR. PLACITELLA:

4 Q. Okay. And do you know why

5 those -- whatever report he gave you was only

6 verbal and never reduced to writing?

7 MR. FARRELL: Objection to form

8 and foundation.

9 Do you know the answer to that

10 question, Mr. Dornbusch?

11 THE WITNESS: I don't know.

12 I'd have to speculate.

13 MR. MARINO: Do not speculate.

14 THE WITNESS: Right.

15 BY MR. PLACITELLA:

16 Q. Okay. So if Dr. Hurst is, in

17 fact, dead and he provided you information

18 concerning asbestos testing of the Johnson

19 mine, and it wasn't in writing, the only

20 person -- the only source left to get that

21 information would be from you?

22 MR. FARRELL: Objection to form

23 and foundation.

24 BY MR. PLACITELLA:

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 50 of 330 PageID:

43639
Page 50

1 Q. Correct?

2 MR. FARRELL: Assumes facts.

3 THE WITNESS: I don't think

4 that's correct, no.

5 BY MR. PLACITELLA:

6 Q. What other source?

7 A. There would probably be people at

8 Cahill.

9 Q. And who would that be?

10 A. Probably Peter Sloane would know.

11 Q. Okay.

12 A. He may also have had personal

13 notes or records that would be part of his

14 files. I don't -- I don't recall.

15 Q. Okay. I'm sorry if I asked -- I

16 asked you this. I'm not sure. Do you know

17 whether he physically went to the Johnson

18 mine, Dr. Hurst?

19 A. I know, yes.

20 Q. And did he?

21 MR. FARRELL: Objection to

22 form. It's a -- just a yes or a no.

23 THE WITNESS: Yes.

24 BY MR. PLACITELLA:

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 51 of 330 PageID:

43640
Page 51

1 Q. Okay. And do you know what he

2 did at the Johnson mine?

3 MR. FARRELL: Objection to form

4 and foundation.

5 Is this something that you can

6 speak to at a high level subject matter?

7 Because as soon as we get into the

8 details, it implicates the privilege.

9 THE WITNESS: Uh-huh. I don't

10 know in detail what he did, no.

11 BY MR. PLACITELLA:

12 Q. Do you know generally what he

13 did?

14 A. I don't know everything that he

15 did. I know some of the things he did,

16 but...

17 Q. Which were what?

18 A. They would be covered by the

19 privilege.

20 MR. FARRELL: Objection to form

21 and --

22 MR. MARINO: Hold on a second,

23 please.

24 MR. FARRELL: The witness has

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 52 of 330 PageID:

43641
Page 52

1 indicated the answer would be covered by

2 privilege, so I instruct him not to

3 answer the question further.

4 BY MR. PLACITELLA:

5 Q. Do you know whether he went to

6 the Johnson mine with anybody but himself?

7 A. I don't know.

8 Q. Do you know whether he interacted

9 with anybody at the Johnson mine when he was

10 there?

11 A. I don't know.

12 Q. When he returned from the Johnson

13 mine, he provided you with a report; is that

14 fair?

15 MR. FARRELL: Objection to

16 form.

17 MR. MARINO: You're asking him

18 for a yes or no --

19 MR. PLACITELLA: Yeah.

20 MR. MARINO: -- response?

21 THE WITNESS: Yes.

22 MR. MARINO: Okay.

23 THE WITNESS: Yes.

24 BY MR. PLACITELLA:

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 53 of 330 PageID:

43642
Page 53

1 Q. Was any of the information that

2 you obtained from Dr. Hurst used in the

3 defense of an Emtal talc litigation?

4 MR. FARRELL: Objection to form

5 and foundation.

6 It's a yes or a no, I think,

7 Mr. Dornbusch.

8 THE WITNESS: I actually don't

9 know.

10 BY MR. PLACITELLA:

11 Q. Who would know that?

12 MR. FARRELL: Objection to

13 form; foundation.

14 THE WITNESS: The people

15 responsible for the defense of the talc

16 litigations.

17 BY MR. PLACITELLA:

18 Q. And who would that be?

19 A. The people at Cahill Gordon.

20 Q. Okay. Is it your belief that

21 Dr. Hurst also provided reports to people at

22 Cahill Gordon?

23 MR. FARRELL: Objection to

24 form.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 54 of 330 PageID:

43643
Page 54

1 THE WITNESS: Yes.

2 BY MR. PLACITELLA:

3 Q. Okay. And what's the basis for

4 that belief?

5 MR. FARRELL: Objection to

6 form.

7 THE WITNESS: Cahill was the

8 counsel coordinating our defense against

9 talc litigation in general. And this

10 would have been certainly part of the

11 overall facts regarding talc that they

12 would have needed to know.

13 BY MR. PLACITELLA:

14 Q. And do you understand that part

15 of the defense that was being asserted by

16 Cahill Gordon was that there was no evidence

17 of asbestos contamination in the Johnson

18 mine?

19 MR. FARRELL: Objection to

20 form.

21 MR. BOISE: Objection to form.

22 MR. FARRELL: Objection to form

23 and foundation.

24 MR. MARINO: Also, can you --

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 55 of 330 PageID:

43644
Page 55

1 can you put a time frame into the

2 question, please.

3 MR. PLACITELLA: At any point

4 in time.

5 MR. FARRELL: Same objections.

6 THE WITNESS: No, I did not.

7 BY MR. PLACITELLA:

8 Q. You never knew that?

9 A. I -- if I did, I've since

10 forgotten. I don't recall --

11 Q. Is the information --

12 A. -- all of that.

13 Q. -- obtained from Dr. Hurst

14 consistent with a position that there was no

15 evidence of asbestos contamination in the

16 Johnson mine?

17 MR. FARRELL: Objection to

18 form; foundation; privilege; work

19 product. I instruct him not to answer

20 the question.

21 BY MR. PLACITELLA:

22 Q. If Dr. Hurst provided you

23 information that was inconsistent with the

24 positions that were being asserted by your

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 56 of 330 PageID:

43645
Page 56

1 counsel, do you believe you had an obligation

2 to reveal that information?

3 MR. MARINO: Objection to the

4 form of the question.

5 MR. FARRELL: Objection to

6 form; foundation.

7 The -- you're asking him a

8 hypothetical about this?

9 MR. PLACITELLA: Yes, sir.

10 MR. FARRELL: Can you answer

11 the question, Mr. Dornbusch, without

12 implicating the content of Mr. Hurst --

13 Dr. Hurst's testing or any communications

14 between you and Cahill or other lawyers

15 for Engelhard in connection with the talc

16 litigation?

17 MR. MARINO: And without

18 speculating, if I may add that.

19 MR. FARRELL: Yeah, in my

20 question.

21 THE WITNESS: No.

22 MR. FARRELL: Then I instruct

23 you not to answer the question on

24 privilege grounds.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 57 of 330 PageID:

43646
Page 57

1 BY MR. PLACITELLA:

2 Q. So is it your understanding that

3 if Dr. Hurst provided you information that

4 was inconsistent with the position that you

5 were taking factually in litigation, that you

6 had no duty to disclose that?

7 MR. MARINO: The -- the

8 question has been -- the -- you -- you

9 understand that Mr. Dornbusch, in his

10 capacity as the general counsel of

11 Engelhard, is now asserting a privilege

12 at the direction of Engelhard's successor

13 in interest. You've asked the same

14 question that he's been directed not to

15 answer.

16 MR. PLACITELLA: I don't think

17 so. Can you answer that question?

18 MR. FARRELL: It was the same

19 question I had just instructed the

20 witness not to answer.

21 MR. PLACITELLA: That's fine.

22 BY MR. PLACITELLA:

23 Q. Do you know who Georgia Tech was?

24 A. The institution, yes.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 58 of 330 PageID:

43647
Page 58

1 Q. Okay. Do you know whether they

2 ever did any work for Engelhard concerning

3 the testing of Emtal talc?

4 A. I don't know.

5 Q. Okay. What was your first

6 involvement that you can recall with lawsuits

7 related to the talc at the Johnson mine?

8 MR. FARRELL: Objection to

9 form.

10 THE WITNESS: I'm not sure if

11 it was the first or not. But I was

12 aware -- the earliest recollection I have

13 today is of litigation in Rhode Island.

14 BY MR. PLACITELLA:

15 Q. Okay. And when was that?

16 A. That was pretty early on.

17 Probably in the '80s, mid -- early or mid

18 '80s.

19 Q. And were there cases -- do you

20 remember that being called the Westfall case?

21 A. I think that's right, yes.

22 Q. You filed Affidavits in that

23 case?

24 A. I don't know.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 59 of 330 PageID:

43648
Page 59

1 Q. Okay. And do you recall whether

2 there were cases filed against Engelhard

3 related to talc prior to Westfall?

4 MR. FARRELL: Objection to

5 form; foundation.

6 THE WITNESS: I do not recall.

7 BY MR. PLACITELLA:

8 Q. Okay. Do you know whether there

9 was ever any Workers' Compensation claims

10 related to talc filed against Engelhard?

11 MR. FARRELL: Objection to

12 form.

13 THE WITNESS: I don't know.

14 MR. PLACITELLA: Okay. Can you

15 give me 214 and 215.

16 BY MR. PLACITELLA:

17 Q. You have in front of you what's

18 been marked P-214, the first page is -- says

19 Engelhard Corporation, William Salling. Do

20 you see that?

21 A. Yes.

22 Q. Okay. And if you go to the third

23 page --

24 MR. TUNIS: Excuse me, Chris,

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 60 of 330 PageID:

43649
Page 60

1 do you intend to show it on the screen?

2 MR. PLACITELLA: Oh, I'm sorry.

3 BY MR. PLACITELLA:

4 Q. The third page -- I'll just do it

5 this way. There's a letter to a Mr. Lockman,

6 from the Royal Insurance Company dated

7 July 15th, 1985. Do you see that?

8 A. I do.

9 Q. Do you know -- do -- what was the

10 relationship between the Royal Insurance

11 Company and Engelhard in 1985, if you know?

12 MR. FARRELL: Objection to

13 form.

14 THE WITNESS: I -- I do not

15 know.

16 BY MR. PLACITELLA:

17 Q. Okay. Do you see where it says,

18 Re: File number, various versus Engelhard

19 Minerals and Chemical Corp.?

20 A. Yes.

21 Q. Okay. Do you know who

22 Mr. Lockman was?

23 A. No.

24 Q. Okay. Do you recall a

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 61 of 330 PageID:

43650
Page 61

1 relationship with Alexander and Alexander and

2 Engelhard while you were at Engelhard?

3 A. No.

4 Q. Okay. This letter -- do you know

5 who H.A. Rhule is, who authored the letter?

6 A. No.

7 Q. Okay. Here it says, Attached is

8 a copy of my April 1, 1985, letter to you. I

9 attach also a copy of April 11, 1985, letter

10 from Kenneth Brockman of Alexander and

11 Alexander. Your company was primary either

12 for the entire period of coverage under our

13 umbrella or your shared -- or you shared that

14 coverage with Aetna. I will write to them

15 for information about their coverage.

16 It says, Please advise on what

17 coverage is afforded by Royal Insurance

18 Company to Engelhard and also what action you

19 have taken to defend the insured. The

20 plaintiff's names are Leroy Kangas, Walter B.

21 Smith --

22 MR. MARINO: Weldon B. Smith.

23 BY MR. PLACITELLA:

24 Q. -- Weldon B. Smith, and William

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 62 of 330 PageID:

43651
Page 62

1 L. Salling.

2 Do you see that?

3 A. I do.

4 Q. A reference is made that Eastern

5 Magnesium Talc Company is a subsidiary of

6 Engelhard.

7 Do you see that?

8 A. Yes.

9 Q. All right. Does that refresh

10 your memory as to whether you were involved

11 in litigation involving Engelhard and talc

12 other than the Westfall case in the early

13 1980s?

14 MR. MARINO: You're asking if

15 this refreshes his recollection of that?

16 MR. PLACITELLA: Yeah.

17 MR. FARRELL: Objection to form

18 and foundation.

19 MR. MARINO: You may answer the

20 question.

21 THE WITNESS: No.

22 BY MR. PLACITELLA:

23 Q. Okay. And can you go to -- I'll

24 put it up here -- the page that's -- that's

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 63 of 330 PageID:

43652
Page 63

1 entitled May 20th, 1985.

2 MR. FARRELL: Which Bates page

3 is that, Chris?

4 BY MR. PLACITELLA:

5 Q. It's -- okay. It's 49428. This

6 one says, Dear Bob: Please refer to the

7 subject litigation. We've recently received

8 the request from one of the excess carriers

9 relevant to the status of the subject matter.

10 You will note that the matter was being

11 coordinated by the insured's counsel, Cahill

12 Gordon & Reindel, with -- and then it gives

13 you the address. And it says, We believe

14 Mr. Howard G. Sloane is the person familiar

15 with this litigation.

16 Do you see that?

17 A. Yes.

18 Q. Is that the Howard Sloane that

19 was in charge of the Engelhard litigation in

20 the early 1980s that you testified about?

21 MR. FARRELL: Objection to

22 form.

23 MR. TUNIS: Objection to form.

24 MR. MARINO: When you ask him,

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 64 of 330 PageID:

43653
Page 64

1 is that the Howard Sloane --

2 MR. PLACITELLA: Yeah.

3 MR. MARINO: -- could -- could

4 I ask you to observe the convention, when

5 refreshing one's recollection with a

6 document, which is to show that person

7 the document, to ask him to review the

8 document, and then to ask him if it

9 refreshes his recollection, rather than

10 simply reading the document into the

11 record before we've established whether

12 it does, in fact, refresh his

13 recollection.

14 BY MR. PLACITELLA:

15 Q. Is that the Howard -- the same

16 Howard Sloane that you testified to before?

17 MR. MARINO: You're asking if

18 Mr. Brockman is referring to the same

19 Howard Sloane? You're asking

20 Mr. Dornbusch if Mr. Brockman is

21 referring to the same Howard Sloane

22 Mr. Dornbusch referred to?

23 MR. PLACITELLA: You can

24 answer.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 65 of 330 PageID:

43654
Page 65

1 MR. FARRELL: Objection to form

2 and foundation.

3 MR. MARINO: Same objection.

4 THE WITNESS: I don't know who

5 Mr. Brockman is -- is referring to. I

6 know a Howard G. Sloane, we called him

7 Peter, at Cahill Gordon, who was

8 generally involved in defending Engelhard

9 from -- in talc litigation.

10 MR. PLACITELLA: Okay. Give me

11 215.

12 MR. MARINO: Thank you.

13 BY MR. PLACITELLA:

14 Q. I'm going to show you what's been

15 marked 215. It's Bates No. 50872.

16 MR. BOISE: Prefix Arrowood?

17 MR. PLACITELLA: Yeah.

18 BY MR. PLACITELLA:

19 Q. It's a January 24, 1985 letter

20 from Harriet Vasilopoulos.

21 Do you know who she is?

22 A. No.

23 Q. To Nancy Remundo.

24 Do you know who she was?

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 66 of 330 PageID:

43655
Page 66

1 A. No.

2 Q. Okay. And it's cc Paulette

3 Bynoe.

4 Do you see that?

5 A. Yes.

6 Q. Do you know who -- who she was?

7 A. No.

8 Q. What about Jesse Pagonis?

9 A. Jesse Pagonis was the Engelhard

10 employee who was responsible for risk

11 management.

12 Q. So when a claim came in, that was

13 under his purview?

14 A. Yeah. He --

15 MR. FARRELL: Objection to

16 form.

17 THE WITNESS: Yeah. He -- he

18 was responsible for all coordination with

19 the insurance carriers.

20 BY MR. PLACITELLA:

21 Q. Okay. And specifically, what was

22 his day-to-day responsibilities?

23 A. I'm not sure. He was responsible

24 to have an appropriate level of insurance in

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 67 of 330 PageID:

43656
Page 67

1 effect for the company.

2 Q. When a claim was -- when a case

3 was filed related to the Emtal talc

4 litigation, would he receive notice of that?

5 A. Yes.

6 MR. FARRELL: Objection to

7 form.

8 BY MR. PLACITELLA:

9 Q. And would he then communicate

10 that to the insurance carrier as part of his

11 job?

12 A. I -- I --

13 MR. FARRELL: Objection to

14 form.

15 THE WITNESS: -- I don't know.

16 BY MR. PLACITELLA:

17 Q. Do you know whether it was his

18 responsibility to communicate all lawsuits to

19 the insurance carrier related to Emtal talc?

20 MR. FARRELL: Objection to

21 form.

22 THE WITNESS: I would think so.

23 I don't know.

24 BY MR. PLACITELLA:

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 68 of 330 PageID:

43657
Page 68

1 Q. Now, do you see the -- the next

2 page, I've highlighted the third and fourth

3 names down. Leroy Kangas and Willia Salling.

4 Do you see that?

5 A. I do.

6 Q. Okay. Do you see where it talks

7 about ACC year all the way at the -- at the

8 end? Do you see the column, ACC --

9 A. Oh.

10 Q. -- YR? I'm sorry.

11 A. Yes. Yes.

12 Q. Okay. Do you know what that

13 stands for?

14 A. No.

15 Q. Is that something we'd have to

16 ask Jesse Pagonis?

17 MR. FARRELL: Objection to form

18 and foundation.

19 THE WITNESS: He -- he would

20 know more than I do on how to read this.

21 BY MR. PLACITELLA:

22 Q. Okay. Do you know whether the

23 findings of Dr. Hurst were ever communicated

24 to Jesse Pagonis?

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 69 of 330 PageID:

43658
Page 69

1 MR. FARRELL: Objection to form

2 and foundation.

3 THE WITNESS: I do not know.

4 BY MR. PLACITELLA:

5 Q. Should they have been in a normal

6 course of business?

7 MR. FARRELL: Objection to form

8 and foundation.

9 THE WITNESS: I'm -- I'm not

10 sure.

11 BY MR. PLACITELLA:

12 Q. Do you know whether the findings

13 of Dr. Hurst were ever communicated to

14 Engelhard's insurance carrier?

15 MR. FARRELL: Objection to form

16 and foundation.

17 THE WITNESS: I do not know.

18 BY MR. PLACITELLA:

19 Q. Should they have been in the

20 normal course of business?

21 MR. FARRELL: Same objections.

22 THE WITNESS: I don't know.

23 MR. PLACITELLA: Okay. Give me

24 Dornbusch-2.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 70 of 330 PageID:

43659
Page 70

1 BY MR. PLACITELLA:

2 Q. I'm going to show you what's been

3 marked -- pre-marked as Dornbusch-2. I

4 represent to you these are excerpts from the

5 BASF privilege log in this case. And I want

6 to just ask you some questions about that.

7 And if you can go to page --

8 MR. FARRELL: This is -- this

9 is something you made, Chris?

10 MR. PLACITELLA: Yes. I culled

11 it and made it.

12 BY MR. PLACITELLA:

13 Q. -- page 11. Oh, sorry. Page 11,

14 the entry --

15 MR. BOISE: Chris, is this -- I

16 don't have a copy of this. Is this

17 page 11 of the log or page 11 of your

18 culling?

19 MR. PLACITELLA: The culling,

20 right. What we did is we just sifted for

21 names, okay. But it's all the original

22 information.

23 MR. COREN: Actually, it's

24 page 1 of the exhibit. The numbers on

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 71 of 330 PageID:

43660
Page 71

1 the bottom all say 11.

2 MR. TUNIS: I'm sorry, it's

3 page 1 of.

4 MR. COREN: It's actually the

5 first page of the exhibit.

6 MR. MARINO: These are not

7 numbered pages.

8 MR. PLACITELLA: Correct.

9 MR. MARINO: I mean, they're

10 all -- they all are numbered 11.

11 MR. PLACITELLA: Well, that's

12 not good. So blame -- blame Mr. Coren.

13 MR. BOISE: You.

14 BY MR. PLACITELLA:

15 Q. So you see where it says

16 privilege number 873?

17 MR. MARINO: We'll make a note

18 of that.

19 MR. PLACITELLA: 873. He gave

20 me a --

21 MR. COREN: I actually sent him

22 the replacement that has the -- has the

23 data.

24 BY MR. PLACITELLA:

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 72 of 330 PageID:

43661
Page 72

1 Q. Do you want me to find it for

2 you?

3 A. No. I found it.

4 Q. Okay.

5 MR. FARRELL: So where -- where

6 are we then?

7 BY MR. PLACITELLA:

8 Q. Where it says privilege 873,

9 4/30/1984.

10 Do you see that?

11 A. I do, yes.

12 Q. And that's an exchange between --

13 MR. FARRELL: One -- one

14 moment, please. Would you give me the

15 priv entry again, please.

16 MR. PLACITELLA: 873.

17 MR. FARRELL: Are they -- are

18 these sorted by priv numbers?

19 MR. COREN: No. They're sorted

20 by date.

21 MR. BOYLE: It's 4/30/84.

22 MR. COREN: It's a tad easier

23 to read them and make sense of them.

24 MR. FARRELL: Okay. Thank you.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 73 of 330 PageID:

43662
Page 73

1 BY MR. PLACITELLA:

2 Q. This is an entry reflecting a

3 communication between Mr. Sloane, yourself,

4 and Mr. Halket.

5 Do you see that?

6 A. Yes.

7 Q. And it says, memo and attachment

8 relating to status report regarding Schwartz

9 litigation?

10 MR. MARINO: Transmitting

11 status.

12 BY MR. PLACITELLA:

13 Q. Transmitting. Do you see that?

14 A. Yes.

15 MR. MARINO: Regarding Schwartz

16 litigation.

17 BY MR. PLACITELLA:

18 Q. What's a status report, if you

19 know?

20 MR. FARRELL: Objection to

21 form.

22 THE WITNESS: A status report

23 would be a memorandum or a document of

24 some sort containing the current status

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 74 of 330 PageID:

43663
Page 74

1 of some matter.

2 BY MR. PLACITELLA:

3 Q. So can we glean from this entry

4 that as of April 30th, 1984, there was a case

5 pending relate -- called Swartz?

6 MR. FARRELL: Objection to

7 form.

8 THE WITNESS: It -- it would

9 appear that way.

10 BY MR. PLACITELLA:

11 Q. Okay. And underneath that, with

12 privilege entry 1516, there is an -- it

13 represents an exchange between yourself and

14 an L. Friedman. Who's L. Friedman?

15 MR. FARRELL: I think that's a

16 J. Friedman.

17 THE WITNESS: Yeah, I think --

18 MR. PLACITELLA: A J. Friedman.

19 THE WITNESS: I think it looks

20 like a J. But I don't recall any

21 Friedman.

22 BY MR. PLACITELLA:

23 Q. Okay. And it talks about

24 Dynatron/Bondo talc litigation.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 75 of 330 PageID:

43664
Page 75

1 Do you see that?

2 A. Yes.

3 Q. Were you involved in litigation,

4 to your recollection, in 1984 with Dynatron

5 corporation over the product Bondo?

6 MR. FARRELL: Objection to form

7 and foundation.

8 THE WITNESS: I have no

9 recollection of that.

10 BY MR. PLACITELLA:

11 Q. Does that appear to represent to

12 you that there were cases pending in 1984

13 related to the Dynatron Bondo talc

14 litigation?

15 MR. MARINO: Objection to the

16 form of the question.

17 MR. FARRELL: Objection.

18 Objection to form and foundation; calls

19 for speculation.

20 THE WITNESS: I mean, that --

21 all I can do is read what's here. It --

22 MR. MARINO: Right.

23 THE WITNESS: It says, Letter

24 regarding Dynatron/Bondo talc

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 76 of 330 PageID:

43665
Page 76

1 litigations.

2 BY MR. PLACITELLA:

3 Q. Right.

4 That wasn't the Westfall case,

5 correct?

6 MR. FARRELL: Objection to form

7 and foundation.

8 THE WITNESS: I don't know.

9 BY MR. PLACITELLA:

10 Q. Can you go down to entry 1561.

11 MR. TUNIS: Chris, if you could

12 put it back on the screen.

13 MR. PLACITELLA: Uh-huh. It's

14 up.

15 THE WITNESS: Yes.

16 BY MR. PLACITELLA:

17 Q. Do you see where it says

18 12/13/1985?

19 A. Yes.

20 Q. Okay. See where it says, Letter

21 containing attorney-client communications

22 regarding Smith versus Emtal litigation?

23 A. Yes.

24 Q. Does that indicate to you there

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 77 of 330 PageID:

43666
Page 77

1 was a case pending in 1985 called Smith?

2 MR. FARRELL: Objection to form

3 and foundation.

4 THE WITNESS: It would -- would

5 appear to do that, yes.

6 BY MR. PLACITELLA:

7 Q. And there was an exchange

8 concerning the Smith case between yourself

9 and Mr. Sloane, according to this, in

10 December 1985, correct?

11 MR. FARRELL: Objection to form

12 and foundation.

13 MR. MARINO: That's what the

14 privilege log says.

15 BY MR. PLACITELLA:

16 Q. Right?

17 A. That's what it says, yes.

18 Q. Okay. And if a representation

19 was -- do you know when the Westfall case

20 settled?

21 A. I don't know.

22 Q. Okay. Assume that's -- that it

23 settled in late 1983. Okay?

24 A. Okay.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 78 of 330 PageID:

43667
Page 78

1 Q. Does that entry indicate to you

2 that there was a case that was pending after

3 the Westfall case settled before 1987?

4 A. No.

5 MR. FARRELL: Objection to form

6 and foundation; calls for speculation.

7 MR. MARINO: I join in those

8 objections; and, in fact, to the entire

9 line of questioning about this. You're

10 just showing Mr. Dornbusch a privilege

11 log and reading him entries from the

12 privilege log.

13 THE WITNESS: Well, all I can

14 say is what's on the piece of paper. It

15 has a date, 12/13/85, and it refers to

16 litigation Smith versus Emtal.

17 BY MR. PLACITELLA:

18 Q. Okay. Now, in terms of your

19 responsibilities for the Emtal litigation,

20 were you in -- were you in charge of

21 overseeing and managing the litigation?

22 MR. FARRELL: Objection to

23 form.

24 THE WITNESS: I had delegated

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 79 of 330 PageID:

43668
Page 79

1 that responsibility to Cahill Gordon. I

2 was the company contact. I mean

3 eventually, I would -- ultimately, I

4 would receive reports from them on an

5 exception basis or I might ask for a -- a

6 routine report or an update. But I

7 wouldn't say that I was directly involved

8 in supervising the litigation.

9 BY MR. PLACITELLA:

10 Q. What -- when you say routine

11 report, what do you mean by that?

12 MR. FARRELL: Objection to

13 form.

14 THE WITNESS: Well, once -- I

15 don't know, maybe several times a year, I

16 might ask for an updated status report.

17 BY MR. PLACITELLA:

18 Q. Okay. And what would be the

19 subject of a status report? What would be

20 included, without divulging any privileged

21 communications?

22 A. Well, how many cases there were,

23 where they were, what the status -- how far

24 advanced they were, whether there had been

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 80 of 330 PageID:

43669
Page 80

1 any settlements made, that sort of thing.

2 Q. And did Cahill Gordon keep a

3 running account of that kind of information?

4 Do you know?

5 MR. FARRELL: Objection to

6 form.

7 THE WITNESS: I don't know what

8 they kept. They were generally on top of

9 all that.

10 BY MR. PLACITELLA:

11 Q. Okay. So if you asked them at

12 any point in time, for example, tell -- tell

13 me how many cases settled and for what, they

14 would be able to tell you that?

15 MR. FARRELL: Objection to form

16 and foundation.

17 THE WITNESS: They might have

18 to do a little work, but -- to pull it

19 together, but yes.

20 BY MR. PLACITELLA:

21 Q. Okay. So -- and who would be the

22 person in charge at Cahill Gordon who would

23 assemble that kind of information for you?

24 MR. FARRELL: Objection to

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 81 of 330 PageID:

43670
Page 81

1 form.

2 THE WITNESS: Well, I would

3 direct my request, probably, to Peter

4 Sloane.

5 MR. PLACITELLA: Okay.

6 THE WITNESS: But there was a

7 paralegal who was -- did a lot of that

8 sort of routine handling of data who

9 would probably have actually done the

10 work.

11 BY MR. PLACITELLA:

12 Q. Is that Michael Sullivan?

13 A. Yes.

14 Q. Okay. And would you, in your

15 reports, also receive information on cases

16 that were dismissed and the reason for

17 dismissals?

18 MR. FARRELL: Objection to

19 form; foundation.

20 THE WITNESS: Yes.

21 BY MR. PLACITELLA:

22 Q. Okay. And is that the kind of

23 information that Cahill Gordon would keep

24 record of --

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 82 of 330 PageID:

43671
Page 82

1 MR. FARRELL: Objection.

2 BY MR. PLACITELLA:

3 Q. -- and that you could access if

4 you needed it?

5 MR. FARRELL: Objection to form

6 and foundation.

7 THE WITNESS: Yes.

8 BY MR. PLACITELLA:

9 Q. Okay. Now, when you received

10 these status reports, what was done with them

11 physically after you read them?

12 MR. FARRELL: Objection to

13 form.

14 THE WITNESS: I'm not -- not

15 sure. I imagine I filed them.

16 BY MR. PLACITELLA:

17 Q. Okay. And where would you file

18 them?

19 A. I'd give them to my secretary and

20 she probably had a file called talc

21 litigation status reports, something like

22 that.

23 Q. Okay. And I'm sorry if you told

24 me this, but how often would you get them?

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 83 of 330 PageID:

43672
Page 83

1 MR. FARRELL: Objection to

2 form.

3 THE WITNESS: Probably two,

4 maybe three times a year.

5 BY MR. PLACITELLA:

6 Q. Okay. Would Engelhard keep its

7 own record of the cases that were settled or

8 dismissed?

9 MR. FARRELL: Objection to

10 form.

11 THE WITNESS: I don't think so.

12 MR. PLACITELLA: Okay.

13 MR. MARINO: Chris, we've been

14 going a little bit more than an hour. Do

15 you think Mr. Dornbusch might have a

16 five-minute break?

17 MR. PLACITELLA: Absolutely.

18 Any time you want.

19 MR. MARINO: Thank you very

20 much.

21 MR. PLACITELLA: Any time you

22 want.

23 MR. MARINO: Thank you.

24 THE VIDEOGRAPHER: The time is

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 84 of 330 PageID:

43673
Page 84

1 now 10:12 a.m. We're going off the

2 record.

3 (Whereupon, there was a

4 discussion held off the record.)

5 (Whereupon, a brief recess was

6 taken.)

7 THE VIDEOGRAPHER: The time is

8 now 10:20 a.m. We are back on the

9 record.

10 BY MR. PLACITELLA:

11 Q. Do you have a general

12 recollection of other cases in addition to

13 Westfall being -- pending around that time?

14 MR. FARRELL: Objection to

15 form; foundation.

16 THE WITNESS: No, not really.

17 BY MR. PLACITELLA:

18 Q. Okay. And other than receiving

19 status reports from Cahill, what other

20 interaction did you have with Cahill related

21 to the Emtal litigation generally?

22 MR. FARRELL: Objection to

23 form. I think Mr. Dornbusch should just

24 be limited to category subject matter,

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 85 of 330 PageID:

43674
Page 85

1 something high level, while preserving

2 any applicable privileges.

3 THE WITNESS: Uh-huh. Nothing

4 specific. Cahill Gordon represented us

5 in a number of matters. And with

6 litigation, it would be the same team of

7 lawyers, so it was not uncommon for me to

8 have a meeting with somebody like Peter

9 Sloane and go over everything they were

10 doing for us at that time.

11 BY MR. PLACITELLA:

12 Q. Okay. In the context of the talc

13 litigation, would you receive copies of

14 depositions of Engelhard executives when they

15 were deposed --

16 MR. FARRELL: Objection to

17 form.

18 BY MR. PLACITELLA:

19 Q. -- as a matter of course?

20 A. Either I would or -- or someone

21 on my staff would.

22 Q. Okay. And would you receive

23 copies of Engelhard -- signed deposition of

24 copies -- strike that.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 86 of 330 PageID:

43675
Page 86

1 Would you receive copies of

2 depositions of Engelhard scientists who were

3 deposed?

4 MR. FARRELL: Objection to

5 form.

6 THE WITNESS: Someone at

7 Engelhard would, yes.

8 BY MR. PLACITELLA:

9 Q. Okay. I want to just ask you

10 some questions about the lawyers at -- in the

11 legal department who worked on the talc

12 litigation. Were there lawyers that worked

13 under you at some point that were assigned to

14 the Emtal talc litigation at Engelhard?

15 A. Well, not to the litigation per

16 se, but to the general talc business. I know

17 Tom Halket was involved. I don't know if

18 anyone -- if there was someone before or

19 after Tom. But I know Tom -- Tom was

20 involved.

21 Q. And what were -- as it related to

22 the talc litigation, what were his

23 responsibilities?

24 A. Well, to ensure that Cahill had

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 87 of 330 PageID:

43676
Page 87

1 everything they needed from us to conduct the

2 defense and to -- well, that was basically

3 it, make sure that they didn't -- if -- if

4 they needed anything, that they got it.

5 Q. Did he attend depositions?

6 MR. FARRELL: Objection to

7 form.

8 THE WITNESS: I think he did.

9 BY MR. PLACITELLA:

10 Q. Okay. And do you remember

11 when -- at what point in time Tom Halket left

12 Engelhard?

13 A. I -- I remember that it was early

14 in January of some year. Which year, I don't

15 know. But the reason I remember, we -- there

16 was a discussion about his bonus for the

17 previous year.

18 Q. Did you give him a good one?

19 You don't have to answer that.

20 A. No. We gave him whatever we

21 would have given him. He worked for the full

22 year.

23 Q. Okay. And who is Lester Fliegel?

24 A. Les was an associate general

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 88 of 330 PageID:

43677
Page 88

1 counsel under me. He was probably -- I think

2 he was the most senior lawyer, other than

3 myself, in the legal department.

4 Q. And did he work on the Emtal talc

5 litigation?

6 A. Not to my recollection.

7 Q. Okay. Do you know whether Tom

8 Halket, when he worked at Engelhard, was

9 aware of the findings of Dr. Hurst?

10 MR. FARRELL: Objection to

11 form.

12 THE WITNESS: I don't know.

13 BY MR. PLACITELLA:

14 Q. Okay. What about a Mr. Hassett,

15 do you recall him?

16 A. Oh, yes.

17 Q. Okay. And did he work on the

18 talc litigations?

19 A. I don't think so.

20 Q. Okay. Was there a paralegal who

21 was assigned to the talc litigation inside of

22 Engelhard?

23 A. No.

24 Q. Who was physically in charge of

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 89 of 330 PageID:

43678
Page 89

1 the talc litigation files at Engelhard?

2 MR. FARRELL: Objection to

3 form; foundation.

4 THE WITNESS: Well, it assumes

5 that there were talc litigations files as

6 such. Halket would have kept his own

7 files related to the business. I would

8 have done the same. At -- at some point,

9 as it became more and more dated, those

10 files would have gone to off-site

11 storage.

12 BY MR. PLACITELLA:

13 Q. So let's assume, for example, a

14 deposition is transferred from Cahill to

15 your -- your offices -- and when I say your

16 offices, I mean the legal department at

17 Engelhard --

18 A. Uh-huh.

19 Q. -- what typically would be done

20 with that deposition?

21 MR. TUNIS: Objection to form.

22 MR. FARRELL: Objection to form

23 and foundation.

24 THE WITNESS: Well, I can tell

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 90 of 330 PageID:

43679
Page 90

1 you what I would do. I don't know -- I

2 imagine what Tom would do would have been

3 very similar. I just put it in a file,

4 labeled Hemstock deposition or whoever it

5 was. And it would be a subfile of the

6 Emtal talc litigation.

7 BY MR. PLACITELLA:

8 Q. Okay. And where would that be

9 physically located?

10 A. It would have been in the -- the

11 legal department for a time. And as it got

12 older, it would have gone to off-site

13 storage.

14 Q. Okay. And where in the legal

15 department physically?

16 MR. FARRELL: Objection to

17 form.

18 THE WITNESS: Well, my office

19 was on the tenth floor of the building.

20 I shared a file room with the HR people.

21 And it would have been in there, in our

22 files. In the legal department, they had

23 their own files in the wall, you know,

24 lining the halls.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 91 of 330 PageID:

43680
Page 91

1 BY MR. PLACITELLA:

2 Q. Okay. I want to talk to you a

3 little bit about the responsibilities of

4 Cahill.

5 Now, you hired them as

6 national counsel; is that fair?

7 A. I don't think I used that title,

8 but yes.

9 Q. Okay.

10 A. I mean, that's the role they

11 played.

12 Q. And what was their -- what were

13 their responsibilities generally as national

14 counsel in the Emtal talc litigation?

15 MR. FARRELL: Objection to

16 form.

17 THE WITNESS: Well, to

18 coordinate our defense in cases that came

19 up, wherever -- wherever they came up in

20 different states.

21 BY MR. PLACITELLA:

22 Q. If discovery responses were

23 prepared in a particular case, would they be

24 reviewed by in-house legal department, excuse

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 92 of 330 PageID:

43681
Page 92

1 me, at Engelhard before they went out?

2 MR. FARRELL: Objection to

3 form; foundation.

4 THE WITNESS: Probably not.

5 Not in the latter stages, when it be --

6 at the point where it became fairly

7 routine, I would think not.

8 BY MR. PLACITELLA:

9 Q. So at what point was that, where

10 it became fairly routine?

11 A. When there --

12 MR. FARRELL: Objection to form

13 and foundation.

14 THE WITNESS: Yeah. I'm sorry.

15 When there were more than just a handful.

16 BY MR. PLACITELLA:

17 Q. So at that point, if some -- if

18 Answers to Interrogatories were prepared, for

19 example, in a case, they would not be

20 reviewed by any -- how -- anyone in-house, in

21 the in-house legal department? Is that what

22 you're saying?

23 MR. FARRELL: Objection to form

24 and foundation.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 93 of 330 PageID:

43682
Page 93

1 THE WITNESS: Not unless there

2 was something that was unique about them.

3 BY MR. PLACITELLA:

4 Q. Okay. And who developed the

5 defense strategy for the Emtal talc

6 litigation?

7 MR. FARRELL: Objection to

8 form.

9 THE WITNESS: Well, to the

10 extent that there was an overall

11 strategy, I guess you would say it

12 would -- would have been me, working in

13 conjunction with Cahill.

14 BY MR. PLACITELLA:

15 Q. Okay. And who made the selection

16 of local counsel to work on the Emtal talc

17 litigation?

18 A. Cahill Gordon.

19 Q. Okay.

20 A. With -- with my blessing.

21 Q. Okay. Was local counsel able to

22 take a position in litigation about facts --

23 factual information without your approval?

24 MR. FARRELL: Objection to form

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 94 of 330 PageID:

43683
Page 94

1 and foundation.

2 THE WITNESS: Yes.

3 BY MR. PLACITELLA:

4 Q. Were they able to take a position

5 in litigation concerning factual information

6 without approval from Cahill Gordon?

7 MR. FARRELL: Same objections.

8 THE WITNESS: I would think

9 not.

10 MR. PLACITELLA: Okay.

11 THE WITNESS: I hope not.

12 BY MR. PLACITELLA:

13 Q. Did you authorize Cahill Gordon

14 to send letters to plaintiffs' counsel

15 related to the Emtal talc litigation?

16 MR. FARRELL: Objection to form

17 and foundation.

18 MR. MARINO: Are you asking as

19 a general matter?

20 MR. PLACITELLA: Yes.

21 THE WITNESS: In general, I

22 would consider that part of defending the

23 company, yes.

24 BY MR. PLACITELLA:

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 95 of 330 PageID:

43684
Page 95

1 Q. Okay. Would you authorize, in

2 general, letters sent by Cahill Gordon,

3 making representation concerning the

4 availability of evidence in the Emtal talc

5 litigation?

6 MR. FARRELL: Objection to form

7 and foundation.

8 THE WITNESS: Only as part of

9 their general representation of the

10 company.

11 BY MR. PLACITELLA:

12 Q. Okay. Would they make you aware

13 of representations they were making

14 concerning the availability of evidence in

15 the Emtal talc litigation?

16 MR. FARRELL: Same objections.

17 Can I have the question,

18 please.

19 (Whereupon, the court reporter

20 read back the record as requested.)

21 MR. FARRELL: This is just a

22 generic subject-matter-type question,

23 Mr. Dornbusch, not anything specific or

24 specific communications.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 96 of 330 PageID:

43685
Page 96

1 THE WITNESS: Uh-huh. Probably

2 not, unless there was something unique.

3 BY MR. PLACITELLA:

4 Q. When you say "unique," what do

5 you mean by that?

6 A. Something different, something

7 out of the ordinary.

8 Q. I'm not sure what you mean by

9 "out of the ordinary." Could you explain?

10 MR. FARRELL: Objection to

11 form.

12 BY MR. PLACITELLA:

13 Q. Give me an example if you can

14 or --

15 A. Well, there were literally

16 hundreds of cases. If there was something

17 that appeared in one but not in 99 others, I

18 would expect them to make me aware of it.

19 Q. Okay.

20 A. But if it just fell into the same

21 pattern, I wouldn't.

22 Q. Were they authorized to serve

23 responses to written discovery on behalf of

24 Engelhard? When I say "they," I mean Cahill

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 97 of 330 PageID:

43686
Page 97

1 Gordon.

2 A. Yes.

3 MR. FARRELL: Objection to

4 form.

5 BY MR. PLACITELLA:

6 Q. Okay. Were they permitted to

7 serve answers to written discovery without

8 your approval?

9 MR. FARRELL: Objection to form

10 and foundation.

11 BY MR. PLACITELLA:

12 Q. Your expressed approval on a

13 specific case.

14 MR. FARRELL: Objection to form

15 and foundation.

16 THE WITNESS: Yes.

17 BY MR. PLACITELLA:

18 Q. Did they have direct access --

19 when I say "they," I mean Cahill Gordon. Did

20 they have direct access to Engelhard

21 executives or research scientists in order to

22 respond to discovery in the Engelhard talc

23 litigation?

24 MR. FARRELL: Objection to

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 98 of 330 PageID:

43687
Page 98

1 form; foundation.

2 THE WITNESS: To -- to the

3 extent they needed it, yes.

4 BY MR. PLACITELLA:

5 Q. Okay. And that's not something

6 they would have to go through the legal

7 department for?

8 MR. FARRELL: Objection to form

9 and foundation.

10 THE WITNESS: They wouldn't

11 have to go through the legal department,

12 especially once they had established who

13 the right people were to -- to give them

14 the information they required. But as a

15 practical matter, they probably would.

16 BY MR. PLACITELLA:

17 Q. Okay. Who made the

18 recommendations to Cahill Gordon as to the

19 source of information that was required to

20 answer discovery in the talc litigation? Who

21 at Engelhard?

22 MR. FARRELL: Objection to form

23 and foundation.

24 THE WITNESS: Well, initially,

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 99 of 330 PageID:

43688
Page 99

1 either I would or Tom Halket. It would

2 have been a lawyer who would have

3 directed them to the right person,

4 probably in -- in research.

5 BY MR. PLACITELLA:

6 Q. Okay. Did you ever direct, for

7 example -- scratch that.

8 You have a recollection that

9 Dr. Hemstock testified in the Westfall case?

10 MR. FARRELL: Objection to

11 form.

12 THE WITNESS: I don't have a

13 recollection. I'm not surprised to hear

14 it, yes.

15 BY MR. PLACITELLA:

16 Q. All right. And he was the head

17 of research and development?

18 A. Yes. Yes, he was.

19 Q. Okay. And did you know who on

20 Emil Triglia was?

21 A. Yes.

22 Q. And who was he?

23 A. He, I think, was -- had a senior

24 position with the unit in research that did

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 100 of 330 PageID:

43689
Page 100

1 testing and that kind of thing.

2 Q. Okay. And Peter Gale, do you

3 know who he is?

4 A. I know the name, but I don't

5 know -- and I think he was a former employee.

6 But I don't know what he did when he was

7 there.

8 Q. Okay. Do you have a recollection

9 of making Dr. Hemstock or Dr. Triglia

10 available to the Cahill Gordon firm to

11 provide information to respond to discovery

12 in the Emtal talc litigation?

13 MR. FARRELL: Objection to form

14 and foundation.

15 THE WITNESS: No.

16 BY MR. PLACITELLA:

17 Q. Okay. Would that have been

18 something -- well, strike that.

19 Did Dr. Hemstock have

20 information relevant to the testing of Emtal

21 talc to your knowledge?

22 MR. FARRELL: Objection to form

23 and foundation.

24 THE WITNESS: I believe he did.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 101 of 330 PageID:

43690
Page 101

1 BY MR. PLACITELLA:

2 Q. What about Dr. Triglia?

3 MR. FARRELL: Same objections.

4 THE WITNESS: I think he

5 probably did.

6 BY MR. PLACITELLA:

7 Q. Okay. Was -- was the information

8 that was in the possession of Dr. Hemstock

9 and Dr. Triglia concerning the testing of

10 Emtal talc made available to Cahill Gordon in

11 order to respond to discovery requests?

12 MR. BOISE: Object to the form

13 of the question; foundation.

14 THE WITNESS: I would -- I

15 would assume that it was.

16 BY MR. PLACITELLA:

17 Q. All right. And how would that

18 information be made available?

19 MR. BOISE: Same objections.

20 THE WITNESS: Well, I -- I

21 don't know. It would depend. They would

22 probably come out, meet with the person,

23 talk to him. If there was a paper copy

24 of something that they had done, they'd

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 102 of 330 PageID:

43691
Page 102

1 give a copy of it to Cahill.

2 MR. TUNIS: I'm going to object

3 to the answer to the extent that it seems

4 clear the witness's answer is based on

5 assumptions rather than on a

6 recollection.

7 THE WITNESS: That's true.

8 BY MR. PLACITELLA:

9 Q. Do you have any evidence that

10 after the Westfall case the identity of

11 either Dr. Hemstock or Dr. Triglia were ever

12 made known in any case involving Engelhard

13 talc?

14 MR. FARRELL: Objection to form

15 and foundation.

16 THE WITNESS: I -- I have no --

17 no such information.

18 BY MR. PLACITELLA:

19 Q. Okay. I want to ask you some

20 questions about -- some additional questions

21 about the reporting requirements that you

22 imposed on the Cahill Gordon firm as it

23 relates to the talc litigation.

24 Did they have any direct --

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 103 of 330 PageID:

43692
Page 103

1 when I say "they," I mean Cahill Gordon --

2 direct contact with your insurance carriers

3 related to the talc litigation?

4 MR. FARRELL: Objection to

5 form.

6 THE WITNESS: I'm not sure.

7 BY MR. PLACITELLA:

8 Q. Okay. Did they have any direct

9 contact with the auditors for Engelhard

10 related to the talc litigation?

11 MR. FARRELL: Objection to

12 form.

13 THE WITNESS: They would be

14 made available to the auditors on a

15 regular basis. And the auditors would --

16 were free to ask them whatever questions

17 they wanted. I believe they did that

18 without me present, at their request,

19 probably.

20 BY MR. PLACITELLA:

21 Q. Do you have a name of a person

22 who -- at the auditor who they would interact

23 with?

24 A. That changed from time to time.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 104 of 330 PageID:

43693
Page 104

1 We had Arthur Anderson at the beginning of my

2 tenure. They had a conflict. And we then

3 had -- I think we may have had

4 Pricewaterhouse. Later we had Coopers &

5 Lybrand. And I'm not very good with names.

6 I don't remember who the person was. There

7 was a Robin Amesbury at one of point who was

8 our contact. But I -- I'm not sure what

9 company he was with.

10 Q. What kind of information,

11 generally, would they be required to provide

12 the auditors as related to the talc

13 litigation?

14 MR. FARRELL: Objection to form

15 and foundation.

16 THE WITNESS: I don't know.

17 I -- they were -- their instructions were

18 to answer any questions they were asked.

19 The auditors were generally interested in

20 litigation that could have a significant

21 financial impact on the corporation and

22 on the defenses that were being asserted.

23 And they'd always try to get a likelihood

24 of success prognosis, that sort of thing.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 105 of 330 PageID:

43694
Page 105

1 BY MR. PLACITELLA:

2 Q. And who at Cahill Gordon would be

3 the person, if you know, that was the point

4 on that exchange with your auditors?

5 A. Certainly Peter Sloane in later

6 years. At the beginning of the period, when

7 people was more junior, I don't know. It

8 might have been Ike Cohen himself or possibly

9 David Hyde.

10 Q. Okay. And was the likelihood of

11 future similar Engel -- Emtal cases something

12 that would have been required to be disclosed

13 by Cahill to the auditors?

14 MR. FARRELL: Objection to form

15 and foundation.

16 MR. BOISE: Objection to form.

17 THE WITNESS: I don't know.

18 BY MR. PLACITELLA:

19 Q. Before a case was settled, did

20 Cahill Gordon have to get authorization from

21 somebody in-house at Engelhard?

22 MR. FARRELL: Objection to form

23 and foundation.

24 BY MR. PLACITELLA:

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 106 of 330 PageID:

43695
Page 106

1 Q. If you know.

2 A. Yes.

3 Q. Okay. And who would that person

4 be? Who would they get the authorization

5 from?

6 MR. FARRELL: Objection to form

7 and foundation.

8 THE WITNESS: They'd get it

9 from me.

10 BY MR. PLACITELLA:

11 Q. Okay. Would they have to provide

12 you with a reason for their recommendation

13 for a particular settlement amount?

14 MR. FARRELL: Objection to form

15 and foundation.

16 THE WITNESS: We'd have a

17 discussion about it.

18 BY MR. PLACITELLA:

19 Q. Okay. And were records kept

20 concerning the settlements and the reasons

21 for the settlements --

22 MR. FARRELL: Objection to form

23 and foundation.

24 BY MR. PLACITELLA:

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 107 of 330 PageID:

43696
Page 107

1 Q. -- as it relates specifically to

2 the Engelhard talc litigation?

3 MR. FARRELL: Same objections.

4 THE WITNESS: Not to my

5 knowledge.

6 BY MR. PLACITELLA:

7 Q. Okay. Did Cahill Gordon have a

8 defense budget for their -- for the defense

9 of the talc litigation?

10 MR. FARRELL: Objection to

11 form.

12 THE WITNESS: No.

13 BY MR. PLACITELLA:

14 Q. So their budget was unlimited?

15 MR. PLACITELLA: Objection to

16 form.

17 THE WITNESS: Yes.

18 BY MR. PLACITELLA:

19 Q. Okay. In terms of -- how did the

20 billing occur, just for the talc litigation?

21 MR. FARRELL: Objection to form

22 and foundation.

23 BY MR. PLACITELLA:

24 Q. If you know.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 108 of 330 PageID:

43697
Page 108

1 A. Well, we would receive a bill

2 monthly. And there would be -- when I say a

3 bill, there would be actually a series of

4 bills, a separate one for each matter. And

5 there would be a general memorandum that

6 would summarize the work that was done for

7 each matter. Talc -- the talc litigation

8 would be one of them.

9 And I would review those. If

10 I had any questions, I would discuss it with

11 Cahill and then approve it for payment.

12 Q. Okay. And when that bill was

13 approved for payment, where did it physically

14 go?

15 MR. FARRELL: Objection to form

16 and foundation.

17 THE WITNESS: To accounts

18 payable, I guess.

19 BY MR. PLACITELLA:

20 Q. Okay. And who was that person in

21 charge, if you remember?

22 A. I don't know.

23 Q. Okay. And do you know what

24 ultimately happened to the bills that were

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 109 of 330 PageID:

43698
Page 109

1 submitted?

2 MR. FARRELL: Objection to

3 form.

4 THE WITNESS: No, I don't.

5 BY MR. PLACITELLA:

6 Q. Did the counts -- the accounts

7 payable have a separate ledger for the

8 defense of the Emtal talc litigation?

9 MR. FARRELL: Objection to

10 form; foundation.

11 THE WITNESS: I don't know.

12 BY MR. PLACITELLA:

13 Q. Did accounts payable ever provide

14 you with summaries of what the legal defense

15 costs were for the defense of the Emtal talc

16 litigation?

17 MR. FARRELL: Objection to

18 form.

19 THE WITNESS: I received a

20 number of things from our finance people

21 that consisted of the -- I call them IBM

22 printouts, but it was -- in those days,

23 you got things on paper with perforations

24 on both margins. And it would have an

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 110 of 330 PageID:

43699
Page 110

1 analysis of legal department

2 expenditures. I believe it was probably

3 broken down, litigation costs were

4 probably broken down by matter.

5 I didn't pay much attention to

6 it because I had reviewed it in more

7 detail on a monthly basis.

8 BY MR. PLACITELLA:

9 Q. Were they permanent business

10 records that -- reports that you're referring

11 to?

12 MR. FARRELL: Objection to form

13 and foundation.

14 THE WITNESS: Well, they would

15 have been covered by the document

16 retention policy. I -- I'm not sure how

17 permanent you would be. Probably after a

18 year or so, they wouldn't be required to

19 be retained.

20 BY MR. PLACITELLA:

21 Q. Now, in terms of the accounts

22 payable records, how did they figure into

23 the -- the accounts -- accounts payable

24 ledgers, how did they figure into the

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 111 of 330 PageID:

43700
Page 111

1 document retention policy?

2 MR. FARRELL: Objection to

3 form.

4 THE WITNESS: I don't -- I

5 don't recall.

6 BY MR. PLACITELLA:

7 Q. Okay. If -- when you were there

8 in, say, 2005, and you wanted to know how

9 much Cahill Gordon billed you from two --

10 2003 to 2005, could you get that information?

11 MR. FARRELL: Objection to form

12 and foundation.

13 THE WITNESS: I'm sure I could.

14 BY MR. PLACITELLA:

15 Q. Okay. And if you were there in

16 2005 and you wanted to know how much Cahill

17 Gordon billed you from 2000 to 2005, could

18 you secure that information?

19 MR. FARRELL: Objection to form

20 foundation.

21 THE WITNESS: I would think I

22 could. I -- but I don't know for a fact.

23 MR. PLACITELLA: Okay.

24 THE WITNESS: I never -- never

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 112 of 330 PageID:

43701
Page 112

1 had occasion to find out.

2 BY MR. PLACITELLA:

3 Q. And how -- who would you ask or

4 what would you -- if you had to make that

5 request, what would you do?

6 MR. FARRELL: Same objections.

7 THE WITNESS: Well, in the

8 first instance, I would ask Mike

9 Sperduto, who was our chief financial

10 officer. And he would put me in touch

11 with somebody in his finance organization

12 who could give me the answer.

13 BY MR. PLACITELLA:

14 Q. Okay. Now, as corporate

15 secretary and general counsel, were you

16 required to keep the board of directors

17 apprized of what was going on in the Emtal

18 talc litigation?

19 MR. FARRELL: Objection to

20 form.

21 THE WITNESS: I don't know that

22 I was required to. I did on an

23 occasional basis.

24 BY MR. PLACITELLA:

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 113 of 330 PageID:

43702
Page 113

1 Q. Okay. And what sort of

2 information would you be reporting to the

3 board of directors about the Engelhard talc

4 litigation?

5 MR. FARRELL: Objection to

6 form; foundation. And I'd also caution

7 you, Mr. Dornbusch, not to reveal the

8 substance of any communications that

9 preserve privileges and work product that

10 would apply to such communications with

11 the board.

12 THE WITNESS: I would give them

13 an overview of where we stood.

14 BY MR. PLACITELLA:

15 Q. And when you say "overview," what

16 do you mean by that?

17 A. Well, I'd tell them how many

18 cases, how many since the last period had

19 been settled; if they were settled for money,

20 how much. That sort of thing.

21 Q. And if they were dismissed with

22 no money, would you tell them that?

23 A. Yes.

24 Q. Okay. Would you tell them the

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 114 of 330 PageID:

43703
Page 114

1 reasons?

2 MR. FARRELL: Objection to

3 form; foundation; privilege, to the

4 extent this gets into the substance of

5 such communications.

6 Can you answer that question

7 without revealing the substance of

8 communications?

9 THE WITNESS: No.

10 MR. FARRELL: Then I instruct

11 you not to answer the question.

12 BY MR. PLACITELLA:

13 Q. What's the purpose -- what was

14 the purpose of reporting to the board of

15 directors concerning the Emtal talc

16 litigation?

17 MR. FARRELL: Objection to form

18 and foundation.

19 THE WITNESS: It was to keep

20 them apprized of the current status.

21 BY MR. PLACITELLA:

22 Q. Would they use that information

23 in making decisions and deciding what they

24 had to report to their auditors, for example?

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 115 of 330 PageID:

43704
Page 115

1 MR. FARRELL: Objection to

2 form; foundation; calls for speculation.

3 THE WITNESS: Yeah, I don't --

4 I don't know what they did with the

5 information.

6 BY MR. PLACITELLA:

7 Q. What was the format of your

8 reports? Were they oral, written, both?

9 MR. FARRELL: Objection.

10 Objection to form.

11 THE WITNESS: Oral.

12 BY MR. PLACITELLA:

13 Q. Okay. And I'm sorry, you might

14 have said this, but how often did you make

15 those reports?

16 MR. FARRELL: Objection to

17 form.

18 THE WITNESS: Perhaps once or

19 twice a year.

20 BY MR. PLACITELLA:

21 Q. Okay. And if there -- something

22 significant happened in the litigation that

23 had the potential to adversely affect the

24 company, would you report that?

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 116 of 330 PageID:

43705
Page 116

1 MR. FARRELL: Objection to form

2 and foundation.

3 THE WITNESS: Yes.

4 BY MR. PLACITELLA:

5 Q. And did you ever make such a

6 report in the Emtal talc litigation?

7 MR. FARRELL: Objection to

8 form; foundation; attorney-client

9 privilege.

10 I instruct you not to answer

11 the question.

12 BY MR. PLACITELLA:

13 Q. Was the board -- board of

14 directors aware of the asbestos testing

15 evidence concerning Emtal talc?

16 MR. FARRELL: Objection to form

17 and foundation; calls for speculation.

18 MR. MARINO: Are you asking

19 Mr. Dornbusch if he advised the board of

20 directors?

21 MR. PLACITELLA: No. I'm

22 asking if they know -- they knew, to his

23 knowledge.

24 MR. MARINO: You're asking him

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 117 of 330 PageID:

43706
Page 117

1 if he knows what they know?

2 MR. PLACITELLA: Right.

3 MR. FARRELL: Without -- can

4 you answer that question without

5 revealing the substance of communications

6 between a lawyer for the company,

7 including yourself, and the board of

8 directors?

9 THE WITNESS: No.

10 MR. FARRELL: Then I instruct

11 you not to answer on privilege grounds.

12 MR. PLACITELLA: Can you read

13 that question back, please.

14 (Whereupon, the court reporter

15 read back the record as requested.)

16 BY MR. PLACITELLA:

17 Q. So to be clear, did you -- do you

18 know whether the board of directors was aware

19 of the asbestos testing evidence related to

20 Emtal talc?

21 MR. FARRELL: Objection to form

22 and foundation.

23 Can you answer that with a yes

24 or no, Mr. Dornbusch?

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 118 of 330 PageID:

43707
Page 118

1 THE WITNESS: No.

2 MR. FARRELL: Then I instruct

3 you not to answer the question on

4 privilege grounds.

5 BY MR. PLACITELLA:

6 Q. Do you know whether the board of

7 directors was aware of the testimony by

8 Engelhard scientists under oath concerning

9 the asbestos testing of Emtal talc?

10 MR. FARRELL: Same objections;

11 same instruction.

12 Can you answer that

13 question -- let me take a step back. Do

14 you know the answer to that question?

15 THE WITNESS: No.

16 BY MR. PLACITELLA:

17 Q. Do you know whether the -- can

18 you -- can you distinguish for me your duties

19 as the corporate secretary versus the general

20 counsel?

21 MR. FARRELL: Objection to

22 form.

23 MR. MARINO: Is the question

24 whether one of those duties entailed --

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 119 of 330 PageID:

43708
Page 119

1 MR. PLACITELLA: No.

2 MR. MARINO: -- his role as a

3 lawyer versus the other?

4 MR. PLACITELLA: Yeah. I want

5 to know if there was a difference.

6 BY MR. PLACITELLA:

7 Q. Was there a difference between

8 being corporate secretary and general

9 counsel? You had two different positions.

10 A. There was. As corporate

11 secretary, I was, of course, responsible for

12 maintaining the minutes, reporting the

13 meetings -- the minutes of the meetings of

14 the board and I think one of the committees

15 too. I think I -- I served as secretary to

16 the finance committee.

17 I -- and as -- as the company

18 lawyer, I would advise them on legal matters

19 that involved the corporation as needed.

20 Q. Okay. Now, when you say "the

21 minutes," what do you mean by that?

22 A. The minutes of the meeting.

23 Q. That you attended?

24 A. Yes.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 120 of 330 PageID:

43709
Page 120

1 Q. And you would physically write

2 them up?

3 A. Yes.

4 Q. And what would happen with those

5 minutes?

6 A. They --

7 MR. FARRELL: Objection to form

8 and foundation.

9 THE WITNESS: They would be

10 circulated with the rest of the board

11 materials prior to the next meeting. And

12 if approved, without any amendment, they

13 would be put in the minute books. If

14 there was a -- a change or something that

15 I had gotten wrong, it would be corrected

16 and then put in the minute books.

17 BY MR. PLACITELLA:

18 Q. And the -- were the minute books

19 kept as permanent records?

20 A. Yes.

21 Q. Okay. And who was in charge of

22 keeping those?

23 A. Well, I was, as secretary.

24 Q. And when you left -- ultimately

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 121 of 330 PageID:

43710
Page 121

1 left Engelhard, did you turn those minute

2 books over to BASF?

3 A. Yes.

4 Q. Okay. And in those -- in those

5 minutes, Did you ever incorporate information

6 related to the Emtal talc litigation?

7 MR. FARRELL: Objection to form

8 foundation.

9 Can you answer that with a yes

10 or a no?

11 THE WITNESS: I can. I --

12 MR. FARRELL: Go ahead.

13 THE WITNESS: Yes.

14 BY MR. PLACITELLA:

15 Q. Okay. And in those minutes, did

16 you ever incorporate information concerning

17 the events that happened in the Emtal talc

18 litigation that had the potential to

19 adversely affect the company?

20 MR. FARRELL: Objection to

21 form; foundation; attorney-client

22 privilege.

23 I instruct you not to answer

24 the question.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 122 of 330 PageID:

43711
Page 122

1 MR. PLACITELLA: So just so

2 we're clear, your position is that the

3 board minutes are privileged?

4 MR. FARRELL: Not the entirety

5 of board minutes. But certainly with

6 respect to that question, asking the

7 general counsel of a corporation whether

8 he advised the board of directors about

9 an adverse event in litigation that would

10 have an impact on the company, yes, I'm

11 asserting privilege over that

12 communication and whether it's in the

13 document. And I've instructed him not to

14 answer the question.

15 MR. PLACITELLA: Okay.

16 MR. FARRELL: You're deposing

17 the former general counsel of a

18 corporation about his communications --

19 MR. PLACITELLA: I don't need a

20 lecture from you. I don't need a lecture

21 from you.

22 MR. MARINO: No, let's --

23 MR. FARRELL: You asked me a

24 question.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 123 of 330 PageID:

43712
Page 123

1 MR. PLACITELLA: Okay. You

2 already -- you already did --

3 MR. FARRELL: You're deposing

4 the former general counsel of a

5 corporation about his communications and

6 updates on litigation with the board of

7 directors of a company.

8 MR. PLACITELLA: Let me know

9 when you're done.

10 MR. FARRELL: I'm finished.

11 MR. PLACITELLA: Thank you.

12 MR. MARINO: Chris, it's not

13 improper for him to make a clarifying

14 statement on the record. There's --

15 there's nothing -- there's nothing

16 objectionable about that.

17 BY MR. PLACITELLA:

18 Q. Did you ever have to provide

19 information to your -- you personally have to

20 provide information to the auditors for

21 Engelhard concerning the talc litigation?

22 MR. FARRELL: Objection to

23 form.

24 THE WITNESS: Yes.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 124 of 330 PageID:

43713
Page 124

1 BY MR. PLACITELLA:

2 Q. Okay. And was that information

3 required in order to comply with the SEC

4 rules?

5 MR. FARRELL: Objection to form

6 and foundation.

7 THE WITNESS: I don't know what

8 it was require --

9 BY MR. PLACITELLA:

10 Q. Did you -- go ahead. I'm sorry.

11 A. It was -- they -- they would

12 frequently meet with me to talk about

13 litigation. And they'd have a checklist of

14 things they wanted to talk about. And if

15 there was something I thought they should

16 know that wasn't on their list, I would tell

17 them about it. We had a very open policy

18 with our auditors.

19 Q. Okay. And did you ever provide

20 information to your auditors related to Emtal

21 talc litigation that you thought could impact

22 negatively the corporation?

23 MR. FARRELL: Objection to

24 form; foundation; privilege.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 125 of 330 PageID:

43714
Page 125

1 I instruct you not to answer

2 the question.

3 MR. PLACITELLA: So we're

4 clear, your position is information

5 provided to the auditors, who were there

6 for purposes of SEC compliance, is

7 privileged?

8 MR. FARRELL: You're asking the

9 former general counsel of a corporation

10 for his opinion regarding the disclosure

11 of information related to litigation.

12 It's work product, and it's privileged.

13 MR. PLACITELLA: Okay.

14 MR. FARRELL: I've asserted an

15 objection.

16 MR. PLACITELLA: All right. So

17 just so we're clear before the Court,

18 it's your position that information

19 provided by Mr. Dornbusch to the

20 corporate auditors, who are not employees

21 or officers of the corporation, is

22 privileged?

23 MR. FARRELL: I didn't say that

24 Mr. Placitella. I was responding to your

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 126 of 330 PageID:

43715
Page 126

1 specific question, which called for

2 Mr. Dornbusch's mental impressions and

3 opinion about facts related to litigation

4 and whether or why they were communicated

5 to somebody. That is work product and it

6 is privileged. I've asserted an

7 objection, and I've instructed the

8 witness not to answer the question.

9 BY MR. PLACITELLA:

10 Q. Did you ever provide information

11 to the auditors concerning information you

12 thought was important that they should know

13 as part of their reporting requirements to

14 the SEC related to the Engelhard talc

15 litigation?

16 MR. FARRELL: Same objections;

17 same instruction not to answer. It's

18 frankly the same question you just asked

19 that I just instructed on.

20 BY MR. PLACITELLA:

21 Q. Did you ever provide -- well, let

22 me ask you this question: Would an accurate

23 disclosure to your auditors include

24 information that you had about the existence

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 127 of 330 PageID:

43716
Page 127

1 or a lack thereof of asbestos in Emtal talc?

2 MR. FARRELL: Same objections;

3 same instruction not to answer.

4 BY MR. PLACITELLA:

5 Q. What specifically did you tell

6 the -- your auditors about the Emtal talc

7 litigation, to your recollection?

8 MR. FARRELL: Objection to form

9 and foundation.

10 I need to confer with the

11 witness before he can respond to this

12 question.

13 MR. PLACITELLA: I don't think

14 so.

15 MR. FARRELL: Well, then I need

16 to instruct him not to answer the

17 question on privilege grounds --

18 MR. PLACITELLA: Okay.

19 MR. FARRELL: -- if you're not

20 going to allow me to confer with him.

21 MR. MARINO: Can we go off the

22 record for a moment?

23 MR. PLACITELLA: Uh-huh.

24 THE VIDEOGRAPHER: The time is

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 128 of 330 PageID:

43717
Page 128

1 now 11 o'clock a.m. We're going off the

2 record.

3 (Whereupon, there was a

4 discussion held off the record.)

5 (Whereupon, a brief recess was

6 taken.)

7 THE VIDEOGRAPHER: The time is

8 now 11:10 a.m. We are back on the

9 record.

10 BY MR. PLACITELLA:

11 Q. Okay. What information did you

12 provide to Engelhard's auditors concerning

13 the Emtal talc litigation?

14 MR. FARRELL: Objection to form

15 and foundation.

16 THE WITNESS: I don't remember.

17 BY MR. PLACITELLA:

18 Q. Was there a record kept of what

19 information you provided to the auditors?

20 A. No.

21 Q. Okay. Did the auditors keep

22 notes of what you told them?

23 MR. FARRELL: Object --

24 objection to form and foundation.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 129 of 330 PageID:

43718
Page 129

1 THE WITNESS: I saw them

2 writing on paper. I -- yeah.

3 BY MR. PLACITELLA:

4 Q. Do you have a recollection of

5 ever telling the auditors that Engelhard was

6 in possession of evidence indicating there

7 was asbestos in the Emtal talc?

8 MR. FARRELL: Objection to form

9 and foundation.

10 THE WITNESS: I have no

11 specific recollection of what I told them

12 about anything.

13 BY MR. PLACITELLA:

14 Q. Would that information have been

15 required to be provided, if you know?

16 A. I --

17 MR. FARRELL: Objection to

18 form; foundation.

19 Are you asking him for his

20 opinion on this?

21 MR. PLACITELLA: I'm asking him

22 his experience.

23 MR. FARRELL: You're asking the

24 general counsel of the company whether it

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 130 of 330 PageID:

43719
Page 130

1 would have been required to do something.

2 Are you asking for his opinion?

3 MR. PLACITELLA: I'm asking him

4 in terms of their business practices and

5 his dealing with the auditor, would that

6 information have been required for

7 disclosure.

8 MR. FARRELL: Those are two

9 different questions.

10 BY MR. PLACITELLA:

11 Q. You can answer it.

12 MR. FARRELL: Mr. Dornbusch,

13 can you respond to that question without

14 getting into your personal assessment of

15 legal issues?

16 THE WITNESS: No.

17 MR. FARRELL: Then I instruct

18 you not to answer the question.

19 BY MR. PLACITELLA:

20 Q. Do you know whether the reasons

21 why Emtal cases were dismissed were ever

22 communicated to your auditors?

23 MR. FARRELL: Objection to form

24 and foundation.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 131 of 330 PageID:

43720
Page 131

1 Can you answer that with a yes

2 or a no?

3 THE WITNESS: No, I can't.

4 MR. FARRELL: Do you know the

5 answer to the question?

6 THE WITNESS: No.

7 BY MR. PLACITELLA:

8 Q. What was your understanding of

9 the type of information you were required to

10 disclose to the auditors of Engelhard related

11 to the Emtal talc litigation?

12 MR. FARRELL: Objection to form

13 and foundation.

14 THE WITNESS: Just a general

15 understanding that anything that could

16 have a material financial impact on the

17 corporation.

18 BY MR. PLACITELLA:

19 Q. Did you ever come to the

20 conclusion that evidence of asbestos in Emtal

21 talc could have a material impact on the

22 corporation?

23 MR. FARRELL: Objection to

24 form; foundation; work product.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 132 of 330 PageID:

43721
Page 132

1 Instruct you not to answer the

2 question.

3 BY MR. PLACITELLA:

4 Q. Do you have a recollection of

5 ever coming to that conclusion?

6 MR. FARRELL: Same objections;

7 same instruction on privilege grounds.

8 BY MR. PLACITELLA:

9 Q. I'm not asking you for what you

10 concluded. I'm asking you if you have a

11 recollection.

12 A. I do not.

13 MR. FARRELL: I've already

14 instructed the witness on this question.

15 BY MR. PLACITELLA:

16 Q. Okay. Did you ever -- whose

17 decision was it to disclose evidence in

18 possession of Engelhard related to the Emtal

19 talc litigation? Whose decision was that?

20 MR. FARRELL: Objection to

21 form; foundation; vague.

22 THE WITNESS: Disclose it to

23 whom?

24 BY MR. PLACITELLA:

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 133 of 330 PageID:

43722
Page 133

1 Q. In the -- to the adverse side in

2 the context of -- good question.

3 A. Uh-huh.

4 Q. Let me rephrase it.

5 Whose decision was it to

6 disclose information or disclose evidence

7 pertinent to the litigation in the Emtal talc

8 litigation to the other side?

9 MR. FARRELL: Objection to form

10 and foundation.

11 THE WITNESS: Well, I guess

12 ultimately, it would have been my

13 decision.

14 MR. PLACITELLA: Okay.

15 THE WITNESS: It would have

16 been -- it would come about through

17 outside counsel, through Cahill. And

18 they would come to me, and we'd talk

19 about it.

20 BY MR. PLACITELLA:

21 Q. Did you ever make a decision --

22 well, scratch that.

23 Do you know whether the

24 information contained in P-1 was ever

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 134 of 330 PageID:

43723
Page 134

1 disclosed in the --

2 A. Oh, that's the big --

3 Q. -- Emtal talc litigation?

4 MR. FARRELL: Objection to form

5 and foundation; vague as to time.

6 THE WITNESS: No, I don't know.

7 BY MR. PLACITELLA:

8 Q. So would it have been your

9 decision, ultimately, whether the information

10 contained in P-1 would be disclosed to

11 litigants in the Emtal talc litigation?

12 MR. FARRELL: Same objections;

13 assumes facts.

14 THE WITNESS: If it came up,

15 yes, I -- I was not aware of the

16 existence of what's been identified as

17 P-1 until my deposition in the state

18 matter.

19 BY MR. PLACITELLA:

20 Q. Well, you were aware of it when

21 the memo was sent to you by Mr. Hyde in 1982,

22 weren't you?

23 A. Oh, yes.

24 Q. Okay.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 135 of 330 PageID:

43724
Page 135

1 MR. FARRELL: Objection to

2 form.

3 BY MR. PLACITELLA:

4 Q. So once you were aware of it in

5 1982, when you received it from Mr. Hyde,

6 whose decision was it whether to disclose

7 that information to litigants in the Emtal

8 talc litigation?

9 MR. FARRELL: Objection to

10 form; foundation; vague; assumes facts.

11 THE WITNESS: I don't recall it

12 ever being discussed.

13 BY MR. PLACITELLA:

14 Q. My question was, whose decision

15 was it whether to disclose that information

16 to the other side?

17 MR. FARRELL: Same objections.

18 THE WITNESS: There was no

19 decision about it. It wasn't discussed.

20 BY MR. PLACITELLA:

21 Q. So no one -- the subject of

22 whether you should disclose asbestos testing

23 to litigants in the Emtal talc litigation

24 never came up?

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 136 of 330 PageID:

43725
Page 136

1 A. I don't re --

2 MR. FARRELL: Objection to

3 form; foundation; asked and answered.

4 Go ahead, Mr. Dornbusch.

5 THE WITNESS: I don't recall.

6 BY MR. PLACITELLA:

7 Q. You don't recall what?

8 A. I don't recall discussing or

9 considering that issue.

10 Q. Well, whose responsibility would

11 it have been to make sure that relevant

12 testing evidence for asbestos in Emtal talc

13 would have been disclosed in litigation

14 involving asbestos in Emtal talc?

15 MR. FARRELL: Objection to

16 form; foundation; assumes facts; vague as

17 to time.

18 THE WITNESS: The disclosure

19 vehicle would have been something that

20 would have been put together by Cahill

21 Gordon. They -- they would not need my

22 approval to -- and they -- they were

23 given this information. This was coming

24 back from them. Having this information,

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 137 of 330 PageID:

43726
Page 137

1 if they felt it was appropriate to

2 disclose it, I would assume they would

3 have disclosed it.

4 BY MR. PLACITELLA:

5 Q. So you had no role whatsoever in

6 making the determination as to whether this

7 information be -- should be disclosed to

8 people who were suing Engelhard for

9 asbestos-related injuries?

10 MR. FARRELL: Objection to

11 form.

12 BY MR. PLACITELLA:

13 Q. Is that what you're saying?

14 MR. FARRELL: Objection to form

15 and foundation.

16 MR. BOISE: Also

17 mischaracterizes testimony.

18 THE WITNESS: I -- I explained

19 that I relied upon Cahill to respond to

20 discovery requests appropriately. I gave

21 them whatever I had, whatever the company

22 had, and counted upon them to draft an

23 appropriate response.

24 BY MR. PLACITELLA:

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 138 of 330 PageID:

43727
Page 138

1 Q. So you basically just outsourced

2 to them whatever was required in order to

3 respond to discovery?

4 MR. FARRELL: Objection to

5 form.

6 THE WITNESS: But -- yeah.

7 Yes.

8 BY MR. PLACITELLA:

9 Q. Okay. Before you -- we mentioned

10 briefly the Westfall case. Can you tell me

11 what were the circumstances that you learned

12 of the Westfall case?

13 A. I don't -- I don't recall. We

14 were sued, and I -- I reserved -- I would

15 have reserved the service papers.

16 Q. Okay. You were involved in that

17 case, correct, yourself?

18 MR. FARRELL: Objection to

19 form.

20 THE WITNESS: No, not really.

21 BY MR. PLACITELLA:

22 Q. You didn't file Affidavits in

23 that case?

24 A. Well, if I did, I did. I -- I

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 139 of 330 PageID:

43728
Page 139

1 don't recall doing it.

2 Q. Now, you left -- can you give me

3 Dornbusch-1.

4 Dornbusch-1 is a report for

5 Engelhard Corporation for the Securities and

6 Exchange Commission.

7 Do you see that?

8 A. Yes.

9 Q. And that report was issued at the

10 time -- at or about the time that you left?

11 MR. FARRELL: Objection to

12 form.

13 THE WITNESS: May of 2006, yes.

14 BY MR. PLACITELLA:

15 Q. Okay. And if I go to page 17, it

16 talks about shares of ownership.

17 Do you see that?

18 A. Yes.

19 Q. Okay. And at the time of -- at

20 the time you left, you owned 754,787 shares?

21 A. That's what it says, yes.

22 Q. And that there was a tender offer

23 for, do you recall, $45 a share?

24 A. I didn't recall that that was the

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 140 of 330 PageID:

43729
Page 140

1 price of the tender, but yes, I see it.

2 Q. Okay.

3 MR. TUNIS: I'm sorry,

4 Mr. Dornbusch --

5 THE WITNESS: Yeah, I -- I see

6 that that's what it says here. I didn't

7 recall that that was the price.

8 BY MR. PLACITELLA:

9 Q. Do you recall, if I did the math,

10 that when you left, you received about

11 $33 million?

12 A. It wasn't that much, but...

13 Q. It was pretty close?

14 A. I received -- yeah, it was my

15 life savings.

16 Q. Okay. And at the time you left,

17 you were making, what, about a million

18 dollars a year with benefits?

19 A. I don't remember.

20 Q. Okay. Now, can you give me

21 Exhibit 3.

22 MS. CALLAHAN: Dornbusch-3?

23 MR. PLACITELLA: No. Just

24 Exhibit 3.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 141 of 330 PageID:

43730
Page 141

1 THE WITNESS: Oh.

2 BY MR. PLACITELLA:

3 Q. Exhibit 3 is the deposition of

4 Dr. Glenn Hemstock given on March 16th, 1983,

5 in the Westfall case.

6 Do you see that?

7 A. Uh-huh.

8 MR. BOISE: This is an excerpt?

9 MR. PLACITELLA: Yes. Well, he

10 has the full. I gave you the excerpts

11 I'm asking questions about.

12 MR. BOISE: I don't even have

13 the excerpts. That's why I'm asking.

14 BY MR. PLACITELLA:

15 Q. Okay. And on the next page, it

16 indicates that Mr. Sloane and Mr. Halket were

17 there on behalf of your corporation, correct?

18 A. Yes.

19 Q. And it -- if you go to page 17 --

20 A. Yes.

21 Q. -- Dr. Halket is asked the

22 following question and answer -- I'm sorry,

23 Dr. Hemstock: "Now, you testified that your

24 department has tested both processed talc and

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 142 of 330 PageID:

43731
Page 142

1 raw talc ore from the Emtal mine for the

2 presence of chrysotile asbestos; is that

3 correct?"

4 Answer: "Yes."

5 "Has your department in its

6 research found chrysotile asbestos in both

7 processed talc and raw ore from the Emtal

8 mine?"

9 And the answer is "Yes."

10 Do you see that?

11 A. Yes.

12 Q. Okay. And when is the first time

13 that you learned about this testimony?

14 A. I don't know.

15 Q. Would you have learned it at or

16 about the time the case was pending?

17 MR. TUNIS: Objection to form.

18 MR. FARRELL: Objection to

19 form.

20 THE WITNESS: I don't know.

21 BY MR. PLACITELLA:

22 Q. Certainly your department was

23 aware of the testimony, correct?

24 MR. FARRELL: Objection to form

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 143 of 330 PageID:

43732
Page 143

1 and foundation.

2 THE WITNESS: Mr. Halket was

3 present, so he -- he would have known.

4 MR. PLACITELLA: Okay.

5 MR. MARINO: Can I -- Chris,

6 can I ask you to show Mr. Dornbusch the

7 complete testimony on this subject? It's

8 a little difficult to see the page

9 numbers. But what appears -- what you've

10 identified as page 17, could you -- could

11 you please show him pages 17 and 18?

12 Does he have that in front of him?

13 MR. PLACITELLA: He's got it in

14 front of him.

15 MR. BOYLE: Well, no. No.

16 Your excerpt actually excludes page 18.

17 So if you'd like, I can -- we can read

18 it.

19 MR. MARINO: Well, I -- I --

20 well, yeah. Why don't I do that.

21 MR. PLACITELLA: Well, no.

22 He's got 18 in front of him.

23 MR. MARINO: Does he?

24 MR. PLACITELLA: Yes.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 144 of 330 PageID:

43733
Page 144

1 THE WITNESS: I have the whole

2 thing, yeah.

3 MR. PLACITELLA: He's got the

4 whole thing.

5 MR. MARINO: Okay. So let's

6 take a moment to just look --

7 MR. PLACITELLA: So why don't

8 you read it, Mr. Dornbusch.

9 MR. MARINO: Yeah. Let's take

10 a moment to do that. That's great.

11 Thank you.

12 THE WITNESS: Okay.

13 BY MR. PLACITELLA:

14 Q. In reading page 18, does that

15 refresh your memory in any way of what

16 Dr. Halket -- Dr. Hemstock testified to?

17 MR. FARRELL: Objection to form

18 and foundation.

19 THE WITNESS: It doesn't

20 refresh my recollection. It -- it -- it

21 states that the amounts of chrysotile

22 found by Dr. Hemstock were trace

23 quantities.

24 BY MR. PLACITELLA:

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 145 of 330 PageID:

43734
Page 145

1 Q. Okay. And then can you go to

2 page 103. I put that up.

3 Does he also testify there

4 about more than trace quantities?

5 MR. FARRELL: Objection to form

6 and foundation; misstates his testimony.

7 BY MR. PLACITELLA:

8 Q. Well let me read it to you. Does

9 Dr. Hemstock provide a response to the

10 following question: "Dr. Hemstock, in the

11 first full paragraph of page two of this

12 memorandum, there is a statement from

13 Mr. Triglia" -- he was the scientist you

14 talked about before, right, Mr. Dornbusch?

15 A. Yes. Yes.

16 Q. -- "that, 'The results showed

17 that although there was a variability in the

18 number of fibers counted from week to week,

19 there were, nevertheless, fibers present in

20 every sample of Emtal 42 tested. A few of

21 the Emtal 42 samples showed relatively high

22 fiber counts.' Do you know to what fiber

23 Mr. Triglia is referring in that sentence?"

24 Answer: "Those would be

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 146 of 330 PageID:

43735
Page 146

1 fibers observed in the electron microscope

2 evaluation of those samples."

3 Did I read that correctly?

4 A. Yes.

5 MR. PLACITELLA: Okay. Now,

6 can you give me Exhibit 4, please.

7 BY MR. PLACITELLA:

8 Q. By the way, was -- after the

9 Westfall case, was Dr. Hemstock's deposition

10 ever disclosed to any other litigant

11 before -- during the time that you worked at

12 Engelhard?

13 MR. FARRELL: Objection to

14 form.

15 THE WITNESS: I do not know. I

16 don't know.

17 BY MR. PLACITELLA:

18 Q. Should it have been?

19 MR. FARRELL: Objection to

20 form; foundation; work product; and

21 privilege.

22 I instruct you not to answer

23 the question.

24 BY MR. PLACITELLA:

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 147 of 330 PageID:

43736
Page 147

1 Q. I'm going to show you what's been

2 marked as Exhibit 4. Exhibit 4 is the

3 deposition of Peter Gale taken on April 26th,

4 1983, in the Westfall case.

5 Have you seen this before?

6 A. Not that I recall.

7 Q. Do you recall actually suing

8 Peter Gale for giving testimony in the

9 Westfall case?

10 MR. FARRELL: Objection to

11 form; foundation.

12 THE WITNESS: Yes, I do.

13 BY MR. PLACITELLA:

14 Q. Okay. And can you go to page 19.

15 In page 19, Peter Gale talks about tests that

16 were performed with an electron microscope at

17 Georgia Tech in 1979.

18 Do you see that?

19 A. I see -- yes, I see the

20 highlighted material.

21 Q. Okay.

22 A. And the date, yes.

23 Q. All right. And on the next page,

24 he indicates, does he not, that the testing

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 148 of 330 PageID:

43737
Page 148

1 showed chrysotile fibers in the Emtal talc?

2 MR. FARRELL: Objection to

3 form; foundation; misstates his

4 testimony.

5 THE WITNESS: I see his

6 testimony, yes.

7 BY MR. PLACITELLA:

8 Q. Okay. Now, if you go back to the

9 second page, you had two lawyers there -- or

10 you had -- I'm sorry, you had Howard Sloane

11 there on behalf of your corporation?

12 A. Yes.

13 Q. Okay. And was the information --

14 was this deposition ever disclosed to any

15 litigant after the Westfall case at any point

16 in time?

17 MR. FARRELL: Objection to form

18 and foundation; assumes facts.

19 THE WITNESS: I don't know.

20 BY MR. PLACITELLA:

21 Q. Do you know who Dr. William

22 Glassley is?

23 A. No.

24 Q. Okay. You don't -- do you have

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 149 of 330 PageID:

43738
Page 149

1 any recollection of any point in time

2 learning that Dr. Glassley found asbestos

3 at -- at the Johnson mine?

4 MR. FARRELL: Objection to form

5 and foundation.

6 THE WITNESS: No.

7 BY MR. PLACITELLA:

8 Q. Okay. After the Westfall case

9 was concluded, what physically happened, if

10 you know, to the physical transcripts of the

11 Engelhard scientists that testified in those

12 cases -- in that case?

13 MR. FARRELL: Objection to form

14 and foundation.

15 THE WITNESS: I do not know.

16 BY MR. PLACITELLA:

17 Q. Who would know that?

18 MR. FARRELL: Objection to form

19 and foundation.

20 THE WITNESS: Peter Sloane

21 would probably know.

22 BY MR. PLACITELLA:

23 Q. And do you know what happened to

24 the exhibits that were attached to the

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 150 of 330 PageID:

43739
Page 150

1 transcripts?

2 MR. FARRELL: Same objections.

3 THE WITNESS: No.

4 BY MR. PLACITELLA:

5 Q. Okay. Do you know whether the

6 original transcripts were ever returned to

7 Engelhard?

8 MR. FARRELL: Same objections.

9 THE WITNESS: I don't know.

10 BY MR. PLACITELLA:

11 Q. Okay. Do you know whether

12 in-house counsel -- and I mean your --

13 your -- your department -- maintained copies

14 of the Westfall file?

15 MR. FARRELL: Objection to form

16 and foundation.

17 THE WITNESS: I don't know.

18 BY MR. PLACITELLA:

19 Q. Okay. Do you know whether it was

20 a matter of procedure or policy that

21 Mr. Halket would have received copies of the

22 transcripts and exhibits?

23 MR. FARRELL: Objection to

24 form.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 151 of 330 PageID:

43740
Page 151

1 MR. TUNIS: Objection to form.

2 THE WITNESS: I don't know.

3 BY MR. PLACITELLA:

4 Q. Okay. Did you have an

5 expectation that Cahill Gordon would be

6 keeping a permanent copy of the Westfall

7 file?

8 MR. FARRELL: Objection to form

9 and foundation.

10 MR. TUNIS: Objection.

11 THE WITNESS: I never thought

12 of it. I don't know.

13 BY MR. PLACITELLA:

14 Q. Okay. Did you have an

15 expectation that that file would be destroyed

16 at the conclusion of the Westfall case?

17 MR. FARRELL: Objection to form

18 and foundation.

19 MR. TUNIS: Objection to form.

20 THE WITNESS: I don't know.

21 BY MR. PLACITELLA:

22 Q. Well, what was your policy

23 concerning the -- destruction of evidence

24 that was created during the course of the

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 152 of 330 PageID:

43741
Page 152

1 Engelhard talc litigation?

2 MR. MARINO: Are you asking

3 about a document retention policy?

4 MR. TUNIS: Form and

5 foundation.

6 MR. PLACITELLA: No.

7 MR. MARINO: Is that your

8 question.

9 MR. PLACITELLA: No.

10 MR. MARINO: What was the

11 policy about the destruction of evidence?

12 Is that your question?

13 MR. PLACITELLA: Yes. Yeah.

14 MR. FARRELL: Objection to form

15 and foundation.

16 MR. TUNIS: Same.

17 THE WITNESS: There -- there

18 was no policy that I'm aware of.

19 BY MR. PLACITELLA:

20 Q. Was it your understanding that

21 you had a responsibility to retain evidence

22 that was created during the course of the

23 Engelhard talc litigation?

24 MR. MARINO: Can I have a time

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 153 of 330 PageID:

43742
Page 153

1 frame, please.

2 MR. PLACITELLA: At any time.

3 MR. FARRELL: Objection to form

4 foundation.

5 MR. TUNIS: Objection; time

6 frame.

7 THE WITNESS: So what -- what

8 is the question as it stands?

9 MR. PLACITELLA: Can you read

10 it back, please.

11 (Whereupon, the court reporter

12 read back the record as requested.)

13 MR. FARRELL: Objection to

14 form; foundation; vague.

15 THE WITNESS: I don't have any

16 current understanding.

17 BY MR. PLACITELLA:

18 Q. What do you mean by that?

19 A. I -- I don't -- I don't recall

20 that issue at all.

21 Q. Well, did you understand, as

22 general counsel, that you had a

23 responsibility to maintain evidence when

24 there were other case -- similar cases

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 154 of 330 PageID:

43743
Page 154

1 pending?

2 MR. FARRELL: Objection to

3 form --

4 MR. TUNIS: Objection.

5 MR. FARRELL: -- and

6 foundation.

7 MR. TUNIS: And vague as to

8 time frame.

9 BY MR. PLACITELLA:

10 Q. At any point in time.

11 A. Yes.

12 Q. Okay. Now, I want to talk to you

13 about document retention policy in general.

14 Prior to 1984, did Engelhard

15 have a document retention policy, if you

16 remember?

17 MR. FARRELL: Objection to

18 form.

19 THE WITNESS: I believe we had

20 several.

21 MR. PLACITELLA: Give me 176,

22 please. 176.

23 BY MR. PLACITELLA:

24 Q. Okay. If you look at -- what you

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 155 of 330 PageID:

43744
Page 155

1 have in front of you are responses to

2 discovery by BASF in this case. And if you

3 look at request No. 21, the request is:

4 "After Engelhard was sued in an asbestos

5 mesothelioma case in Rhode Island known as

6 the Westfall case, Engelhard changed its

7 Research And Development's document retention

8 policy." Do you see that?

9 A. Yes.

10 Q. And underneath that, after the

11 objections, it says, "BASF admits that

12 Engelhard finalized a new document retention

13 policy in 1984."

14 Do you see that?

15 A. Yes.

16 Q. What was the document retention

17 policy before that, if you know?

18 MR. FARRELL: Objection to

19 form; foundation; vague.

20 BY MR. PLACITELLA:

21 Q. Well, let me ask you a question,

22 so maybe this will be easier.

23 A. Okay.

24 Q. Do you have a recollection of a

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 156 of 330 PageID:

43745
Page 156

1 new document retention policy being arrived

2 at after the Westfall case was filed?

3 MR. FARRELL: Objection to

4 form.

5 THE WITNESS: I -- I don't know

6 about it with respect to after the

7 Westfall case was filed. I know that we

8 had an ongoing undertaking that took some

9 time to formulate a comprehensive

10 document retention policy for both

11 divisions of the company. My answer to

12 your previous question, I believe both

13 the Engelhard industry's division and the

14 minerals and chemicals division had their

15 own, not necessarily consistent policies.

16 And whatever policies those were, were

17 not enforced. Our recommend -- document

18 retention facility was basically a great

19 big wastebasket.

20 And under my instruction -- at

21 my instructions, Cahill prepared a

22 document retention policy that would be

23 consistent with all applicable laws and

24 regulations. It took some time. It was

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 157 of 330 PageID:

43746
Page 157

1 also reviewed by Fish & Neave to ensure

2 that we were giving adequate protection

3 to intellectual property matters. And

4 it was finalized sometime in 1984.

5 BY MR. PLACITELLA:

6 Q. Okay. Do you have a recollection

7 that you did not come up with this document

8 retention policy, a final version, until

9 after the Westfall case was terminated?

10 MR. FARRELL: Objection to

11 form; foundation; asked and answered.

12 THE WITNESS: Well, I think you

13 told me it was -- that the Westfall

14 litigation was settled in '83, and this

15 was in '84, so I guess the answer is yes.

16 BY MR. PLACITELLA:

17 Q. What was the document retention

18 policy for the evidence in the Engelhard

19 research and development department

20 specifically related to the department that

21 was headed by Dr. Hemstock prior to 1984?

22 MR. FARRELL: Objection to form

23 and foundation.

24 THE WITNESS: Yeah, I don't

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 158 of 330 PageID:

43747
Page 158

1 recall.

2 BY MR. PLACITELLA:

3 Q. And what was the document

4 retention policy that was arrived at

5 concerning the R&D department headed by

6 Dr. Hemstock in 1984?

7 MR. FARRELL: Same objections,

8 form and foundation.

9 THE WITNESS: I don't recall

10 the whole policy, but it was -- can

11 you -- if you can be more specific,

12 perhaps I can respond.

13 BY MR. PLACITELLA:

14 Q. Prior to 1984, was -- did your

15 policy permit the destruction of R and -- the

16 R&D files that were in Dr. Hemstock's

17 department?

18 MR. FARRELL: Objection to form

19 and foundation.

20 THE WITNESS: I don't know.

21 BY MR. PLACITELLA:

22 Q. Who would know that?

23 MR. FARRELL: Objection to form

24 and foundation.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 159 of 330 PageID:

43748
Page 159

1 THE WITNESS: You'd have to

2 look at the -- the -- the old policy for

3 the minerals and chemicals division.

4 BY MR. PLACITELLA:

5 Q. And with the new policy that was

6 arrived at in 1984, did it permit the

7 research and development information related

8 to Emtal talc to be destroyed that was in the

9 department of Dr. Hemstock?

10 MR. FARRELL: Objection to form

11 and foundation.

12 THE WITNESS: It called for the

13 destruction of files related to

14 discontinued operations of the company.

15 BY MR. PLACITELLA:

16 Q. All right. You -- but you didn't

17 answer my question. Did it permit you to

18 destroy the R&D files in Dr. Hemstock's

19 department related to Emtal talc?

20 MR. FARRELL: Objection to

21 form; foundation; asked and answered.

22 THE WITNESS: As a discontinued

23 operation, yes.

24 BY MR. PLACITELLA:

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 160 of 330 PageID:

43749
Page 160

1 Q. Even if there were other cases

2 pending at the time?

3 MR. FARRELL: Objection.

4 BY MR. PLACITELLA:

5 Q. Even if there was litigation

6 pending at the time related to Emtal talc?

7 MR. FARRELL: Objection to form

8 and foundation.

9 THE WITNESS: There was a

10 general exception for pending litigation.

11 BY MR. PLACITELLA:

12 Q. So if there were cases pending in

13 1984, am I correct, in 1985, you would not be

14 permitted to destroy Engelhard Emtal talc

15 research and development files? True?

16 MR. TUNIS: Objection to form.

17 MR. FARRELL: Objection to

18 form; foundation; vague.

19 THE WITNESS: True.

20 BY MR. PLACITELLA:

21 Q. Did -- do you -- did you have an

22 understanding, as general counsel, of what

23 the concept of a litigation hold was?

24 A. A litigation hold is something

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 161 of 330 PageID:

43750
Page 161

1 that we would institute upon the commencement

2 of a lawsuit, either by or against the

3 company, whereby we would suspend the

4 application of the new document retention

5 policy with respect to that subject area.

6 Q. Did you ever issue a litigation

7 hold as it related to the testing evidence

8 that was in the possession of the R&D

9 department headed by Dr. Hemstock concerning

10 Emtal talc?

11 MR. FARRELL: Objection to

12 form; foundation; vague as to time;

13 assumes facts.

14 THE WITNESS: I'm not aware of

15 any.

16 BY MR. PLACITELLA:

17 Q. What was your understanding of

18 the purpose of a litigation hold directive --

19 MR. TUNIS: Objection.

20 BY MR. PLACITELLA:

21 Q. -- in terms of a -- the policy at

22 your corporation?

23 MR. FARRELL: Objection to

24 form.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 162 of 330 PageID:

43751
Page 162

1 MR. TUNIS: Are -- are you

2 asking with respect to the specific 1984

3 policy?

4 BY MR. PLACITELLA:

5 Q. I'm asking what your

6 understanding was of the purpose of issuing a

7 litigation hold directive, generally?

8 A. It was to prevent the destruction

9 of documents that would be relevant to the

10 litigation in question.

11 MR. PLACITELLA: Okay. Okay.

12 Can you give me Exhibit 15. I have lots

13 of these, so...

14 BY MR. PLACITELLA:

15 Q. Okay. You have in front of you

16 Exhibit 15, which is a March 7th, 1984 memo

17 from G.A. Hemstock to all R&D personnel.

18 Do you see that?

19 A. Yes.

20 Q. Okay. And it talks about

21 document retrieval - discontinued operations,

22 correct?

23 A. Correct.

24 Q. Okay. This was issued prior to a

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 163 of 330 PageID:

43752
Page 163

1 final document retention policy being arrived

2 at, correct?

3 MR. FARRELL: Objection to

4 form; foundation; misstates his

5 testimony.

6 THE WITNESS: I don't know what

7 the official date of implementation of

8 the document retention policy was.

9 BY MR. PLACITELLA:

10 Q. Did you have a role in drafting

11 this memo?

12 MR. MARINO: The document

13 retention policy?

14 MR. PLACITELLA: The doc --

15 this memo right here, document

16 retrieval - discontinued operations.

17 MR. MARINO: Thank you.

18 THE WITNESS: I don't recall.

19 BY MR. PLACITELLA:

20 Q. Okay. So if Dr. Hemstock

21 testified that you were the author of the

22 memo, does that refresh your recollection?

23 MR. MARINO: Objection to the

24 form of the question. Can you show him

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 164 of 330 PageID:

43753
Page 164

1 that testimony by Dr. Hemstock?

2 MR. PLACITELLA: I can go dig

3 it out at lunchtime.

4 MR. MARINO: Well, I -- you

5 don't need to.

6 MR. BOYLE: We have it right

7 here.

8 MR. MARINO: I have it right

9 here.

10 MR. PLACITELLA: Okay.

11 MR. MARINO: So I'm looking at

12 page 34, lines -- line -- the question

13 begins on line 6.

14 MR. PLACITELLA: Well, hold on

15 for a second. Is this -- because let me

16 pull -- let me find it.

17 MR. MARINO: Yeah, please.

18 MR. PLACITELLA: Okay. What?

19 MS. CALLAHAN: Is that the tab?

20 Is that the tab?

21 MR. PLACITELLA: Uh-huh.

22 MS. CALLAHAN: Right there.

23 MR. PLACITELLA: Okay. No,

24 it's not the one. It's a different one.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 165 of 330 PageID:

43754
Page 165

1 Give me a second.

2 Why don't you give me your

3 page. I'm happy to read it.

4 MR. MARINO: You -- would you

5 like to read it?

6 MR. PLACITELLA: Well, I'm

7 happy to read it. Just tell me what you

8 want me to read.

9 MR. MARINO: It's highlighted.

10 MR. PLACITELLA: Just to cut

11 things shorter.

12 BY MR. PLACITELLA:

13 Q. Okay. Had you ever seen the

14 testimony from the Sampson case of

15 Dr. Hemstock?

16 MR. MARINO: Would you -- stop.

17 MR. PLACITELLA: I'm just --

18 I'm just asking --

19 MR. MARINO: Either -- either

20 do as I was going to do, which is what

21 you said you were going to do, or let me

22 do it. But don't go off into another --

23 MR. PLACITELLA: It's my

24 question, with all due respect to you,

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 166 of 330 PageID:

43755
Page 166

1 okay.

2 MR. MARINO: I just -- I just

3 want you to ask him, because you made a

4 representation to him in a hypothetical

5 fashion that I think misstates the

6 testimony.

7 MR. PLACITELLA: I'm happy to

8 read it.

9 MR. MARINO: Please do.

10 MR. PLACITELLA: I'm just

11 asking him if he's ever seen it before.

12 MR. MARINO: Okay. Then

13 let's --

14 BY MR. PLACITELLA:

15 Q. Have you ever seen a deposition

16 of Dr. Hemstock in the Sampson case?

17 A. I -- I don't recall it.

18 Q. Okay.

19 A. I may have in the course of this.

20 Q. Okay. Now -- and I'll go back

21 and pull mine at -- at lunchtime but Mr. --

22 MR. MARINO: Well, I'm happy

23 to -- we -- we can -- we can let --

24 Chris, just --

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 167 of 330 PageID:

43756
Page 167

1 MR. PLACITELLA: Let me just

2 read it.

3 MR. MARINO: If you want to

4 delay, you can do that. I'm not --

5 MR. PLACITELLA: Let me just

6 read it.

7 MR. MARINO: All right.

8 MR. PLACITELLA: Okay.

9 MR. MARINO: If you want to

10 delay and do it when you pull it out, do

11 it when you pull it out.

12 BY MR. PLACITELLA:

13 Q. Okay. Do you have any

14 recollection of having a role in drafting the

15 March 7th, 1984, memo?

16 A. No, I don't -- do not.

17 Q. Okay. Do you have any

18 recollection of anybody in your department

19 having a role --

20 MR. FARRELL: Objection to

21 form.

22 BY MR. PLACITELLA:

23 Q. -- in drafting that memo?

24 A. No.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 168 of 330 PageID:

43757
Page 168

1 Q. Okay. In the memo, did you --

2 let me ask this question, did you see this

3 memo before it went out?

4 MR. FARRELL: Objection to

5 form.

6 THE WITNESS: I don't know.

7 BY MR. PLACITELLA:

8 Q. Would a memo like this be able to

9 go out without your approval?

10 MR. FARRELL: Objection to

11 form.

12 MR. TUNIS: Objection.

13 MR. FARRELL: Foundation and

14 calls for speculation.

15 THE WITNESS: Glenn Hemstock

16 did not report to me and could issue a

17 memo to his people whenever he wanted to.

18 BY MR. PLACITELLA:

19 Q. So your -- your testimony is,

20 just to be clear, that Glenn Hemstock would

21 have been authorized to send a memo like this

22 without your approval?

23 A. I didn't say he would have been

24 authorized. I said he could have done it.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 169 of 330 PageID:

43758
Page 169

1 Q. Okay.

2 A. A memo like this, one would think

3 would be authorized by somebody in the legal

4 department.

5 Q. Okay. Is it your recollection

6 that a memo like this, as a matter of

7 practice and policy at Engelhard, could be

8 issued by Dr. Hemstock without approval from

9 the legal department?

10 MR. FARRELL: Objection to form

11 and foundation.

12 THE WITNESS: I think the key

13 is "as a matter of practice and policy."

14 It should not -- it would not be in

15 accordance with our policy for that to

16 happen. However, it is possible that a

17 department head would do something

18 without checking with the legal

19 department.

20 BY MR. PLACITELLA:

21 Q. Do you have any idea why the

22 department head would issue a memo like this

23 without checking with the legal department?

24 MR. FARRELL: Objection; form;

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 170 of 330 PageID:

43759
Page 170

1 foundation.

2 MR. MARINO: Calls for

3 speculation.

4 MR. TUNIS: Mischaracterizes

5 testimony.

6 BY MR. PLACITELLA:

7 Q. Do you have any idea?

8 MR. FARRELL: Misstates his

9 testimony.

10 THE WITNESS: Oh, no.

11 BY MR. PLACITELLA:

12 Q. Okay. Now, in the second

13 paragraph, it says, "All information

14 contained in your files" -- and this was sent

15 to R&D, right -- "pertaining to these

16 operations," which included the Emtal talc

17 operation, correct?

18 A. Yes.

19 Q. Okay.

20 A. It says Emtal.

21 Q. -- "should be withdrawn and

22 placed in file boxes for discard.

23 Appropriate file boxes can be obtained from

24 Chuck Hachat at extension 5072."

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 171 of 330 PageID:

43760
Page 171

1 Do you see that?

2 A. Yes.

3 Q. Who is Chuck Hachat.

4 A. Hachat.

5 Q. Hachat.

6 A. He was sort of the office

7 manager.

8 Q. Okay. And it says, "Please keep

9 these boxes in your office area, available

10 for pick up on March 16th, 1984."

11 Do you see that?

12 A. Yes.

13 Q. Okay. And then it talks about

14 the intent to retain copies.

15 Do you see that?

16 A. Yes.

17 Q. Okay. Now, do you have a

18 recollection of this happening, that the

19 documents were gathered up from the R&D

20 department pursuant to this memo?

21 MR. FARRELL: Objection to

22 form.

23 THE WITNESS: I don't have a

24 recollection specific to the R&D

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 172 of 330 PageID:

43761
Page 172

1 department. I just know that there was a

2 corporate-wide effort to implement the

3 new policy. And to the extent that any

4 of the business groups required

5 assistance or help in understanding the

6 new policy, that they could call upon

7 the -- the help of the attorney assigned

8 to their group.

9 BY MR. PLACITELLA:

10 Q. Okay. It says here, "Please

11 understand that it is our intent to retain

12 copies of those documents to be preserved

13 from discontinued operations only in our

14 central files and can be accessed there

15 should the need arise."

16 Do you see that?

17 A. I see that.

18 Q. Who was in charge of central

19 files?

20 MR. FARRELL: Objection to

21 form; foundation.

22 THE WITNESS: I think, although

23 I'm not sure about at the time, but it

24 was probably a man named Al Viner,

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 173 of 330 PageID:

43762
Page 173

1 V-I-N-E-R.

2 BY MR. PLACITELLA:

3 Q. Okay. And who did he work for?

4 Who was his direct -- what department was he

5 in?

6 A. He probably worked for Chuck

7 Hachat as part of the general office

8 administration group.

9 Q. And do you have a -- and did --

10 was he part of legal?

11 A. No.

12 Q. Do you have a recollection of any

13 of the R&D files collected in 1984 being

14 transferred to your department?

15 MR. FARRELL: Objection to form

16 and foundation.

17 THE WITNESS: I do not.

18 BY MR. PLACITELLA:

19 Q. Okay. Do you recall whether,

20 before a document could be discarded,

21 pursuant to your document retention policy,

22 whether those documents had to be reviewed by

23 anybody in legal?

24 MR. FARRELL: Objection to

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 174 of 330 PageID:

43763
Page 174

1 form; foundation.

2 THE WITNESS: No.

3 BY MR. PLACITELLA:

4 Q. Okay. Before documents related

5 to research and development could be

6 discarded that were the subject of pending

7 litigation, would they have to be reviewed by

8 legal?

9 MR. FARRELL: Objection to form

10 and foundation.

11 MR. TUNIS: Objection; form.

12 Same.

13 THE WITNESS: If they were a

14 subject of pending litigation, they would

15 have been subject to a hold. And legal

16 would be involved in lifting that hold.

17 BY MR. PLACITELLA:

18 Q. So if there were cases pending

19 when this memo was issued, would the

20 documents first have to go to legal? If

21 there were -- let me rephrase the question.

22 If there were Emtal litigation

23 cases pending at the time of Dr. Hemstock's

24 memo, would those documents have to be first

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 175 of 330 PageID:

43764
Page 175

1 sent to legal before that they could be

2 discarded?

3 MR. FARRELL: Objection to

4 form --

5 MR. TUNIS: Objection to form.

6 MR. FARRELL: -- foundation;

7 misstates Dr. Hemstock's memo.

8 THE WITNESS: I -- I can't

9 answer.

10 MR. PLACITELLA: Okay.

11 THE WITNESS: I -- I don't

12 know.

13 MR. PLACITELLA: Okay. What do

14 you -- how do you want to handle lunch?

15 MR. MARINO: Do you want to go

16 off?

17 MR. PLACITELLA: Yeah. Go

18 ahead.

19 THE VIDEOGRAPHER: The time is

20 now 12:01 p.m. We're going off the

21 record.

22 (Whereupon, there was a

23 discussion held off the record.)

24 (Whereupon, a lunch recess was

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 176 of 330 PageID:

43765
Page 176

1 taken.)

2 THE VIDEOGRAPHER: The time is

3 now 1:07 p.m. We are back on the record.

4 MR. PLACITELLA: We're ready.

5 Kevin, are you ready?

6 MR. MARINO: I'm ready.

7 BY MR. PLACITELLA:

8 Q. Okay. So Mr. Marino was correct

9 before, that it -- it was actually BASF who

10 identified you.

11 Could you go to -- you have in

12 front of you Exhibit 41.

13 A. Uh-huh.

14 Q. And could you go to response No.

15 10 on page 11.

16 A. All right.

17 Q. Do you see where it says,

18 "Identify all persons and participants

19 involved in the development, drafting,

20 revising, dissemination, and execution of the

21 March 7, 1984 memorandum by Dr. Glen

22 Hemstock."

23 Do you see that?

24 A. Uh-huh. Yes.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 177 of 330 PageID:

43766
Page 177

1 Q. And do you see the response is --

2 BA -- after an objection, "BASF identifies:

3 Glen Hemstock; Arthur Dornbusch; Tom Halket;

4 and attorneys from Cahill Gordon."

5 Do you see that?

6 A. Yes.

7 Q. All right. Does that refresh

8 your recollection as to whether you were

9 involved in the drafting of the March 7th,

10 1984 memo we went over this morning?

11 A. No, it doesn't.

12 Q. It should have been marked

13 Exhibit 15.

14 A. No.

15 Q. All right. As you sit here

16 today, what is your testimony, were you

17 involved in -- I want to go through each one

18 specifically.

19 Did you have any role in the

20 development of the March 7th, 1984 memo?

21 MR. FARRELL: Objection to form

22 and foundation.

23 THE WITNESS: Not that I

24 recall.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 178 of 330 PageID:

43767
Page 178

1 BY MR. PLACITELLA:

2 Q. Okay. How about next, drafting?

3 MR. FARRELL: Same objections.

4 THE WITNESS: Same answer.

5 BY MR. PLACITELLA:

6 Q. Revising?

7 MR. FARRELL: Same objections.

8 THE WITNESS: No.

9 BY MR. PLACITELLA:

10 Q. Dissemination?

11 MR. FARRELL: Same objections.

12 THE WITNESS: No.

13 MR. MARINO: Please speak up

14 just a little bit, okay.

15 THE WITNESS: Yeah. Okay.

16 I -- I don't recall any of this.

17 BY MR. PLACITELLA:

18 Q. Or execution?

19 MR. FARRELL: Same objections.

20 THE WITNESS: No.

21 BY MR. PLACITELLA:

22 Q. Okay. Now, as it relates to

23 Dr. Hemstock, I think this is where

24 Mr. Marino was before, on page 35, he's

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 179 of 330 PageID:

43768
Page 179

1 asked: "And Mr. Dornbusch was who?"

2 "He was head of the legal

3 department at the time."

4 "And he worked at Menlo Park?"

5 "He did."

6 "Do you know who physically

7 drafted this memo?"

8 "No I can't tell you who

9 physically drafted. I don't know."

10 "But the legal department

11 basically told you to send this memo out,

12 right?"

13 Answer: "Yes."

14 Now, I think before that, he

15 actually asked you something -- a question

16 about Mr. Dornbusch. Hold on for a second.

17 I got it. Hold on.

18 MR. FARRELL: What are you

19 reading from Chris? Is this Sampson?

20 MR. PLACITELLA: Yeah.

21 MR. FARRELL: This is Hemstock

22 in Sampson?

23 MR. PLACITELLA: Yeah. Well, I

24 don't have the page.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 180 of 330 PageID:

43769
Page 180

1 BY MR. PLACITELLA:

2 Q. So Mr. -- Mr. Marino was correct.

3 A. Uh-huh.

4 Q. Do you have any recollection of

5 legal telling you to send that -- legal

6 telling Dr. Hemstock to send out this memo?

7 MR. FARRELL: Objection to form

8 and foundation.

9 THE WITNESS: No.

10 BY MR. PLACITELLA:

11 Q. Okay. Now, do you have any

12 recollection of reviewing any of the

13 materials that were retrieved pursuant to the

14 March 7, 1984 memo?

15 MR. FARRELL: Objection to

16 form.

17 THE WITNESS: No.

18 BY MR. PLACITELLA:

19 Q. Did you -- or -- is it you don't

20 remember, it didn't happen, or what?

21 MR. FARRELL: Objection to

22 form.

23 THE WITNESS: I don't remember.

24 BY MR. PLACITELLA:

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 181 of 330 PageID:

43770
Page 181

1 Q. Okay. And Dr. Hemstock, on

2 page 62 -- do you have that, Kevin?

3 MR. MARINO: I do.

4 BY MR. PLACITELLA:

5 Q. Okay. He's asked the following

6 question --

7 MR. BOYLE: What line?

8 MR. PLACITELLA: Fifteen.

9 BY MR. PLACITELLA:

10 Q. "After these documents were

11 retrieved pursuant to the March 7, 1984 memo,

12 where did they physically go?"

13 Answer: "I can't answer the

14 question except that they were sent to the

15 central storage, central storage repository

16 in the legal department, as best I know."

17 Question: "Who became the

18 custodian of those documents?"

19 Answer: "I would assume it

20 would be Mr. Dornbusch."

21 Do you see that?

22 A. I see it.

23 MR. PLACITELLA: All right. Is

24 there anything else you want me to read

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 182 of 330 PageID:

43771
Page 182

1 that's connected to that? Because I see

2 you flipping through the pages furiously,

3 Kevin?

4 MR. MARINO: No. You know that

5 when I flip furiously --

6 MR. PLACITELLA: Okay.

7 MR. MARINO: -- it's a much

8 different look than this.

9 BY MR. PLACITELLA:

10 Q. Okay. So does that refresh your

11 memory as to whether you took possession of

12 the documents that were retrieved pursuant to

13 the March 7, 1984 memo?

14 A. No.

15 Q. Okay. Now -- fifty -- 57.

16 MR. MARINO: Thank you.

17 MR. FARRELL: Thank you.

18 BY MR. PLACITELLA:

19 Q. I've given you -- let me put it

20 up here for everybody to see -- Answers to

21 Interrogatories served on behalf of Engelhard

22 Corporation in the United States District

23 Court for the Eastern District of

24 Pennsylvania.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 183 of 330 PageID:

43772
Page 183

1 Do you see that?

2 A. Yes.

3 Q. Okay. And if you look at the

4 second to last page, do you see they're

5 certified by Charles Carter?

6 A. Yes.

7 Q. Okay. And he was an executive at

8 Engelhard, correct?

9 MR. FARRELL: Objection to

10 form.

11 THE WITNESS: Yes.

12 BY MR. PLACITELLA:

13 Q. Who selected Charles Carter to

14 verify the discovery responses?

15 A. I don't know. I don't recall.

16 Q. Okay. Now, if you go to No. 12,

17 which I believe is on page 11, it says,

18 "Identify all past and present officers,

19 agents, servants, employees, representatives,

20 consultants, expert witnesses, or independent

21 contractors of this defendant who have ever

22 testified or been deposed in connection with

23 any claim or a lawsuit for asbestos-related

24 disease or exposure."

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 184 of 330 PageID:

43773
Page 184

1 Do you see that?

2 A. I see it, yes.

3 Q. And then it asks for copies of

4 the transcripts, et cetera.

5 Do you see that?

6 A. Yes.

7 Q. Do you see underneath that,

8 what's the answer?

9 A. None.

10 Q. Is that truthful?

11 MR. BOISE: Objection; form.

12 MR. FARRELL: Objection to form

13 and foundation.

14 BY MR. PLACITELLA:

15 Q. Is that accurate?

16 MR. BOISE: Same objections.

17 MR. MARINO: Wait. Can we

18 allow Mr. Dornbusch the opportunity to

19 review these.

20 MR. PLACITELLA: Absolutely.

21 MR. MARINO: Thank you.

22 THE WITNESS: I don't know.

23 BY MR. PLACITELLA:

24 Q. Do you --

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 185 of 330 PageID:

43774
Page 185

1 A. I don't know.

2 Q. So here, the representation

3 that's being made by Engelhard, that no one

4 was ever deposed in any asbestos case,

5 correct?

6 MR. FARRELL: Objection to

7 form; foundation.

8 MR. MARINO: Just take your

9 time and review the document.

10 MR. FARRELL: It misstates the

11 document.

12 MR. MARINO: Please take your

13 time and review the document.

14 MR. FARRELL: Can I have the

15 question again, please.

16 THE WITNESS: Yeah. The

17 question was?

18 MR. PLACITELLA: I'll -- I'll

19 reframe it.

20 THE WITNESS: Okay.

21 BY MR. PLACITELLA:

22 Q. This does not mention the

23 depositions taken of the Engelhard

24 scientists, correct?

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 186 of 330 PageID:

43775
Page 186

1 A. That --

2 MR. FARRELL: Objection to

3 form.

4 THE WITNESS: That is correct,

5 yes.

6 BY MR. PLACITELLA:

7 Q. All right. And they were clearly

8 known that they were taken to Engelhard at

9 the time that these Interrogatories were

10 answered, weren't they?

11 MR. FARRELL: Objection to

12 form.

13 BY MR. PLACITELLA:

14 Q. Engelhard knew that they were

15 deposed?

16 MR. FARRELL: Objection to

17 form; foundation.

18 MR. MARINO: It's -- and also

19 object to the form.

20 Can you clarify the question,

21 please, Chris.

22 BY MR. PLACITELLA:

23 Q. Engelhard was aware that

24 Dr. Hemstock, Dr. Triglia and Dr. Gale were

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 187 of 330 PageID:

43776
Page 187

1 deposed and gave testimony under oath,

2 correct, at the time that these

3 Interrogatories were answered?

4 MR. FARRELL: Objection to form

5 and foundation.

6 THE WITNESS: Okay. Well, the

7 date of these was September 12, 1995.

8 MR. PLACITELLA: Right.

9 THE WITNESS: And the testimony

10 of Dr. Hemstock and Triglia was in 1984.

11 So it would appear to be inaccurate.

12 BY MR. PLACITELLA:

13 Q. Okay. Now, I'm going to show you

14 what's been marked Exhibit 57. Take your

15 time and take a look at it. And I --

16 MR. TUNIS: Chris, is this a

17 different set of Interrogatories?

18 MR. PLACITELLA: Yes, it is.

19 Let me identify them for the record.

20 MR. TUNIS: Yeah. Could you do

21 that, please.

22 MR. PLACITELLA: Sure. Good

23 point.

24 BY MR. PLACITELLA:

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 188 of 330 PageID:

43777
Page 188

1 Q. These are Responses to

2 Interrogatories submitted to the Supreme

3 Court of the State of New York, in -- in Re:

4 New York City Asbestos Litigation, and

5 underneath that, the caption of Steven

6 Chernick.

7 Do you see that?

8 And if you go to No. 63 --

9 this was in 2002, correct?

10 A. This was apparently in April of

11 2002. And I see Interrogatory No. 63 and the

12 response to it appear to be similar to the

13 previous Interrogatory.

14 Q. And that's not accurate, is it?

15 MR. FARRELL: Objection to

16 form; foundation.

17 BY MR. PLACITELLA:

18 Q. It says here, "If any of your

19 employees or officers have testified" --

20 MR. FARRELL: Are you

21 withdrawing the last question?

22 MR. PLACITELLA: No. But he

23 already answered.

24 MR. FARRELL: He hasn't

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 189 of 330 PageID:

43778
Page 189

1 answered the question. I was in the

2 middle of serving an objection.

3 MR. PLACITELLA: I'll withdraw

4 and ask that -- this question.

5 BY MR. PLACITELLA:

6 Q. It says, "If any of your

7 employees or officers have testified at trial

8 or by deposition or before any Congressional

9 Committee or administration agency concerning

10 asbestos exposure, pulmonary or

11 asbestos-related disease or industrial

12 hygiene relating to asbestos use."

13 Do you see that? And it says

14 if none -- no, right?

15 MR. FARRELL: Objection.

16 Which question are you on?

17 MR. PLACITELLA: Sixty-three.

18 THE WITNESS: Well, this

19 question talks about asbestos.

20 So before -- go ahead.

21 MR. PLACITELLA: He's answering

22 a question. Let him answer the question.

23 MR. FARRELL: No, I.

24 MR. PLACITELLA: You can't --

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 190 of 330 PageID:

43779
Page 190

1 you can't interrupt in the middle of his

2 answer. Let him finish answering the

3 question.

4 MR. MARINO: He can interrupt

5 in the middle of his answer --

6 MR. FARRELL: I -- I --

7 MR. MARINO: -- to the extent

8 he wants to caution him --

9 MR. FARRELL: Not to waive --

10 MR. MARINO: Privileged

11 information.

12 MR. FARRELL: -- work product,

13 exactly.

14 Mr. Dornbusch is giving you

15 his opinion about a document that he's

16 never seen before in his former capacity

17 as general counsel for the company,

18 about whether information is or is not

19 responsive to requests, is calling for

20 the lawyer's opinion about responses to

21 requests in the context of litigation

22 and implicates work product. And that

23 was why I interrupted, because he was

24 about to offer his opinion as opposed to

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 191 of 330 PageID:

43780
Page 191

1 factual information.

2 So I would instruct

3 Mr. Dornbusch not to offer his opinions

4 on these subjects because they are

5 protected by privilege and work product.

6 BY MR. PLACITELLA:

7 Q. I'll ask the question this way.

8 There's no mention in response to this

9 question about the deposition of Dr. Hemstock

10 where he talked about asbestos testing,

11 correct?

12 MR. FARRELL: Objection to form

13 and foundation.

14 MR. MARINO: You're just asking

15 him to read the answer and say what it

16 says?

17 BY MR. PLACITELLA:

18 Q. There's no mention in response to

19 the Interrogatory about Dr. Hemstock,

20 correct, and his testimony?

21 A. Correct.

22 Q. There's no mention about the

23 testimony given by Peter Gale and about how

24 his testing found asbestos in the Emtal talc,

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 192 of 330 PageID:

43781
Page 192

1 correct?

2 MR. TUNIS: Objection.

3 MR. FARRELL: Objection to form

4 and foundation.

5 THE WITNESS: That's correct.

6 BY MR. PLACITELLA:

7 Q. There's no mention about the

8 deposition of Mr. -- Dr. Triglia, correct?

9 A. Correct.

10 MR. FARRELL: Same objections.

11 BY MR. PLACITELLA:

12 Q. Okay. Now, can you go to the

13 second page of the document.

14 Do you see under question one,

15 where it asks for the people answering the

16 Interrogatories?

17 A. I do.

18 Q. And who does it say answered the

19 Interrogatories?

20 A. Michael J. Hassett, associate

21 general counsel.

22 Q. He worked for you, correct?

23 A. Yes, he did.

24 Q. And Mr. Hassett would have had

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 193 of 330 PageID:

43782
Page 193

1 access to the testing evidence, correct --

2 MR. FARRELL: Objection to

3 form; foundation.

4 BY MR. PLACITELLA:

5 Q. -- for asbestos in Emtal talc?

6 MR. FARRELL: Objection to

7 form; foundation; misstates the record;

8 assumes facts.

9 THE WITNESS: I do not recall

10 Mike Hassett being involved in connection

11 with the talc litigation or the talc

12 business. It's possible that he became

13 involved later at -- at the time of this

14 matter and was not aware of the

15 previous -- previous litigation.

16 BY MR. PLACITELLA:

17 Q. So Mr. Hassett -- who authorized

18 him at the corporation to answer the

19 Interrogatories on behalf of the corporation?

20 MR. FARRELL: Objection to form

21 and foundation. The witness has

22 testified he doesn't even recall Hassett

23 being involved in the litigation. How

24 would he know who authorized him to do

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 194 of 330 PageID:

43783
Page 194

1 something in the litigation?

2 MR. PLACITELLA: That's a

3 speaking objection and not permitted

4 under the rules.

5 MR. FARRELL: We've been doing

6 this now for three hours.

7 MR. PLACITELLA: So could you

8 please -- could you please not do that.

9 MR. FARRELL: Objection to form

10 and foundation.

11 MR. PLACITELLA: Okay. Okay.

12 Because I will --

13 MR. FARRELL: Lacks foundation.

14 MR. PLACITELLA: -- take that

15 to the Court, okay. So I'd ask you to

16 comply with the rules and don't do that.

17 Okay? Apparently --

18 MR. FARRELL: I'd ask that you

19 lay a proper foundation for your

20 questions.

21 BY MR. PLACITELLA:

22 Q. Here's my foundation,

23 Mr. Dornbusch. Does the Interrogatory

24 answers that were submitted on behalf of your

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 195 of 330 PageID:

43784
Page 195

1 corporation in fact indicate that Mr. Hassett

2 was supplying the information?

3 MR. FARRELL: Objection to form

4 and foundation.

5 MR. MARINO: Can you direct him

6 to the page of the Interrogatories where

7 it indicates that Mr. Hassett is

8 providing the information, please.

9 MR. PLACITELLA: Page 2.

10 MR. MARINO: Okay.

11 MR. PLACITELLA: State the full

12 name, address, telephone number, and

13 position of the corporate officer

14 answering these Interrogatories.

15 MR. MARINO: Right.

16 MR. PLACITELLA: Michael J.

17 Hassett, Esquire, associate general

18 counsel for Engelhard Corporation,

19 coordinated Engelhard's responses to the

20 standard set.

21 MR. MARINO: Right.

22 BY MR. PLACITELLA:

23 Q. Do you see that?

24 MR. MARINO: And everybody sees

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 196 of 330 PageID:

43785
Page 196

1 it.

2 MR. PLACITELLA: I'm going --

3 I'm going --

4 MR. MARINO: My question to you

5 is, what are you gaining from asking

6 Mr. Dornbusch for hours to tell you what

7 these documents say? What is it -- what

8 does it -- how does it advance the ball

9 for you to ask this witness if, in fact,

10 where it says in an Interrogatory answer

11 that Mr. X provided the answers, it says

12 that Mr. X provided the answers. That's

13 my only -- I don't want to -- it's not a

14 speaking objection, just to add -- I'm

15 just trying to give you my --

16 MR. PLACITELLA: Is that

17 objection to form?

18 MR. MARINO: I'm trying to have

19 you understand the reason for it, because

20 maybe that could streamline things a

21 little.

22 MR. PLACITELLA: Right.

23 MR. MARINO: That's all.

24 And ask him the question.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 197 of 330 PageID:

43786
Page 197

1 It's not -- you know, he'll -- it will

2 be objected to or not objected to

3 according to form. He'll either be

4 directed to answer or not to answer, as

5 BASF determines.

6 But believe it or not, I'm --

7 I'm actually trying to facilitate rather

8 than impede. I just don't understand

9 what it adds.

10 BY MR. PLACITELLA:

11 Q. Do you know who Mr. Hassett -- so

12 today's -- well, let me ask you this

13 question. Today's the first day you ever

14 learned that Mr. Hassett, who worked for you

15 in the legal department, was involved in the

16 defense of the Emtal talc litigation?

17 MR. FARRELL: Objection to form

18 and foundation; misstates his testimony.

19 THE WITNESS: No. I -- I -- I

20 was not aware of today. I don't -- just

21 don't remember. Obviously, at the time,

22 I probably knew that he -- he was

23 involved. And I should also -- well,

24 okay. I'll just leave it at that.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 198 of 330 PageID:

43787
Page 198

1 BY MR. PLACITELLA:

2 Q. What -- do you understand what

3 his role was, his authorized role, for

4 coordinating Engelhard's responses to

5 standard discovery in the New York City

6 litigation?

7 MR. FARRELL: Objection to form

8 and foundation.

9 THE WITNESS: Well, other

10 than -- I mean, I would -- what you just

11 said, he was coordinating, pulling

12 together the facts to answer these

13 Interrogatories.

14 BY MR. PLACITELLA:

15 Q. Well, do you know what facts were

16 made available to him or what sources of

17 information were made available to him in

18 order to provide sworn answers to discovery?

19 MR. FARRELL: Objection to

20 form; foundation; calls for speculation.

21 THE WITNESS: And I don't know.

22 BY MR. PLACITELLA:

23 Q. Were the depositions of the

24 former Engelhard scientists who testified in

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 199 of 330 PageID:

43788
Page 199

1 the Westfall case made available to him?

2 MR. FARRELL: Same objections;

3 calls for speculation.

4 THE WITNESS: I don't know.

5 BY MR. PLACITELLA:

6 Q. Did you understand that a

7 corporate off -- a lawyer working in your

8 department, when helping respond to

9 discovery, had an obligation to do a

10 reasonable investigation of the information

11 that was available to the corporation before

12 providing sworn answers?

13 MR. FARRELL: Objection to

14 form.

15 THE WITNESS: Yes.

16 BY MR. PLACITELLA:

17 Q. Okay. And do you know whether

18 either Cahill Gordon or yourself made the

19 Hem -- the Westfall file available to

20 Mr. Hassett in responding to these answers?

21 MR. FARRELL: Objection to form

22 and foundation; assumes facts; misstates

23 the record.

24 THE WITNESS: I don't know.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 200 of 330 PageID:

43789
Page 200

1 BY MR. PLACITELLA:

2 Q. Did you make available to

3 Mr. Hassett the testing evidence that was

4 found in your files that were -- that was the

5 subject of the Hyde memo?

6 MR. MARINO: Objection to that

7 question. That misstates the record.

8 MR. FARRELL: Objection to form

9 and foundation; misstates the record.

10 BY MR. PLACITELLA:

11 Q. I'll ask the question a different

12 way. You have P-1 here in front of you.

13 Did you make available to

14 Mr. Hassett any of the information that's

15 contained in P-1 which was the memo -- or

16 attached to the memo written to you by

17 Mr. Hyde concerning the testing evidence in

18 Emtal talc?

19 MR. MARINO: Objection to form;

20 misleading.

21 MR. FARRELL: Objection to form

22 and foundation; misstates the record and

23 assumes facts.

24 MR. PLACITELLA: Why don't you

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 201 of 330 PageID:

43790
Page 201

1 state what the record is so we know.

2 MR. FARRELL: I'm happy to

3 state what the record is. This record is

4 that the witness so far has testified to

5 having no present recollection of Michael

6 Hassett being involved in the case at all

7 and no present recollection of the

8 document you've labeled P-1 being in his

9 file at any point in time, has never

10 before seen. And you haven't laid any

11 foundation for the witness having before

12 seen the Chernick Interrogatory

13 responses.

14 Moreover, we've been over and

15 over again on the fact that the document

16 was not in Mr. Dornbusch's possession at

17 this point in time. And you're now

18 asking layer upon layer of speculation

19 and assumed facts to a witness who

20 said -- you've -- you still have not

21 established any foundation for a single

22 question you've asked about this

23 document, that the witness has never

24 seen before, apparently.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 202 of 330 PageID:

43791
Page 202

1 MR. PLACITELLA: Okay.

2 MR. FARRELL: So that is what

3 the record is.

4 MR. PLACITELLA: Okay.

5 MR. FARRELL: You're now asking

6 misleading questions that are contrary to

7 the record to a witness who has no

8 personal knowledge of the answers you're

9 trying to elicit.

10 MR. PLACITELLA: Okay. Thank

11 you.

12 BY MR. PLACITELLA:

13 Q. Now, did you make this document

14 available to Mr. Hassett when he was

15 coordinating discovery responses in the New

16 York City litigation?

17 MR. FARRELL: Objection to

18 form; foundation; misstates the record;

19 assumes facts.

20 MR. MARINO: I join in all

21 those objections. That's not -- that's

22 not what the testimony has been, Chris,

23 in fairness.

24 MR. PLACITELLA: Okay. The

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 203 of 330 PageID:

43792
Page 203

1 testimony will speak for itself.

2 MR. MARINO: Yes.

3 BY MR. PLACITELLA:

4 Q. Did you make this document

5 available to him?

6 MR. FARRELL: Same objections.

7 THE WITNESS: I don't know.

8 BY MR. PLACITELLA:

9 Q. Okay. Did you make any of the

10 testing evidence concerning asbestos in Emtal

11 talc available to Mr. Hassett in coordinating

12 discovery responses in the New York City

13 litigation?

14 MR. FARRELL: Same objections;

15 assumes facts.

16 THE WITNESS: I don't -- I

17 don't know. I don't -- I didn't even

18 recall, until you showed me this Exhibit

19 57, that there was a New York City

20 litigation.

21 MR. PLACITELLA: Can you give

22 me -- what was -- give me these.

23 BY MR. PLACITELLA:

24 Q. For the record, I'm just going to

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 204 of 330 PageID:

43793
Page 204

1 identify them, and then I'll hand them to

2 everyone. Exhibit 108 is a January 22nd,

3 1990 letter to a Mr. Hobson from Eric Sarner.

4 Exhibit 121 is an April 23rd, 1990 letter

5 from Eric Sarner to Jim LaFevor. Exhibit 210

6 is a January (sic) 16th, 1991 letter from

7 Eric Sarner to David Shroyer. Exhibit 148 is

8 a November 18th, 2003 letter from Patrick

9 Newell to a Mr. Rudberg. I ask you to take a

10 look at these.

11 A. (The witness complies.) Okay.

12 Q. Okay. And all of those letters

13 talk about requesting dismissals of cases; is

14 that fair?

15 A. Yes.

16 MR. FARRELL: Objection to

17 form.

18 BY MR. PLACITELLA:

19 Q. Okay. And in all of those

20 letters, Mr. Fliegel, is cc'd, correct?

21 MR. FARRELL: Objection to

22 form; misstates the letters.

23 THE WITNESS: I did not -- I

24 did not check. The first one, Exhibit

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 205 of 330 PageID:

43794
Page 205

1 148, does not name Fliegel. It names

2 Hassett, Peter Sloane and Mike Sullivan.

3 BY MR. PLACITELLA:

4 Q. You're correct about that.

5 A. He's named in Exhibit 210 and

6 123.

7 MR. MARINO: Just for clarity,

8 named, you mean copied on, right?

9 THE WITNESS: Copied on, yeah.

10 Copied in -- on 121 and 108.

11 BY MR. PLACITELLA:

12 Q. Okay. Now, do these letters

13 indicate to you that Cahill Gordon was

14 keeping Mr. Fliegel in -- up to speed in

15 terms of what was going on in the litigation?

16 MR. FARRELL: Objection to

17 form; foundation; calls for speculation.

18 MR. MARINO: Are -- just for

19 clarity, are you asking him if he has

20 some independent knowledge of that, or

21 are you asking him to read these letters,

22 see that Mr. Fliegel is copied on them,

23 and -- and into it -- the conclusion

24 that you suggested?

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 206 of 330 PageID:

43795
Page 206

1 MR. PLACITELLA: Well, I'll ask

2 the first question.

3 MR. MARINO: Please.

4 BY MR. PLACITELLA:

5 Q. Do you know that -- are you aware

6 that Cahill Gordon was keeping Mr. Fliegel

7 informed as to what was going on in the

8 litigation?

9 MR. TUNIS: Objection to the

10 form.

11 THE WITNESS: I was not aware

12 of it until I -- I saw these exhibits.

13 BY MR. PLACITELLA:

14 Q. Okay. Did you -- Did you ever

15 authorize either one of your lawyers or

16 Cahill Gordon to seek dismissals on the basis

17 that there -- Emtal talc was asbestos free?

18 MR. FARRELL: Objection to

19 form; foundation.

20 Are you asking him whether

21 weather he gave that specific

22 instruction?

23 MR. PLACITELLA: The question

24 stands.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 207 of 330 PageID:

43796
Page 207

1 MR. FARRELL: Then I need to

2 assert attorney-client privilege and

3 instruct you not to answer it.

4 THE WITNESS: I'm not --

5 MR. FARRELL: You've been

6 instructed not to answer the question.

7 THE WITNESS: -- I'm going

8 to answer --

9 MR. MARINO: Just no response.

10 BY MR. PLACITELLA:

11 Q. Were you aware that the lawyers

12 who worked for you and Cahill Gordon were

13 seeking dismissal of talc cases based upon a

14 representation than there was no asbestos in

15 the Emtal talc?

16 MR. FARRELL: Objection to

17 form; foundation; assumes facts.

18 MR. BOISE: Misstates the

19 record.

20 THE WITNESS: I'm -- I don't

21 recall if I was or was not.

22 BY MR. PLACITELLA:

23 Q. Would that have been an accurate

24 representation?

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 208 of 330 PageID:

43797
Page 208

1 MR. FARRELL: Objection to

2 form; foundation; work product; and

3 attorney-client privilege.

4 I instruct you not to answer

5 the question.

6 BY MR. PLACITELLA:

7 Q. I'm going to show you what's been

8 marked as Exhibit 5.

9 MR. MARINO: Thank you.

10 BY MR. PLACITELLA:

11 Q. Exhibit 5 is a -- an Affidavit

12 executed by William Ashton.

13 Have you ever seen that

14 Affidavit before?

15 MR. TUNIS: Chris, are you

16 going to flash this on the screen,

17 please.

18 MR. PLACITELLA: Okay.

19 BY MR. PLACITELLA:

20 Q. Do you see that?

21 A. Yes.

22 Q. Have you ever seen this before?

23 A. I don't know.

24 Q. Do you know who William Ashton

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 209 of 330 PageID:

43798
Page 209

1 was?

2 A. I -- I wouldn't off the top of my

3 head. I see in the Affidavit that he was

4 employed by the Johnson & Johnson company.

5 Q. Do you have a recollection

6 whether you ever authorized your attorneys to

7 use the Ashton Affidavit to secure dismissals

8 of cases around the country?

9 MR. FARRELL: Objection to form

10 and foundation.

11 Can you answer that with a yes

12 or no, Mr. Dornbusch?

13 THE WITNESS: No.

14 MR. FARRELL: Do you know the

15 answer to the question?

16 THE WITNESS: No, I don't.

17 BY MR. PLACITELLA:

18 Q. Okay. I'm going to show you --

19 you have Dornbusch-2 in front of you? Are we

20 keeping these straight?

21 MR. BOISE: Is this log

22 excerpts?

23 MR. PLACITELLA: Yes.

24 BY MR. PLACITELLA:

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 210 of 330 PageID:

43799
Page 210

1 Q. I'm going to -- I put in front of

2 you the Dornbusch-2, which was the privilege

3 log. And specifically, I'm looking at entry

4 195 and it looks like 572.

5 MR. MARINO: Can you give us

6 the date, by date, please.

7 MR. PLACITELLA: 4/28/89,

8 5/18/89, respectively. It's at the very

9 top of the page.

10 MR. MARINO: 4/28, and what's

11 the second one?

12 MR. PLACITELLA: 5/18.

13 MR. MARINO: Got it.

14 BY MR. PLACITELLA:

15 Q. This log addresses an exchange

16 between -- the first one, between yourself

17 and Mr. Sloane.

18 Do you see that?

19 A. Yes.

20 Q. And it talks about a letter

21 transmitting attorney-client communication

22 regarding the Ashton Affidavit?

23 A. I see that.

24 Q. And then 572 is an exchange

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 211 of 330 PageID:

43800
Page 211

1 between Mr. Dembrow -- he worked for Cahill

2 Gordon?

3 A. Yes.

4 Q. -- okay, yourself, Mr. Fliegel

5 and Mr. Sloane.

6 Do you see that?

7 A. I do.

8 Q. And it's memo and attachments

9 transmitting the Ashton Affidavit.

10 Do you see that?

11 A. I do, yes.

12 Q. Does that refresh your

13 recollection as to whether you had ever seen

14 or known about the Ashton Affidavit being

15 used in litigation?

16 MR. FARRELL: Objection to form

17 and foundation.

18 THE WITNESS: No.

19 BY MR. PLACITELLA:

20 Q. Okay. Do you have Exhibit 41 in

21 front of you?

22 A. Yes.

23 Q. It's your Answers to

24 Interrogatories. Interrogatory No. 11 --

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 212 of 330 PageID:

43801
Page 212

1 MR. TUNIS: Could you flash it

2 on the screen, please.

3 MR. PLACITELLA: I'm sorry. I

4 thought I did that.

5 BY MR. PLACITELLA:

6 Q. -- asks, "Identify all persons

7 and participants involved in the development,

8 drafting, revising, dissemination and

9 execution of the May 8th, 1989 affidavit of

10 Mr. William H. Ashton, (Attached as Ex. 4 to

11 Plaintiffs' Second Amended Class Action

12 Complaint)."

13 Do you see that?

14 A. Yes, I do.

15 Q. It says, after the objections,

16 "BASF states that Cahill attorneys, including

17 Peter Sloane and Ira Dembrow, drafted,

18 revised, and worked with William Ashton to

19 finalize and sign the May 8, 1989 affidavit

20 of William H. Ashton. Attorneys for Johnson

21 & Johnson also were involved. BASF further

22 states that, in addition to various other

23 materials that vary by case, Cahill attorneys

24 disseminated Mr. Ashton's May 8, 1989 at

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 213 of 330 PageID:

43802
Page 213

1 various points in time while Cahill served as

2 national counsel in Engelhard personal injury

3 litigation from 1989 until the 2000s.

4 Did I read that correct so

5 far?

6 A. Yes.

7 Q. Okay. Now, I have some questions

8 about that.

9 Do you know -- were you aware

10 this was going on?

11 MR. MARINO: Objection to the

12 form of the question.

13 BY MR. PLACITELLA:

14 Q. That that -- were you aware that

15 this Affidavit was being drafted in

16 conjunction with Johnson & Johnson and then

17 being disseminated around the country?

18 MR. FARRELL: Objection to

19 form.

20 THE WITNESS: I don't remember.

21 BY MR. PLACITELLA:

22 Q. Do you know why Johnson & Johnson

23 was involved in drafting an Affidavit related

24 to the defense of your cases?

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 214 of 330 PageID:

43803
Page 214

1 MR. FARRELL: Objection to the

2 form; foundation.

3 You may give a yes or no

4 answer to that.

5 THE WITNESS: No.

6 BY MR. PLACITELLA:

7 Q. Is this the first time that

8 you've learned that Johnson & Johnson was

9 involved in the defense of Emtal talc cases

10 on behalf of Engelhard?

11 MR. FARRELL: Objection to form

12 and foundation; misstates the record.

13 MR. MARINO: Join in that

14 objection.

15 THE WITNESS: I knew that the

16 mine had been purchased from Johnson &

17 Johnson. So I'm not surprised that they

18 might -- that they would have been

19 involved in the defense, but I don't

20 recall working with them.

21 BY MR. PLACITELLA:

22 Q. Okay. Can you go back to

23 Dornbusch-3. Oh, you don't have it. I'm

24 sorry.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 215 of 330 PageID:

43804
Page 215

1 Do you know who -- let me

2 just -- take a second to take a look at it.

3 A. (The witness complies.)

4 MR. FARRELL: What are we

5 looking at here?

6 MR. PLACITELLA: We are -- what

7 we have is an excerpt of the BASF

8 privilege log.

9 BY MR. PLACITELLA:

10 Q. So let me refer your -- you to

11 directly to the last two entries on the page.

12 Do you see where it states 7/18/1995, and

13 there's an exchange between yourself and a

14 Mr. O'Shaughnessy?

15 A. Well, there's -- O'Shaughnessy is

16 the author and it's -- the recipients are

17 listed as Les Fliegel, myself, and Peter

18 Sloane.

19 Q. Correct.

20 Do you know who

21 Mr. O'Shaughnessy was?

22 A. No.

23 Q. Okay. Do you know whether he was

24 counsel to Johnson & Johnson.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 216 of 330 PageID:

43805
Page 216

1 MR. FARRELL: Objection to form

2 and foundation.

3 THE WITNESS: I have no idea --

4 no information about that.

5 MR. PLACITELLA: Okay.

6 THE WITNESS: I would have

7 guessed he was a Cahill lawyer, but --

8 BY MR. PLACITELLA:

9 Q. Okay. So you don't know who he

10 is?

11 A. No.

12 Q. Okay. Do you know you -- well, I

13 want to go up to the third and -- to the

14 fourth -- the third and fourth entry. The

15 first date is 4/4/1989. And then there's

16 another entry from 4/4/89.

17 Do you see that?

18 A. Yes.

19 Q. Okay. And it -- and the subject

20 is, Memo providing legal analysis regarding

21 preparation of the Ashton Affidavit.

22 Do you see that?

23 A. Yes.

24 Q. Okay. And there is an exchange

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 217 of 330 PageID:

43806
Page 217

1 between Mr. Dembrow and Mr. Sloane,

2 Mr. Sarner, and Mr. O'Shaughnessy.

3 Do you see that?

4 A. Yes.

5 Q. All right. Do you have any idea

6 what his role was, Mr. O'Shaughnessy, in --

7 in drafting of the Ashton Affidavit?

8 MR. FARRELL: Objection to

9 form; foundation.

10 THE WITNESS: No.

11 BY MR. PLACITELLA:

12 Q. Okay. Can you go back to

13 Dornbusch-2, please.

14 MR. FARRELL: Is that the other

15 priv log?

16 MR. PLACITELLA: Uh-huh. Yes.

17 BY MR. PLACITELLA:

18 Q. Can you go down to --

19 MR. TUNIS: That's on the

20 screen?

21 MR. PLACITELLA: Yep.

22 BY MR. PLACITELLA:

23 Q. -- the entry for 7/1/83.

24 MR. FARRELL: That's the date,

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 218 of 330 PageID:

43807
Page 218

1 Chris?

2 MR. PLACITELLA: Yes.

3 BY MR. PLACITELLA:

4 Q. And that's --

5 A. On --

6 Q. -- it talks about --

7 MR. MARINO: On the second

8 page?

9 MR. PLACITELLA: Yes.

10 THE WITNESS: Okay.

11 BY MR. PLACITELLA:

12 Q. It talks about a letter and

13 attachment containing legal strategy

14 regarding tolling agreement in Westfall

15 litigation. And it's from Mr. Sloane to

16 yourself, Mr. Halket, Mr. Hyde, and Mr. Kohn.

17 Do you see that?

18 A. I do, yes.

19 Q. Do you have a recollection of

20 entering into a tolling agreement in the

21 context of the Westfall litigation?

22 MR. FARRELL: Objection to

23 form.

24 THE WITNESS: No.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 219 of 330 PageID:

43808
Page 219

1 BY MR. PLACITELLA:

2 Q. Okay. Did you ever enter into a

3 tolling agreement at any point in time with

4 Johnson & Johnson?

5 MR. FARRELL: Same objection.

6 THE WITNESS: I'm not aware of

7 it.

8 BY MR. PLACITELLA:

9 Q. Okay. Did you ever have any kind

10 of arrangement with Johnson & Johnson whereby

11 they would assist you with the defense if you

12 agreed not to sue them?

13 MR. FARRELL: Objection to the

14 form; foundation; privilege; common

15 interest privilege. I instruct him not

16 to answer the question.

17 MR. PLACITELLA: Okay. Give me

18 Exhibit 6.

19 BY MR. PLACITELLA:

20 Q. Exhibit 6 is an August 18th, 1989

21 Affidavit drafted by Charles Carter -- or

22 signed by Charles Carter?

23 A. Yes.

24 Q. And he was an Engelhard

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 220 of 330 PageID:

43809
Page 220

1 executive?

2 MR. FARRELL: Object to the

3 form.

4 THE WITNESS: He was an

5 employee of Engelhard.

6 BY MR. PLACITELLA:

7 Q. Okay. And do you know who

8 authorized Charles Carter to sign this

9 Affidavit on behalf of Engelhard?

10 MR. FARRELL: Objection to form

11 and foundation.

12 THE WITNESS: No.

13 BY MR. PLACITELLA:

14 Q. Okay. Do you see on the -- do

15 you see where he says he does it based on his

16 personal knowledge under penalty of perjury?

17 A. Yes.

18 Q. Okay. And do you see the third

19 paragraph, where it says, "In addition,

20 Engelhard does not currently possess any

21 testing data other than the data provided to

22 you by way of the Ashton Affidavit and the

23 report of Dr. Pooley"?

24 Do you see that?

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 221 of 330 PageID:

43810
Page 221

1 A. Yes.

2 Q. Is that an accurate statement --

3 MR. FARRELL: Objection.

4 BY MR. PLACITELLA:

5 Q. -- from your knowledge of what

6 was available to Engelhard --

7 MR. FARRELL: Objection to

8 form.

9 BY MR. PLACITELLA:

10 Q. -- in terms of testing data?

11 MR. FARRELL: Are you finished?

12 MR. PLACITELLA: Yeah.

13 MR. FARRELL: Object --

14 objection to form; foundation; calls for

15 speculation.

16 THE WITNESS: I don't know.

17 BY MR. PLACITELLA:

18 Q. Well, you had the testing data in

19 your possession, didn't you?

20 A. In 1989, I don't know.

21 MR. FARRELL: Same.

22 BY MR. PLACITELLA:

23 Q. Okay. So you don't know whether

24 this is an accurate statement or not?

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 222 of 330 PageID:

43811
Page 222

1 A. I do not.

2 MR. FARRELL: Objection to

3 form; foundation; misstates the witness's

4 testimony.

5 MR. MARINO: The question also

6 misstates the record and is, in that

7 regard, a representation.

8 BY MR. PLACITELLA:

9 Q. I'm just asking you --

10 A. I -- I don't know.

11 Q. Okay. Based on what you knew

12 about the testing data that was in the

13 possession of Engelhard, would you have

14 authorized this Affidavit?

15 MR. FARRELL: Objection to

16 form; foundation; calls for speculation;

17 and misstates the record.

18 MR. MARINO: Objection;

19 misstates the record.

20 BY MR. PLACITELLA:

21 Q. You can answer.

22 A. It would depend on what -- what I

23 knew at the time. If I -- and what I had in

24 my possession at the time.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 223 of 330 PageID:

43812
Page 223

1 Q. Okay. Do you recall receiving a

2 copy of this Affidavit before it was sent

3 out?

4 MR. FARRELL: Objection to form

5 and foundation.

6 THE WITNESS: No.

7 BY MR. PLACITELLA:

8 Q. Okay. Can you go to Dornbusch-2

9 again, please. Let me direct your attention

10 to the entry on the privilege log, Number

11 1472, 8/18/89.

12 Do you see that?

13 A. Yes.

14 Q. That's the date that the

15 Affidavit was signed, correct?

16 A. Well, it was signed by that date.

17 Q. Well, it indicates on the

18 Affidavit that it was signed on 8/18/89,

19 correct?

20 A. No. It says it -- it's

21 transmitting this signed Affidavit.

22 Q. No. I'm sorry. We're talking --

23 A. It was signed on or before that

24 date.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 224 of 330 PageID:

43813
Page 224

1 Q. Do you see Mr. Carter's

2 signature?

3 A. Yes.

4 Q. That was what date?

5 A. August 18.

6 Q. 1989?

7 A. Yes.

8 Q. And this is -- according to this,

9 this is a letter, an attachment, transmitting

10 the signed Affidavit by Mr. Carter to you on

11 the exact same date, correct?

12 A. Correct.

13 Q. Did there ever come a time

14 shortly before you retired where you became

15 aware of evidence --

16 A. It's an ambulance.

17 Q. -- related to the Westfall case?

18 MR. FARRELL: Objection to form

19 and foundation.

20 Can you answer this with a yes

21 or no, Mr. Dornbusch, without getting

22 into the substance of any

23 communications?

24 THE WITNESS: Yes.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 225 of 330 PageID:

43814
Page 225

1 MR. FARRELL: Okay. What is

2 the answer?

3 THE WITNESS: The answer is

4 yes.

5 MR. FARRELL: Okay.

6 BY MR. PLACITELLA:

7 Q. And do you recall a case called

8 Martin?

9 A. No.

10 Q. Okay. If you go to Exhibit 41

11 and go to question No. 14. I'm sorry, it's

12 the wrong one.

13 MR. TUNIS: Chris, could you

14 identify or have the witness --

15 MR. PLACITELLA: Yeah, sure.

16 MR. TUNIS: -- identify what 41

17 is?

18 MR. PLACITELLA: Yeah,

19 absolutely.

20 MR. TUNIS: And put on the

21 screen the question that you are

22 referring to. Thank you.

23 BY MR. PLACITELLA:

24 Q. Okay. The -- Exhibit No. 41,

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 226 of 330 PageID:

43815
Page 226

1 again, is the Interrogatory answers submitted

2 by BASF in this case. And Interrogatory No.

3 12 indicates, Identify all BASF personnel

4 knowledgeable about, or involved in, the

5 matter captioned as Martin vs. Uniroyal,

6 filed in the Superior Court of the State of

7 Rhode Island.

8 Do you see that?

9 A. No. 12?

10 MR. MARINO: Thirteen.

11 MR. PLACITELLA: Thirteen, my

12 fault.

13 THE WITNESS: Oh, 13.

14 MR. PLACITELLA: Yeah.

15 THE WITNESS: I see that, yeah.

16 Yes.

17 BY MR. PLACITELLA:

18 Q. Okay. And then, if you go to the

19 next page, after the objection it states that

20 BASF states that Engelhard employees Arthur

21 Dornbusch and Michael Hassett were aware of

22 the Martin case and communicated with the

23 Cahill attorneys who defended the case in the

24 Martin case.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 227 of 330 PageID:

43816
Page 227

1 Do you see that?

2 A. Yes.

3 Q. All right. Does that refresh

4 your memory as to whether you had knowledge

5 about the Martin case?

6 MR. FARRELL: Objection to form

7 and foundation.

8 THE WITNESS: It does -- no, it

9 does not --

10 MR. PLACITELLA: Okay.

11 THE WITNESS: -- refresh my

12 recollection.

13 BY MR. PLACITELLA:

14 Q. Had you ever learned from

15 Mr. Hassett that in the context of the case

16 that was pending in the 2004, 2005 time

17 frame, that a report of Dr. Glassley, who was

18 the plaintiff's expert in the Westfall case,

19 had surfaced?

20 MR. FARRELL: Objection to

21 form; foundation.

22 You're asking -- can I have

23 the question again, please.

24 (Whereupon, the court reporter

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 228 of 330 PageID:

43817
Page 228

1 read back the record as requested.)

2 MR. FARRELL: Attorney-client

3 privilege, given that you're asking about

4 a communication between Mr. Dornbusch and

5 Mr. Hassett.

6 I instruct you not to answer

7 the question.

8 BY MR. PLACITELLA:

9 Q. Were you aware, in the 2004, 2005

10 time frame, that an expert who was prepared

11 to testify that there was asbestos in the

12 Johnson mine existed?

13 MR. FARRELL: Objection to form

14 and foundation.

15 THE WITNESS: I'm -- I don't

16 recall that.

17 BY MR. PLACITELLA:

18 Q. Okay. Do you recall at some

19 point in time Mr. Sullivan, at the Cahill

20 Gordon firm, locating copies of the

21 transcripts from the Westfall case?

22 MR. FARRELL: Objection to

23 form; foundation.

24 THE WITNESS: No.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 229 of 330 PageID:

43818
Page 229

1 BY MR. PLACITELLA:

2 Q. Okay. Were you ever made aware

3 that Engelhard settled the Martin case for

4 $400,000 and required the report of

5 Dr. Glassley, where he indicated there was

6 asbestos found in the samples that he tested,

7 were required to be returned in exchange for

8 the $400,000 payment?

9 A. No.

10 MR. FARRELL: Objection to

11 form; foundation; misstates the record.

12 Can you specify, made aware by

13 whom?

14 MR. PLACITELLA: Any source.

15 He said no.

16 MR. FARRELL: Are you including

17 lawyers in that source? Because the

18 question then implicates privilege

19 issues. Or do you want to rephrase it in

20 a way to get out of the communications?

21 MR. PLACITELLA: I think he

22 already answered it, frankly.

23 MR. FARRELL: Was it a no?

24 THE WITNESS: No.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 230 of 330 PageID:

43819
Page 230

1 MR. MARINO: Yes.

2 MR. PLACITELLA: Okay.

3 MR. FARRELL: Done.

4 BY MR. PLACITELLA:

5 Q. What information concerning the

6 Westfall case did you become aware of shortly

7 before you retired?

8 MR. FARRELL: Objection to

9 form; foundation; attorney-client

10 privilege; and work product.

11 I instruct you not to answer

12 the question.

13 BY MR. PLACITELLA:

14 Q. Okay. Did there come a point in

15 time --

16 (Whereupon, there was a brief

17 interruption.)

18 MR. PLACITELLA: Sorry. My

19 mother.

20 MR. MARINO: Do you want to

21 take a break?

22 MR. PLACITELLA: That's all

23 right.

24 MR. MARINO: Are you sure?

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 231 of 330 PageID:

43820
Page 231

1 MR. PLACITELLA: Yeah.

2 MR. MARINO: For the record, I

3 just want to say that when my mother

4 calls, I take a break.

5 MR. PLACITELLA: Yeah. Well, I

6 will take a break in a second, because

7 it -- off the record.

8 (Whereupon, there was a

9 discussion held off the record.)

10 BY MR. PLACITELLA:

11 Q. At some point in time, there was

12 a hostile takeover bid for Engelhard by BASF;

13 is that correct?

14 A. Yes.

15 Q. Okay. And when was that?

16 A. I think it -- it began in

17 December of 2005.

18 Q. Okay. And what, if any, role did

19 you have in that circumstance?

20 MR. FARRELL: Objection to

21 form.

22 THE WITNESS: As company

23 counsel, I provided legal services and

24 advised to our management in responding

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 232 of 330 PageID:

43821
Page 232

1 to the proposal.

2 BY MR. PLACITELLA:

3 Q. Okay. And did Engel -- did BASF

4 have its own representation in that

5 transaction?

6 MR. FARRELL: Objection to

7 form.

8 THE WITNESS: I'm -- I'm sure

9 they did. I --

10 MR. PLACITELLA: Okay.

11 THE WITNESS: -- don't recall

12 who it was.

13 BY MR. PLACITELLA:

14 Q. Did there ever come a time when

15 you had a face-to-face meeting with BASF

16 concerning the takeover?

17 MR. FARRELL: Objection to

18 form.

19 THE WITNESS: There were

20 several meetings, I believe.

21 BY MR. PLACITELLA:

22 Q. All right. And who was present

23 at those meetings?

24 MR. FARRELL: Objection to form

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 233 of 330 PageID:

43822
Page 233

1 and foundation.

2 THE WITNESS: There were a lot

3 of people. I couldn't tell you -- begin

4 to tell you everybody.

5 BY MR. PLACITELLA:

6 Q. Well, give me the people you

7 remember.

8 A. Well, there was our senior

9 management, Barry Perry, Mike Sperduto, our

10 CFO, myself, counsel -- we had outside -- we

11 had counsel from Cahill Gordon and also

12 counsel from -- oh, the -- we had retained

13 special counsel for the acquisition. Marty

14 Lipton's firm.

15 Q. Okay.

16 A. And I forget the name of his

17 partner who was working with us. And there

18 was also an associate whose name I don't

19 recall. That was on our side.

20 Then on -- on the BASF side,

21 there were a number of senior people from

22 Germany. I don't remember their names. But

23 all together, there were, I'd say, a couple

24 dozen people in the room.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 234 of 330 PageID:

43823
Page 234

1 Q. Okay. Any names you remember?

2 A. I know -- I remember Stryker.

3 And I always get his name confused with the

4 golf player. It wasn't Steve Stryker. What

5 was -- his first name --

6 Q. Was it David Stryker?

7 A. Yeah, David Stryker. He was

8 there. He was the lawyer. I don't -- I just

9 don't remember. I'm not very good with

10 names.

11 Q. Okay. Was this an arm's length

12 negotiation that was going on?

13 MR. MARINO: Objection.

14 MR. FARRELL: Objection; form

15 foundation.

16 THE WITNESS: Yes.

17 MR. PLACITELLA: Okay.

18 THE WITNESS: Yes.

19 BY MR. PLACITELLA:

20 Q. And the -- did you understand

21 that as part of the takeover, that you, as

22 corporate counsel, had an obligation to

23 disclose any significant litigation risks

24 that the company was facing at the time?

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 235 of 330 PageID:

43824
Page 235

1 MR. FARRELL: Objection to

2 form.

3 THE WITNESS: Yes.

4 BY MR. PLACITELLA:

5 Q. Okay. And did you, in fact,

6 disclose any significant litigation risks

7 that the company was disclosing at the time?

8 MR. FARRELL: Objection to form

9 and foundation. If you can answer that

10 without disclosing the substance of any

11 such communications, if there were any.

12 So I think a yes or a no or I don't know.

13 THE WITNESS: Yes.

14 BY MR. PLACITELLA:

15 Q. You did disclose?

16 A. Yes.

17 Q. Did the subject of the Emtal tank

18 talc litigation come up?

19 MR. MARINO: Objection to form

20 and foundation.

21 BY MR. PLACITELLA:

22 Q. You can answer it.

23 A. Yes.

24 Q. Okay. And what was the context

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 236 of 330 PageID:

43825
Page 236

1 of that coming up?

2 MR. FARRELL: Objection to form

3 and foundation. You mean the nature of a

4 meeting or something?

5 MR. MARINO: Could you rephrase

6 the question, please.

7 BY MR. PLACITELLA:

8 Q. Did you provide information

9 concerning the Emtal talc litigation?

10 MR. FARRELL: Objection to form

11 and foundation.

12 THE WITNESS: Yes.

13 BY MR. PLACITELLA:

14 Q. Okay. After the takeover

15 occurred, did BASF have the same information

16 in their possession as you had before the

17 takeover?

18 MR. FARRELL: Objection to form

19 and foundation.

20 BY MR. PLACITELLA:

21 Q. Concerning the Emtal talc

22 litigation?

23 MR. FARRELL: Same objections.

24 THE WITNESS: Yes.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 237 of 330 PageID:

43826
Page 237

1 BY MR. PLACITELLA:

2 Q. Did BASF understand the risks

3 that they were facing as it related to the

4 Emtal talc litigation prior to the actual

5 take over?

6 MR. MARINO: Oh, that -- that's

7 an improper question, Chris. How can you

8 ask him what someone else knew or

9 understood?

10 MR. PLACITELLA: To your

11 knowledge.

12 MR. FARRELL: Objection to form

13 and foundation.

14 The only way he could answer

15 the question is to implicitly disclose

16 the content of communications between

17 Engelhard and BASF about the litigation.

18 And it would reveal privileged

19 information for him to respond to the

20 question.

21 So I'm going to instruct him

22 not to answer the question because the

23 only other answer he can give is

24 speculative anyway.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 238 of 330 PageID:

43827
Page 238

1 BY MR. PLACITELLA:

2 Q. Did you, at the time, recognize

3 that there was a significant litigation risk

4 to Engelhard because of information relating

5 to asbestos in Emtal talc?

6 MR. FARRELL: Objection to

7 form; foundation; privilege; and work

8 product.

9 I instruct you not to answer

10 the question.

11 BY MR. PLACITELLA:

12 Q. At the time of the takeover, you

13 certainly had historical knowledge that

14 Engelhard scientists were deposed and gave

15 testimony about asbestos in Emtal talc,

16 correct?

17 MR. FARRELL: Objection to form

18 and foundation; vague as to time.

19 Is it -- can you answer that

20 with a yes or a no?

21 THE WITNESS: Yes.

22 MR. PLACITELLA: Okay.

23 THE WITNESS: Yes.

24 BY MR. PLACITELLA:

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 239 of 330 PageID:

43828
Page 239

1 Q. Okay. And -- and at the time of

2 the takeover, you certainly had historical

3 knowledge about the information concerning

4 asbestos testing that was transmitted to you,

5 correct?

6 MR. FARRELL: Same objections

7 and same caution.

8 THE WITNESS: Yes.

9 BY MR. PLACITELLA:

10 Q. Okay. And after the takeover,

11 did BASF have that same knowledge?

12 MR. FARRELL: Objection to

13 form; foundation; calls for speculation;

14 privilege; and work product.

15 I instruct you not to answer

16 the question.

17 BY MR. PLACITELLA:

18 Q. After the takeover, were you

19 still an employee of BASF?

20 MR. FARRELL: Objection to

21 form.

22 THE WITNESS: I was. There was

23 a transition period of a month or so when

24 I was, I guess, an employee of BASF, yes.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 240 of 330 PageID:

43829
Page 240

1 BY MR. PLACITELLA:

2 Q. Okay. Now, do you know whether

3 Cahill Gordon at the time of the takeover --

4 who was there, by -- by the way, with you at

5 these negotiations from Cahill Gordon?

6 MR. FARRELL: Objection to

7 form.

8 MR. BOISE: And foundation.

9 THE WITNESS: The principal

10 lawyer was a man named Duffy. I -- I

11 want to say his first name was Phil. But

12 I may be confusing him with another Duffy

13 that I know. And I -- I'm sure there

14 were associates involved. I don't

15 recall.

16 BY MR. PLACITELLA:

17 Q. Okay. Am I correct that at the

18 time of the takeover, Cahill Gordon had

19 historical knowledge concerning the asbestos

20 testing of Emtal talc?

21 MR. BOISE: Object to the form;

22 foundation.

23 THE WITNESS: Yes.

24 BY MR. PLACITELLA:

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 241 of 330 PageID:

43830
Page 241

1 Q. And am I correct that at the time

2 of the takeover, Cahill Gordon had historical

3 knowledge concerning the testimony provided

4 by Engelhard scientists under oath about the

5 asbestos testing of Emtal talc?

6 MR. BOISE: Object to the form

7 and foundation.

8 THE WITNESS: Yes.

9 BY MR. PLACITELLA:

10 Q. Am I correct that after the

11 takeover, Cahill Gordon continued to

12 represent BASF in the Emtal talc litigation?

13 MR. FARRELL: Objection to

14 form.

15 THE WITNESS: I don't know.

16 I've seen something, somewhere in the

17 paper you've shown me today that suggest

18 that that is so. But I don't -- didn't

19 know of my own knowledge.

20 BY MR. PLACITELLA:

21 Q. Okay. What is it that you told

22 BASF about the risks related to the Emtal

23 talc litigation at the time of the

24 takeover --

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 242 of 330 PageID:

43831
Page 242

1 MR. FARRELL: Objection to

2 form.

3 BY MR. PLACITELLA:

4 Q. -- but before you went to work

5 for them?

6 MR. FARRELL: Objection to

7 form; foundation; privilege; work

8 product.

9 I instruct you not to answer

10 the question; common interest privilege.

11 MR. PLACITELLA: What is the

12 basis for the work product assertion?

13 MR. FARRELL: You're asking a

14 lawyer for the company to talk about his

15 assessment of active and pending

16 litigation and communications between him

17 and BASF, which then came to acquire the

18 same company, about the status and his

19 assessment of that litigation. So I've

20 asserted objections based on work

21 product, attorney-client privilege, and

22 the common interest privilege. And I've

23 instructed him not to answer the

24 question.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 243 of 330 PageID:

43832
Page 243

1 BY MR. PLACITELLA:

2 Q. Okay. During the time that you

3 worked for Engelhard, was the board of

4 directors aware of the testimony of Engelhard

5 scientists under oath in the Westfall case?

6 MR. FARRELL: Objection to form

7 and foundation.

8 THE WITNESS: I don't know.

9 BY MR. PLACITELLA:

10 Q. Okay. When the conversations

11 occurred concerning the litigation risks

12 related to Emtal talc, who was present?

13 MR. FARRELL: Objection to form

14 and foundation.

15 BY MR. PLACITELLA:

16 Q. I'm talking about at the time of

17 the takeover.

18 MR. FARRELL: Same objections.

19 THE WITNESS: There were

20 several conversations. One was the large

21 group that I mentioned before. There was

22 then a smaller meeting consisting of only

23 attorneys and the control group people to

24 talk specifically about litigation.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 244 of 330 PageID:

43833
Page 244

1 Present at that meeting were Mr. Stryker,

2 a member of his staff, whose name I don't

3 recall, someone from my staff, I'm not --

4 I don't recall who it was, David Wexler,

5 who was our -- in charge of mergers and

6 acquisitions for the company. We -- our

7 CFO may or may not have been there. I

8 don't recall.

9 BY MR. PLACITELLA:

10 Q. Did the historic information you

11 had on the asbestos in Emtal talc impact your

12 assessment of the litigation risk associated

13 with that litigation?

14 MR. FARRELL: Objection to form

15 and foundation.

16 THE WITNESS: I -- I don't

17 understand your question.

18 BY MR. PLACITELLA:

19 Q. Sure.

20 Did the historical information

21 that you had in the -- concerning the testing

22 of asbestos enter into your risk assessment

23 when communicating as part of the takeover

24 what the risks were related to litigation

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 245 of 330 PageID:

43834
Page 245

1 involving Engelhard?

2 MR. FARRELL: Objection to

3 form; foundation; misstates the record;

4 privileged; work product; common interest

5 privilege.

6 I instruct you not to answer

7 the question.

8 BY MR. PLACITELLA:

9 Q. Okay. Did you believe that after

10 the takeover was complete, you had exercised

11 your duty to disclose to BASF all of the

12 litigation risks that you thought would

13 materially -- could materially affect the

14 corporation?

15 MR. MARINO: Objection to the

16 form of the question.

17 MR. FARRELL: Objection to form

18 and foundation.

19 Can you answer that?

20 THE WITNESS: Yes.

21 BY MR. PLACITELLA:

22 Q. Did you ever reach the conclusion

23 that the information concerning the asbestos

24 content in Emtal talc created a material risk

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 246 of 330 PageID:

43835
Page 246

1 to the corporation?

2 MR. FARRELL: Objection to

3 form; foundation; privilege; work

4 product.

5 I instruct you not to answer

6 the question.

7 BY MR. PLACITELLA:

8 Q. Did you ever come to the

9 conclusion that the deposition testimony of

10 the Engelhard scientists given under oath

11 concerning the asbestos in Emtal talc created

12 a material risk to the corporation?

13 MR. FARRELL: Same objection;

14 same instruction not to answer.

15 BY MR. PLACITELLA:

16 Q. And who did you meet with in

17 order to prep for today's deposition?

18 A. My counsel.

19 Q. The ever good-looking Mr. Marino?

20 A. And --

21 Q. Mr. Boyle?

22 A. And Mr. Boyle, yes.

23 Q. Okay. Did you review any

24 materials or documents in preparation?

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 247 of 330 PageID:

43836
Page 247

1 A. No.

2 MR. PLACITELLA: Okay. Can you

3 give me Exhibit No. 14.

4 Kevin.

5 BY MR. PLACITELLA:

6 Q. Exhibit No. 14 is a report

7 authored by Dr. William Glassley entitled

8 Summary of Activities Related to Services

9 rendered for Decof and Grimm in the case of

10 David H. Westfall versus Whittaker, Clark and

11 Daniels, et al.

12 Do you see that?

13 A. Yes.

14 Q. Okay. Can you go to the fifth

15 page of the report, where it says conclusion.

16 It states, Asbestiform chrysotile occurs in

17 serpentine intermingled with the talc at the

18 Johnson mine. Its overall abundance could

19 not be established.

20 Do you see that?

21 A. Yes.

22 Q. Were you ever -- were you aware

23 of this report at any point in time?

24 MR. FARRELL: Objection to

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 248 of 330 PageID:

43837
Page 248

1 form.

2 THE WITNESS: Not that I

3 recall.

4 BY MR. PLACITELLA:

5 Q. Okay. Did anybody -- if a report

6 like this came in in the context of a case,

7 did it have to be, as a matter of practice,

8 disclosed to you?

9 MR. FARRELL: Objection to form

10 and foundation; calls for speculation.

11 THE WITNESS: Well, the -- I --

12 I think the technical answer to your

13 question is no. But a lot would depend

14 upon the circumstances under which the --

15 the report was compiled.

16 BY MR. PLACITELLA:

17 Q. Okay. Such -- such as what?

18 A. If it was done at the request of

19 somebody in the legal department or outside

20 counsel, then I would expect that when it

21 came to the company, I would be on the

22 distribution.

23 Q. Okay. And if it came from an

24 expert on the plaintiff's side in a

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 249 of 330 PageID:

43838
Page 249

1 litigation, this is something that you would

2 be apprized of?

3 MR. FARRELL: Same objections;

4 calls for speculation.

5 THE WITNESS: Yeah. If it were

6 deemed by counsel to be of significance,

7 I would -- would expect that I would be

8 told about it.

9 BY MR. PLACITELLA:

10 Q. Okay. And here it talks about

11 chrysotile being found in the Johnson mine.

12 Do you see that?

13 A. Yes.

14 Q. Did you have an understanding

15 whether that was, in fact, the case, that

16 there was chrysotile asbestos in the Johnson

17 mine?

18 MR. FARRELL: Objection; form

19 and foundation.

20 THE WITNESS: I had no -- no

21 information about that.

22 BY MR. PLACITELLA:

23 Q. At any point in time?

24 MR. FARRELL: Same objections.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 250 of 330 PageID:

43839
Page 250

1 THE WITNESS: In 2000 -- in

2 1982, I did not.

3 BY MR. PLACITELLA:

4 Q. Okay. At some point in time, did

5 you learn that there was chrysotile asbestos

6 in the Johnson mine?

7 MR. FARRELL: Same objections.

8 THE WITNESS: I can't answer

9 that question without breaching the

10 attorney-client privilege.

11 MR. FARRELL: I instruct you

12 not to answer further.

13 THE WITNESS: Okay.

14 MR. FARRELL: Can we take a

15 break at some point?

16 MR. PLACITELLA: Yeah. Sure.

17 Now's fine.

18 THE VIDEOGRAPHER: The time is

19 now 2:31 p.m. We're going off the

20 record.

21 (Whereupon, there was a

22 discussion held off the record.)

23 (Whereupon, a brief recess was

24 taken.)

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 251 of 330 PageID:

43840
Page 251

1 THE VIDEOGRAPHER: The time is

2 now 2:53 p.m. We are back on the record.

3 BY MR. PLACITELLA:

4 Q. Okay. During the time that you

5 were general counsel and corporate secretary

6 to Engelhard, did you know that there were

7 cases being dismissed based upon the

8 representation that there was no asbestos in

9 Emtal talc?

10 MR. FARRELL: Objection to form

11 and foundation; misstates the record.

12 MR. MARINO: Are you

13 representing to him that that was the

14 basis for dismissals?

15 MR. PLACITELLA: I'm asking him

16 a question.

17 MR. MARINO: Thank you.

18 THE WITNESS: No.

19 BY MR. PLACITELLA:

20 Q. Okay. During the time that you

21 were general counsel and corporate secretary,

22 were -- did you ever become aware that cases

23 were being dismissed based upon the

24 representation that there was no evidence of

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 252 of 330 PageID:

43841
Page 252

1 asbestos in Emtal talc?

2 MR. MARINO: Are you making the

3 representation to him?

4 MR. PLACITELLA: I'm just

5 asking him a question.

6 MR. FARRELL: Same -- same

7 objections.

8 Can you answer these questions

9 without accessing the content of

10 communications between yourself and

11 Cahill Gordon? In other words, do you

12 have firsthand knowledge of these

13 questions at all, or would you have to

14 draw on the content of communications

15 between yourself and other lawyers for

16 the company?

17 THE WITNESS: The latter.

18 MR. FARRELL: Then I need to

19 instruct you not to answer the questions

20 on privilege grounds.

21 BY MR. PLACITELLA:

22 Q. Okay. Do you have any

23 information that cases brought against

24 Engelhard for exposure to Emtal talc were

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 253 of 330 PageID:

43842
Page 253

1 settled under value based upon assertions

2 that there was no asbestos in Emtal talc?

3 MR. FARRELL: Same objection;

4 same instruction not to answer the

5 question.

6 BY MR. PLACITELLA:

7 Q. Do you know whether Engelhard,

8 the company, was aware that cases were being

9 dismissed based upon the assertion by

10 Engelhard's lawyers that there was not

11 asbestos in Emtal talc?

12 MR. FARRELL: Same objection;

13 same instruction not to answer.

14 BY MR. PLACITELLA:

15 Q. Do you know whether the Johnson

16 mine, which was owned by Engelhard, contained

17 asbestos?

18 MR. FARRELL: Objection to form

19 and foundation.

20 I believe you said a few

21 minutes ago, Mr. Dornbusch, in response

22 to a similar question that you couldn't

23 answer that question without disclosing

24 privileged information. So I want to

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 254 of 330 PageID:

43843
Page 254

1 confirm whether you can answer that

2 question without revealing privileged

3 information as opposed to something you

4 would know from independent knowledge.

5 THE WITNESS: No, your

6 recollection is correct. Any information

7 of that kind was privileged.

8 BY MR. PLACITELLA:

9 Q. Okay. Do you know whether the

10 Johnson mine, which was owned by Engelhard,

11 was contaminated with asbestos?

12 MR. FARRELL: Same objection

13 and same caution to you, Mr. Dornbusch.

14 THE WITNESS: Right. And the

15 same answer.

16 BY MR. PLACITELLA:

17 Q. Do you know the answer to the

18 question?

19 MR. FARRELL: Can you answer it

20 one way or the other? Do you know the

21 answer?

22 THE WITNESS: I'm not sure --

23 I -- I can't -- I can't answer it without

24 relying upon attorney-client privileged

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 255 of 330 PageID:

43844
Page 255

1 information. And I would -- I would need

2 to -- to seek further clarification of

3 the question.

4 BY MR. PLACITELLA:

5 Q. Were you ever made aware or do

6 you know whether Engelhard had a program of

7 x-raying the employee -- its employees at the

8 Johnson mine, having x-rays of their lungs

9 done?

10 A. I do not know that.

11 Q. Do you know whether the evidence

12 of x-rays of Johnson mine employees was ever

13 disclosed to Engelhard's insurance carriers?

14 MR. FARRELL: Objection to

15 form; foundation.

16 THE WITNESS: No.

17 BY MR. PLACITELLA:

18 Q. Okay. Were executives -- or

19 strike that.

20 Was management at Engelhard

21 aware that the Johnson mine owned by

22 Engelhard contained asbestos?

23 MR. FARRELL: Objection to form

24 and foundation.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 256 of 330 PageID:

43845
Page 256

1 BY MR. PLACITELLA:

2 Q. If you know.

3 MR. FARRELL: Mr. Dornbusch,

4 can you answer this question without

5 revealing the substance of

6 attorney-client communications --

7 THE WITNESS: No.

8 MR. FARRELL: -- communications

9 you've had with management or some other

10 lawyers had with management?

11 THE WITNESS: No.

12 MR. FARRELL: Then I instruct

13 you not to answer the question on

14 privilege grounds.

15 BY MR. PLACITELLA:

16 Q. Would you be able to answer the

17 question but for privilege?

18 A. I'm not sure.

19 Q. Okay.

20 A. I'd have to hear the question

21 again.

22 Q. Okay. Was Engelhard management

23 aware that the Ental products made from the

24 Johnson mine contained asbestos?

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 257 of 330 PageID:

43846
Page 257

1 MR. FARRELL: Same objection

2 and same caution.

3 Can you answer this without

4 revealing the substance of

5 attorney-client communications?

6 THE WITNESS: No.

7 MR. FARRELL: I instruct you

8 not to answer the question.

9 BY MR. PLACITELLA:

10 Q. While the Westfall case was

11 pending, did Engelhard's management have

12 reason to believe that other similar cases

13 would be filed in the future?

14 MR. FARRELL: Objection to

15 form; foundation; privilege; work

16 product.

17 I instruct you not to answer

18 the question.

19 BY MR. PLACITELLA:

20 Q. Do you know whether Engelhard

21 management had reason to believe, while the

22 Westfall case was pending, whether future

23 similar cases were likely?

24 MR. FARRELL: Are you just

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 258 of 330 PageID:

43847
Page 258

1 asking whether he knows the answer to the

2 question?

3 MR. PLACITELLA: Yeah.

4 THE WITNESS: I don't know.

5 BY MR. PLACITELLA:

6 Q. Okay. During the pendency of the

7 Westfall case, were you aware that the

8 Johnson mine owned by Engelhard contained

9 asbestos?

10 MR. FARRELL: Same objections;

11 same instruction. We just had this

12 question a few minutes ago.

13 MR. PLACITELLA: Different

14 question.

15 MR. FARRELL: Can you answer

16 this question without revealing the

17 substance were attorney-client

18 communications, Mr. Dornbusch?

19 THE WITNESS: No.

20 MR. FARRELL: I instruct you

21 not to answer.

22 BY MR. PLACITELLA:

23 Q. Did you ever form the

24 understanding that Engelhard would be

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 259 of 330 PageID:

43848
Page 259

1 repeatedly sued in Emtal talc litigation?

2 MR. FARRELL: Objection to

3 form; foundation; work product;

4 privilege.

5 I instruct you not to answer

6 the question.

7 BY MR. PLACITELLA:

8 Q. At any point in time, did you

9 make sure that the information concerning the

10 testimony of Engelhard scientists concerning

11 asbestos in Emtal talc was disclosed to

12 litigants who had sued Engelhard claiming

13 personal injury from Emtal talc?

14 MR. FARRELL: Can you repeat

15 the question, please.

16 (Whereupon, the court reporter

17 read back the record as requested.)

18 MR. FARRELL: Objection to

19 form; foundation; assumes facts;

20 misstates the record.

21 BY MR. PLACITELLA:

22 Q. You can answer.

23 A. No.

24 Q. Okay. At any point in time,

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 260 of 330 PageID:

43849
Page 260

1 did -- as general counsel in charge of all

2 litigation, did you do anything to ensure

3 that litigants who were suing Engelhard

4 alleging personal injury from Emtal talc were

5 made aware of the testing information in

6 possession of Engelhard concerning asbestos

7 in Emtal talc?

8 MR. MARINO: Objection to the

9 form of the question.

10 MR. FARRELL: Objection to

11 form; foundation; assumes facts;

12 misstates the record.

13 THE WITNESS: No.

14 BY MR. PLACITELLA:

15 Q. Okay. What was your

16 understanding of the obligation of Thomas

17 Halket to disclose the information that he

18 had concerning the testimony of Engelhard

19 scientists in cases that he was involved in?

20 MR. BOISE: Objection to form.

21 MR. FARRELL: Objection to form

22 and foundation.

23 THE WITNESS: I -- I don't --

24 yeah, I don't -- don't recall what it

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 261 of 330 PageID:

43850
Page 261

1 was.

2 BY MR. PLACITELLA:

3 Q. You don't recall what it was?

4 A. What -- right.

5 Q. I'm sorry?

6 A. I don't recall what my

7 understanding was as to Mr. Halket's

8 obligations at that time.

9 Q. Okay. Did you have an

10 expectation that if the lawyers who were

11 working for you had information indicating

12 there was asbestos in Emtal talc, that that

13 would be disclosed to litigants who were

14 requesting that information?

15 MR. TUNIS: Objection to form.

16 MR. FARRELL: Objection to form

17 and foundation; calls for speculation.

18 THE WITNESS: I don't -- I

19 don't recall thinking about that issue.

20 BY MR. PLACITELLA:

21 Q. Okay. Would you have ever

22 countenanced the destruction of samples used

23 for testing Emtal talc while cases were

24 pending involving exposure to Emtal talc?

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 262 of 330 PageID:

43851
Page 262

1 MR. TUNIS: Objection to form.

2 MR. FARRELL: Objection to form

3 and foundation.

4 MR. BOISE: Incomplete

5 hypothetical.

6 THE WITNESS: Would I have

7 countenanced?

8 MR. PLACITELLA: Yes.

9 THE WITNESS: No.

10 BY MR. PLACITELLA:

11 Q. Would you have ever authorized

12 the destruction of evidence related --

13 underlying evidence relating to the testing

14 of Emtal talc during the time when cases were

15 pending, alleging exposure to Emtal talc?

16 MR. FARRELL: Objection to form

17 and foundation.

18 MR. TUNIS: Objection to form.

19 THE WITNESS: No.

20 BY MR. PLACITELLA:

21 Q. Okay. Do you know whether Cahill

22 Gordon was aware that the Johnson mine owned

23 by Engelhard contained asbestos?

24 MR. FARRELL: Objection to

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 263 of 330 PageID:

43852
Page 263

1 form; foundation.

2 Can you answer this question

3 without getting into the substance of

4 communications between yourself and

5 Cahill Gordon?

6 THE WITNESS: No.

7 MR. FARRELL: Then I instruct

8 you not to answer the question on

9 privilege grounds.

10 BY MR. PLACITELLA:

11 Q. Do you agree with me that during

12 the pendency of the Westfall case, Cahill

13 Gordon would have received full and complete

14 copies of the depositions of Hemstock,

15 Triglia, and Gale?

16 MR. FARRELL: Objection to

17 form; foundation.

18 THE WITNESS: I would expect

19 that they would have, yes.

20 BY MR. PLACITELLA:

21 Q. Okay. And did you have an

22 expectation that Cahill Gordon, whom you

23 indicated you outsourced the defense of the

24 Emtal litigation to, would have disclosed the

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 264 of 330 PageID:

43853
Page 264

1 information they had concerning the asbestos

2 testing in Emtal talc to litigants who were

3 suing Engelhard alleging injury from that

4 exposure?

5 MR. TUNIS: Objection.

6 MR. FARRELL: Objection to

7 form; foundation; misstates the record;

8 calls for speculation.

9 THE WITNESS: I don't recall if

10 I had such an expectation or not.

11 BY MR. PLACITELLA:

12 Q. Did you understand that the rules

13 of professional conduct required candor in

14 the disclosure of evidence to litigants in

15 possession of Engelhard?

16 MR. FARRELL: Objection to form

17 and foundation.

18 THE WITNESS: I don't recall

19 what I understood about -- at that time.

20 BY MR. PLACITELLA:

21 Q. Okay. Did -- do you have an

22 understanding of what the duty of candor is?

23 A. Yes, I do.

24 Q. And what is that?

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 265 of 330 PageID:

43854
Page 265

1 A. Well, I -- I would say it's

2 basically honesty.

3 Q. Okay. And do you believe that

4 the lawyers for Engelhard had a duty of

5 honesty to provide the people who they were

6 litigating against with the information

7 concerning the testing of asbestos of Emtal

8 talc if it was requested?

9 MR. FARRELL: Objection to

10 form; foundation; misstates the record;

11 calls for speculation.

12 MR. BOISE: Incomplete

13 hypothetical.

14 THE WITNESS: I --

15 MR. MARINO: And what would be

16 the significance if he said no?

17 BY MR. PLACITELLA:

18 Q. You can answer.

19 A. I had an expectation that the

20 lawyers at Cahill, as the -- as with the

21 other lawyers that Engelhard had retained

22 from time to time, would conduct themselves

23 strictly in accordance with the code of

24 professional responsibility.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 266 of 330 PageID:

43855
Page 266

1 Q. And would that be -- include

2 being honest about what information was

3 available concerning the asbestos content of

4 Emtal talc?

5 MR. FARRELL: Objection to

6 form; foundation; misstates the record;

7 calls for speculation.

8 MR. BOISE: It's an incomplete

9 hypothetical.

10 THE WITNESS: I -- I believe

11 so.

12 BY MR. PLACITELLA:

13 Q. Okay. Did you have an

14 understanding that when the document

15 retention policy was finalized in 1984, that

16 if research and development evidence was

17 disposed of concerning -- in accordance with

18 that policy, that information would not be

19 available to litigants?

20 MR. TUNIS: Objection to form.

21 MR. FARRELL: Objection. Can I

22 have the question again, please.

23 (Whereupon, the court reporter

24 read back the record as requested.)

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 267 of 330 PageID:

43856
Page 267

1 MR. FARRELL: Are you asking,

2 Chris, whether he had that specific

3 thought in 1984?

4 MR. PLACITELLA: I'm ask -- my

5 question stands.

6 MR. FARRELL: Well, I'm trying

7 to understand the question, because one

8 interpretation of it calls for privileged

9 and work product information --

10 MR. PLACITELLA: Okay.

11 MR. FARRELL: -- I would need

12 to instruct him not to answer. So I'm

13 asking you to clarify the question.

14 MR. PLACITELLA: No. My

15 question stands. Can you read it back,

16 please.

17 (Whereupon, the court reporter

18 read back the record as requested.)

19 MR. FARRELL: Well, in light of

20 plaintiff's refusal to clarify the

21 question as requested, I need to instruct

22 you not to answer the question based on

23 privilege and work product grounds.

24 BY MR. PLACITELLA:

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 268 of 330 PageID:

43857
Page 268

1 Q. Okay. Am I correct that you have

2 no evidence, as you sit here today, that

3 after the document retention policy was

4 arrived at in 1984, as you testified to, that

5 the research and development information

6 concerning the testing of Emtal talc was ever

7 disclosed to a single litigant?

8 MR. TUNIS: Objection to form.

9 MR. FARRELL: Objection to form

10 and foundation.

11 THE WITNESS: I have no

12 information about that.

13 BY MR. PLACITELLA:

14 Q. Okay. You have no such evidence,

15 correct?

16 MR. FARRELL: Same objections.

17 THE WITNESS: Correct.

18 BY MR. PLACITELLA:

19 Q. Am I correct that from 1984 until

20 2006 there was never a period exceeding three

21 years where Engelhard was not sued in an

22 Emtal talc case?

23 MR. FARRELL: Objection to form

24 and foundation.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 269 of 330 PageID:

43858
Page 269

1 THE WITNESS: I have no

2 information that would allow me to answer

3 that.

4 BY MR. PLACITELLA:

5 Q. Okay. In terms of the document

6 retention policy that you finalized in 1984,

7 how long did you have to retain evidence that

8 was generated in a lawsuit?

9 MR. FARRELL: Objection to form

10 and foundation; assumes facts; misstates

11 the policy.

12 THE WITNESS: I don't know.

13 BY MR. PLACITELLA:

14 Q. Did you know who Howard Shafer

15 was?

16 A. Yes.

17 Q. Who was he?

18 A. He ran the Johnson, Vermont talc

19 operations. He was our general manager.

20 Q. Okay. And did you ever have any

21 interaction with him?

22 A. I'm -- I think I probably met

23 him, but either at a -- a meeting in this

24 area or a -- a business meeting somewhere off

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 270 of 330 PageID:

43859
Page 270

1 site. I never -- I never visited Johnson,

2 Vermont.

3 Q. Would he be somebody who would be

4 knowledgeable concerning the testing that

5 went on at the Johnson mine?

6 MR. FARRELL: Objection to form

7 and foundation and calls for speculation.

8 BY MR. PLACITELLA:

9 Q. If you know.

10 A. If testing took place on site, he

11 probably would know. If samples were

12 collected and tested elsewhere, he may or may

13 not know. I don't...

14 Q. He would know, though, who

15 visited the site for purposes of extracting

16 samples, correct?

17 MR. FARRELL: Objection to

18 foundation and form; calls for

19 speculation.

20 THE WITNESS: I would think so.

21 BY MR. PLACITELLA:

22 Q. If I was to ask for the person,

23 assuming he was alive, with the most

24 knowledge concerning the day-to-day

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 271 of 330 PageID:

43860
Page 271

1 operations of the Johnson mine, would it be

2 Howard Shafer?

3 MR. FARRELL: Same objections.

4 THE WITNESS: It would during

5 the period of time when he was general

6 manager.

7 BY MR. PLACITELLA:

8 Q. Okay. Did there ever come a

9 point in time when Engelhard sold the Johnson

10 mine to another entity?

11 A. I don't think so.

12 Q. Okay. So I just want to be clear

13 on something you said before. Were you

14 actually involved in the due diligence

15 investigation being conducted by BASF before

16 the takeover of Engelhard?

17 MR. FARRELL: Objection to form

18 and foundation.

19 THE WITNESS: Yes.

20 BY MR. PLACITELLA:

21 Q. Okay. And did you understand

22 that the -- that due diligence investigation

23 required BASF to learn whatever significant

24 litigation risks faced them before the

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 272 of 330 PageID:

43861
Page 272

1 takeover?

2 MR. FARRELL: Same objection.

3 THE WITNESS: Yes.

4 BY MR. PLACITELLA:

5 Q. Okay. And did you understand

6 that BASF's due diligence required them to

7 know any material information related to the

8 Emtal talc litigation?

9 MR. FARRELL: Objection to form

10 and foundation.

11 THE WITNESS: Yes.

12 BY MR. PLACITELLA:

13 Q. And were they actually made aware

14 of material information related to the Emtal

15 talc litigation as part of their due

16 diligence?

17 MR. FARRELL: Objection to

18 form; foundation; privileged; work

19 product; and common interest privilege.

20 I instruct you not to answer

21 the question.

22 MR. PLACITELLA: So let me just

23 break this down. I understand common

24 interest. That's a fight for another

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 273 of 330 PageID:

43862
Page 273

1 day.

2 What is the work product and

3 what is the work -- and what is the

4 privilege?

5 MR. FARRELL: The work product

6 is that you're asking the general counsel

7 of a corporation for his assessment of

8 legal issues that were pending at the

9 time, and I take it we're in early -- or

10 spring of 2006, while there were cases

11 pending, and would also require him to

12 draw on the substance of communications

13 between himself and his client and

14 himself and Cahill Gordon.

15 So the question necessarily

16 asks for both his opinion, work product,

17 and for attorney-client communications

18 concerning active and pending litigation

19 at the time.

20 MR. PLACITELLA: Okay. Well, I

21 don't agree with that. What's the next

22 one? What's the privilege issue?

23 MR. FARRELL: I just covered

24 that one.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 274 of 330 PageID:

43863
Page 274

1 To answer these questions,

2 Mr. Dornbusch, I take it you would need

3 to draw on the substance of

4 communications between yourself and

5 Cahill or yourself and others at

6 Engelhard concerning the status of

7 pending litigation as of the spring of

8 2006, give or take, correct?

9 THE WITNESS: Yes.

10 MR. FARRELL: That was the

11 basis --

12 MR. PLACITELLA: Okay.

13 MR. FARRELL: -- for the

14 objection and instruction.

15 BY MR. PLACITELLA:

16 Q. The -- was BASF informed by

17 Engelhard prior to the acquisition in

18 June 2006 that there was evidence indicating

19 there was asbestos in Emtal talc?

20 MR. FARRELL: Same objections;

21 same instructions not to answer.

22 BY MR. PLACITELLA:

23 Q. Was BASF made aware that Emtal

24 talc cases were being defended, at least in

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 275 of 330 PageID:

43864
Page 275

1 part, on the assertion that the Emtal talc

2 was asbestos free?

3 MR. FARRELL: Same objections;

4 same instruction not to answer.

5 BY MR. PLACITELLA:

6 Q. Do you know the answer to that

7 question?

8 A. I don't know.

9 Q. Okay. To what extent, if any,

10 was Engelhard management involved in the

11 construction of litigation strategies for

12 cases alleging exposure to Emtal talc?

13 MR. FARRELL: Objection to form

14 and foundation.

15 Am I correct, Chris, this --

16 you're just asking about roles --

17 MR. PLACITELLA: Uh-huh.

18 MR. FARRELL: -- roles people

19 had?

20 MR. PLACITELLA: Uh-huh.

21 THE WITNESS: I informed the

22 control group, senior management of the

23 company, and before that, the division,

24 of all litigation, and the talc

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 276 of 330 PageID:

43865
Page 276

1 litigation, and my strategy for dealing

2 with it.

3 BY MR. PLACITELLA:

4 Q. Okay. And did that strategy

5 include assertions that the Emtal talc was

6 asbestos free?

7 MR. FARRELL: Objection to

8 form; foundation; privilege; work

9 product.

10 I instruct you not to answer

11 the question.

12 BY MR. PLACITELLA:

13 Q. Okay. Do you know whether any

14 non-lawyers ever provided information to BASF

15 concerning the issue of asbestos in Emtal

16 talc?

17 MR. FARRELL: Objection to form

18 and foundation.

19 THE WITNESS: I don't know of

20 any.

21 BY MR. PLACITELLA:

22 Q. Okay. Do you -- do you know

23 whether Jesse Pagonis ever had any meetings

24 with BASF concerning what he knew about the

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 277 of 330 PageID:

43866
Page 277

1 asbestos content of Emtal talc?

2 MR. FARRELL: Objection to form

3 and foundation.

4 THE WITNESS: I'm pretty

5 certain that he did not. I believe he

6 retired sometime before this.

7 BY MR. PLACITELLA:

8 Q. That would have made it harder

9 then, wouldn't it?

10 A. Yes.

11 Q. Okay.

12 A. He's still around, but...

13 Q. Okay. Do you know what, if any

14 information Jesse Pagonis knew about the

15 asbestos content of Emtal talc as it related

16 to his job in risk management?

17 MR. FARRELL: Objection to

18 form; foundation; calls for speculation.

19 Can you answer this question

20 without drawing on the substance of

21 communications between yourself and

22 Mr. Pagonis --

23 THE WITNESS: No.

24 MR. FARRELL: -- concerning the

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 278 of 330 PageID:

43867
Page 278

1 Emtal talc litigation?

2 THE WITNESS: No.

3 MR. FARRELL: Then I instruct

4 you not to answer on privilege grounds.

5 THE WITNESS: Mr. Pagonis is

6 also an attorney.

7 MR. PLACITELLA: Okay. The --

8 thank you for telling me that.

9 BY MR. PLACITELLA:

10 Q. At any point in time, after you

11 left Engelhard -- scratch that.

12 Did you ever undertake an

13 investigation yourself concerning what

14 happened to the research and development

15 documents related to Emtal talc?

16 MR. FARRELL: Objection to form

17 and foundation; assumes facts.

18 THE WITNESS: No.

19 BY MR. PLACITELLA:

20 Q. Okay. Did you ever form a

21 conclusion that the asbestos testing evidence

22 concerning Emtal talc no longer existed?

23 MR. FARRELL: Objection to form

24 and foundation.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 279 of 330 PageID:

43868
Page 279

1 THE WITNESS: I assumed that it

2 was disposed of in accordance with the

3 document retention policy of 1984.

4 BY MR. PLACITELLA:

5 Q. And when did that happen, in

6 1984?

7 A. Yes.

8 MR. FARRELL: Objection to

9 form.

10 BY MR. PLACITELLA:

11 Q. Do you know whether Engelhard

12 ever informed its insurance carriers or

13 insurance brokers that it was foreseeable

14 that they would be sued in asbestos cases

15 related to talc?

16 MR. FARRELL: Objection to form

17 and foundation.

18 Can you answer that with a yes

19 or no as to whether you know the answer

20 to that question?

21 THE WITNESS: Yes.

22 MR. FARRELL: Do you know the

23 answer to it?

24 THE WITNESS: Yes. The answer

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 280 of 330 PageID:

43869
Page 280

1 is yes.

2 MR. PLACITELLA: Okay. Can you

3 just read back the question. I want to

4 make sure I got it right.

5 (Whereupon, the court reporter

6 read back the record as requested.)

7 MR. FARRELL: And,

8 Mr. Dornbusch, I understood you to say

9 yes, you know the answer to the question.

10 In terms of the substance of

11 communications on this subject matter

12 between Engelhard and the insurer, I want

13 to caution you not to disclose the

14 content of privileged or work product

15 information. I think the answer to --

16 the substantive answer to that question

17 would be covered by privileges and I

18 would instruct you not to answer them.

19 MR. PLACITELLA: So we're

20 clear, it's your position that

21 disclosures to insurance carriers by

22 Engelhard is protected by privilege

23 concerning the subject matter we just

24 went -- went over?

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 281 of 330 PageID:

43870
Page 281

1 MR. FARRELL: Not all

2 disclosures. You asked about a very

3 specific disclosure. And the specific

4 disclosure you asked about would be

5 protected by privilege, the common

6 interest privilege, and work product.

7 And that was why I objected as I did.

8 MR. PLACITELLA: So it's your

9 position that there's a common interest

10 privilege between Engelhard and its

11 insurance carrier, and that's why he's

12 not allowed to answer the question?

13 MR. FARRELL: In this context,

14 yes.

15 MR. PLACITELLA: Okay.

16 MR. MARINO: Chris, do you have

17 a lot more?

18 MR. PLACITELLA: I have some.

19 MR. MARINO: Let me take five

20 minutes.

21 THE VIDEOGRAPHER: The time is

22 now 3:27 p.m. We're going off the

23 record.

24 (Whereupon, there was a

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 282 of 330 PageID:

43871
Page 282

1 discussion held off the record.)

2 (Whereupon, a brief recess was

3 taken.)

4 THE VIDEOGRAPHER: The time is

5 now 3:42 p.m. We are back on the record.

6 BY MR. PLACITELLA:

7 Q. Mr. Dornbusch, at the time of the

8 takeover by BASF, who was working on the

9 Emtal talc litigation who stayed on with BASF

10 after the takeover?

11 MR. FARRELL: Objection to form

12 and foundation.

13 BY MR. PLACITELLA:

14 Q. If you know.

15 A. I'm not -- I don't have an

16 independent recollection. Based on documents

17 that I've seen here today, I -- I would be

18 tempted to say Mike Hassett. But I don't

19 know that of my own recollection.

20 Q. Okay. Do you know whether

21 Engelhard's management took any risk control

22 or management steps relating to the asbestos

23 content of Emtal talc?

24 MR. FARRELL: Objection to form

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 283 of 330 PageID:

43872
Page 283

1 and foundation.

2 THE WITNESS: I'm not --

3 MR. FARRELL: In what context

4 and time?

5 BY MR. PLACITELLA:

6 Q. Well, during the time that you

7 served as general counsel and corporate

8 secretary, did Engelhard's management take

9 any risk control measures to address the

10 issue of asbestos in Emtal talc?

11 A. I'm not --

12 MR. FARRELL: Objection to form

13 and foundation.

14 THE WITNESS: I was going to

15 say, I'm not sure what you mean by risk

16 control measures.

17 BY MR. PLACITELLA:

18 Q. Okay. Any measures taken in

19 terms of -- well, wait. Let me -- I'll

20 rephrase it.

21 During the time you were

22 general counsel and corporate secretary, did

23 Engelhard's management ever take any steps in

24 terms of minimizing the risk of financial

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 284 of 330 PageID:

43873
Page 284

1 loss related to the issue of asbestos in

2 Emtal talc?

3 MR. FARRELL: Objection to form

4 and foundation.

5 THE WITNESS: No.

6 BY MR. PLACITELLA:

7 Q. Okay. Did you ever provide to

8 the board facts concerning -- not legal

9 advice, but facts concerning the results of

10 asbestos testing of Emtal talc?

11 MR. FARRELL: Can you answer

12 that with a yes or no as to whether that

13 subject matter was addressed between you

14 and the board without getting into the

15 substance of it?

16 THE WITNESS: No, I cannot.

17 BY MR. PLACITELLA:

18 Q. You can't say whether you

19 provided facts concerning the asbestos

20 content of Emtal talc versus legal advice?

21 A. I can't differentiate, no.

22 Q. Okay. Am I correct that your

23 testimony here today has been that the

24 discovery responses that were provided became

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 285 of 330 PageID:

43874
Page 285

1 such a matter of routine that -- that Cahill

2 was basically allowed to submit those

3 responses without them running them by you?

4 MR. FARRELL: Objection to

5 form.

6 MR. BOYLE: Join in that

7 objection.

8 THE WITNESS: Yes.

9 BY MR. PLACITELLA:

10 Q. Okay. And when I say a matter of

11 routine, the information that was contained

12 in there, they were pretty much the same in

13 any case; is that fair?

14 MR. FARRELL: Objection to form

15 and foundation.

16 MR. BOYLE: Join.

17 MR. BOISE: Mischaracterizes

18 the record.

19 MR. BOYLE: Join in those

20 objections.

21 BY MR. PLACITELLA:

22 Q. You answer it.

23 A. Yes.

24 Q. Okay. And am I correct, based on

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 286 of 330 PageID:

43875
Page 286

1 your testimony, that the correspondence, like

2 you saw today, became such a matter of

3 routine that Cahill would send correspondence

4 out like that to plaintiffs' lawyers without

5 getting your prior approval?

6 MR. FARRELL: Objection to

7 form; foundation; calls for speculation.

8 THE WITNESS: Yes.

9 BY MR. PLACITELLA:

10 Q. Okay. Now, if BASF asserted that

11 it was unaware of the evidence of the

12 Westfall case prior to 2009, would that be a

13 correct assertion?

14 MR. FARRELL: Objection to

15 form; foundation; attorney-client

16 privilege; work product.

17 I instruct you not to answer

18 the question.

19 BY MR. PLACITELLA:

20 Q. Could you answer that question?

21 A. Could I?

22 Q. Yeah.

23 A. Yes.

24 Q. Okay. If BASF asserted that it

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 287 of 330 PageID:

43876
Page 287

1 was unaware of any evidence indicating there

2 was asbestos in Emtal talc prior to 2009,

3 would that be accurate? I'm not representing

4 to you that's what they said. I'm asking

5 you, would that be accurate?

6 MR. FARRELL: Same objections;

7 same instruction not to answer.

8 BY MR. PLACITELLA:

9 Q. Could you answer that question?

10 MR. BOYLE: Could you repeat

11 the question, please.

12 (Whereupon, the court reporter

13 read back the record as requested.)

14 MR. BOYLE: And you're just

15 asking if he could answer?

16 MR. PLACITELLA: Uh-huh.

17 THE WITNESS: I could answer

18 that, yes.

19 BY MR. PLACITELLA:

20 Q. To your knowledge, was

21 Engelhard's management aware of the

22 litigation defense strategies that were being

23 executed by Cahill Gordon in the defense of

24 the Emtal talc litigation?

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 288 of 330 PageID:

43877
Page 288

1 MR. FARRELL: Objection to

2 form, foundation. I think this has

3 already been asked and addressed through

4 a privilege instruction and instruction

5 not to answer in light of Mr. Dornbusch

6 indicating he would need to disclose the

7 contents of such communications to answer

8 the question.

9 So I'll instruct him not to

10 answer it again.

11 BY MR. PLACITELLA:

12 Q. Can you answer that question?

13 MR. BOYLE: He's been

14 instructed not to answer.

15 MR. FARRELL: Well, he's been

16 instructed not to answer.

17 BY MR. PLACITELLA:

18 Q. Are you able to answer that

19 question but for the instruction?

20 A. Yes.

21 Q. Okay. Did Engelhard's management

22 authorize the litigation strategies executed

23 by Cahill Gordon in the defense of the Emtal

24 talc litigation?

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 289 of 330 PageID:

43878
Page 289

1 MR. FARRELL: Same objections;

2 same instructions not to answer the

3 question.

4 MR. PLACITELLA: Okay. Just,

5 what's the basis?

6 MR. FARRELL: Privilege and

7 work product.

8 MR. PLACITELLA: It's

9 privileged whether the management had

10 authorized the information -- the

11 strategies? That's privileged?

12 MR. FARRELL: Well, I think

13 that Mr. Dornbusch was in management and

14 had already indicated that he was

15 involved in the strategy.

16 I understood your question to

17 be more referring to other members of

18 management. And I do not know how

19 Mr. Dornbusch would answer what they did

20 or did not authorize without revealing

21 the content of communications between

22 himself and management about the

23 strategy for handling litigation.

24 So yes, I'm asserting

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 290 of 330 PageID:

43879
Page 290

1 privilege and work product over the

2 question -- in response to the question.

3 BY MR. PLACITELLA:

4 Q. All right. Do you know whether

5 management, other than yourself, was aware of

6 the strategy in defending Emtal talc

7 litigation to assert that Emtal talc was

8 asbestos free?

9 MR. FARRELL: Objection to

10 form; foundation; asked and answered.

11 He -- he's asking you whether

12 you know the answer to that question. I

13 believe you've already testified that

14 you know the answer to the question, but

15 I've instructed you not to answer it.

16 THE WITNESS: Okay.

17 BY MR. PLACITELLA:

18 Q. Do you know the answer to the

19 question?

20 A. I'm afraid I've lost track of the

21 question.

22 Q. Okay. Am I correct that

23 Engelhard's employees were involved in -- in

24 implementing the litigation strategies that

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 291 of 330 PageID:

43880
Page 291

1 were being employed by Cahill Gordon?

2 MR. TUNIS: Objection to form.

3 MR. BOYLE: Objection to form.

4 MR. FARRELL: Form and

5 foundation.

6 BY MR. PLACITELLA:

7 Q. You can answer it.

8 A. Yes.

9 Q. Okay. During the time that

10 Engelhard was involved in litigation

11 concerning Emtal talc claims, was it aware of

12 the litigation strategies being used to

13 defend those cases?

14 MR. BOYLE: Are you -- you're

15 asking about the entire corporation, his

16 knowledge --

17 MR. PLACITELLA: Generally

18 speaking --

19 MR. BOYLE: He's not a

20 corporate representative.

21 MR. PLACITELLA: -- speaking.

22 I'll ask him what he knows.

23 MR. FARRELL: Objection to form

24 and foundation; asked and answered.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 292 of 330 PageID:

43881
Page 292

1 MR. PLACITELLA: You can

2 answer.

3 THE WITNESS: Could I have the

4 question, please.

5 (Whereupon, the court reporter

6 read back the record as requested.)

7 MR. PLACITELLA: No. You

8 didn't get it right. Let me ask it

9 again.

10 BY MR. PLACITELLA:

11 Q. During the time that Engelhard

12 was involved in the litigation concerning

13 Emtal talc cases, were -- was its insurance

14 carriers aware of the defense strategies that

15 were being used to defend those cases?

16 MR. FARRELL: Objection to

17 form; foundation. That's a different

18 question than the one that was just

19 asked.

20 But do you know the answer to

21 the question?

22 THE WITNESS: I -- I don't -- I

23 don't know the answer.

24 BY MR. PLACITELLA:

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 293 of 330 PageID:

43882
Page 293

1 Q. Okay. That obviates my last --

2 next two questions.

3 During the time that Engelhard

4 was involved in the litigation of Emtal

5 claims, do you know whether its insurance

6 carriers were aware of evidence indicating

7 there was asbestos in Emtal talc?

8 MR. FARRELL: Objection to form

9 and foundation.

10 Do you know the answer to the

11 question?

12 THE WITNESS: I don't know.

13 BY MR. PLACITELLA:

14 Q. Do you know, during the time that

15 Engelhard was litigating the Emtal talc

16 cases, whether its insurance carriers were

17 aware that litigants were being told that

18 Emtal talc was asbestos free?

19 MR. FARRELL: Objection to form

20 and foundation.

21 Again, do you know the answer

22 to the question?

23 THE WITNESS: I do not know.

24 BY MR. PLACITELLA:

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 294 of 330 PageID:

43883
Page 294

1 Q. As you sit here today, are you

2 aware of any claim or demand being made upon

3 you relating to the facts asserted in this

4 case by either BASF, Cahill, or Mr. Halket?

5 MR. BOYLE: Objection.

6 MR. FARRELL: Objection; form.

7 THE WITNESS: No.

8 BY MR. PLACITELLA:

9 Q. Okay. Have you or anyone on your

10 behalf asserted a claim or demand upon BASF

11 relating to the facts in the Williams case?

12 MR. BOYLE: Objection.

13 MR. FARRELL: Objection to

14 form.

15 THE WITNESS: No. No.

16 MR. PLACITELLA: When lawyers

17 flip through pages, that's good.

18 Oh, Marino's here; I'm done.

19 No. No. Okay. I'm going to

20 take five and look, but I think I'm

21 there, okay.

22 THE VIDEOGRAPHER: The time is

23 now 3:56 p.m. We're going off the

24 record.

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 295 of 330 PageID:

43884
Page 295

1 (Whereupon, there was a

2 discussion held off the record.)

3 (Whereupon, a brief recess was

4 taken.)

5 THE VIDEOGRAPHER: The time is

6 now 3:59 p.m. We are back on the record.

7 BY MR. PLACITELLA:

8 Q. I assume that if I spent an hour

9 going through P-1, one document at a time,

10 you'd basically say whatever's in there is in

11 there and you have no independent

12 recollection; is that fair?

13 A. Yes.

14 MR. PLACITELLA: Okay. Now,

15 other than my challenging privilege

16 issues and subject to any other

17 questions, I appreciate your time.

18 THE WITNESS: Thank you.

19 MR. FARRELL: No questions from

20 BASF at this time.

21 MR. MARINO: I have no

22 questions for Mr. Dornbusch at this time.

23 MR. PLACITELLA: Okay.

24 MR. BOISE: No questions at

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 296 of 330 PageID:

43885
Page 296

1 this time.

2 MR. TUNIS: No questions for

3 Halket.

4 MR. PLACITELLA: Wait a second.

5 Wait a second. You cut -- off the

6 record.

7 (Whereupon, there was a

8 discussion held off the record.)

9 THE VIDEOGRAPHER: The time is

10 now 4 o'clock p.m. This conclude's

11 today's deposition. We're going off the

12 record.

13 (Whereupon, there was a

14 discussion held off the record.)

15

16

17

18

19

20

21

22

23

24

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 297 of 330 PageID:

43886
Page 297

1

2 CERTIFICATE

3

4

5 I hereby certify that the proceedings and

6 evidence noted are contained fully and

7 accurately in the notes in the deposition of

8 of the above matter, and that this is a

9 correct transcript of the same.

10

11

12

13 --------------------------

14 DEBORAH A. BRAZUKAS, RPR

 NJ CSR LICENSE #XI 01938

15

16

17

18 (The foregoing certification of this

19 transcript does not apply to any reproduction

20 of the same by any means, unless under the

21 direct control and/or supervision of the

22 certifying reporter.)

23

24

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 298 of 330 PageID:

43887
Page 298

1 CERTIFICATE OF DEPONENT

2

3

4 I, ARTHUR DORNBUSCH, have read

5 the entire transcript of my testimony taken

6 on Monday, May 14, 2018, contained within

7 Pages 1 through 296, and it is true, correct

8 and complete to the best of my knowledge,

9 recollection and belief, except for the list

10 of corrections, if any, attached on a

11 separate sheet herewith.

12

13 _____________________________ __________

14 ARTHUR DORNBUSCH DATE

15

16 SUBSCRIBED AND SWORN to before me this

17 ___________ day of ________________, 2018,

18 in the jurisdiction aforesaid.

19

20 _____________________ _____________________

21 My commission expires Notary Public

22

23

24

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 299 of 330 PageID:

43888
Page 299

1 ERRATA SHEET

2 CASE CAPTION: WILLIAMS, ET AL. VS.

 BASF CATALYSTS, LLC, ET AL.

3

DEPONENT: ARTHUR DORNBUSCH

4

5 PAGE LINE CORRECTION

6 _____ _____ _______________________________

7 _____ _____ _______________________________

8 _____ _____ _______________________________

9 _____ _____ _______________________________

10 _____ _____ _______________________________

11 _____ _____ _______________________________

12 _____ _____ _______________________________

13 _____ _____ _______________________________

14 _____ _____ _______________________________

15 _____ _____ _______________________________

16 _____ _____ _______________________________

17 _____ _____ _______________________________

18 _____ _____ _______________________________

19 _____ _____ _______________________________

20 _____ _____ _______________________________

21 _____ _____ _______________________________

22 _____ _____ _______________________________

23 SIGNATURE:_____________________DATE:_________

24 ARTHUR DORNBUSCH

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 300 of 330 PageID:

43889
Page 1

A

ABB 6:12

able 29:16 41:4

80:14 93:21 94:4

168:8 256:16

288:18

absolutely 83:17

184:20 225:19

abundance 247:18

ACC 68:7,8

acceptable 23:4

access 82:3 97:18

97:20 193:1

accessed 172:14

accessing 252:9

account 80:3

accounts 108:17

109:6,13 110:21

110:23,23

accurate 126:22

184:15 188:14

207:23 221:2,24

287:3,5

accurately 297:7

accustomed 34:13

acquire 242:17

acquisition 233:13

274:17

acquisitions 244:6

action 1:3 10:7

61:18 212:11

active 242:15

273:18

Activities 5:12

247:8

actual 237:4

add 56:18 196:14

addition 84:12

212:22 220:19

additional 102:20

address 63:13

195:12 283:9

addressed 38:18

284:13 288:3

addresses 210:15

adds 197:9

adequate 157:2

administration

173:8 189:9

admissibility 44:6

Admissions 6:22

admits 155:11

advance 196:8

advanced 79:24

adverse 122:9

133:1

adversely 115:23

121:19

advice 284:9,20

advise 61:16

119:18

advised 116:19

122:8 231:24

Aetna 61:14

affairs 13:6 14:4

affect 115:23

121:19 245:13

affidavit 5:6,8

208:11,14 209:3,7

210:22 211:9,14

212:9,19 213:15

213:23 216:21

217:7 219:21

220:9,22 222:14

223:2,15,18,21

224:10

Affidavits 58:22

138:22

afforded 61:17

aforesaid 298:18

afraid 290:20

agency 189:9

agents 183:19

ago 29:14 36:24

253:21 258:12

agree 263:11

273:21

agreed 219:12

agreement 218:14

218:20 219:3

ahead 121:12

124:10 136:4

175:18 189:20

air 12:17,17

al 1:3,6 4:21 5:5,11

5:15,20,21 6:12

6:23,23 7:5,6 10:4

10:5 172:24

247:11 299:2,2

Alexander 61:1,1

61:10,11

alive 48:1 270:23

alleging 260:4

262:15 264:3

275:12

allow 127:20

184:18 269:2

allowed 281:12

285:2

alluded 24:11

ambulance 224:16

Amended 212:11

amendment 120:12

Amesbury 104:7

amount 106:13

amounts 144:21

analysis 38:5 110:1

216:20

Anderson 104:1

and/or 32:12 33:19

47:3,5,11,12

297:21

answer 8:4 15:14

16:15,17,21 19:14

20:20 23:4 29:2,6

29:10,12 31:16

34:20 35:6,8,9,13

35:15,18 36:2,23

37:4,6,15 38:15

41:4,13 42:12,15

43:15 44:23,24

45:2,10 46:15

49:9 52:1,3 55:19

56:10,23 57:15,17

57:20 62:19 64:24

87:19 98:20 102:3

102:4 104:18

112:12 114:6,11

116:10 117:4,11

117:23 118:3,12

118:14 121:9,23

122:14 125:1

126:8,17 127:3,16

130:11,18 131:1,5

132:1 141:22

142:4,9 145:24

146:22 156:11

157:15 159:17

175:9 178:4

179:13 181:13,13

181:19 184:8

189:22 190:2,5

191:15 193:18

196:10 197:4,4

198:12 207:3,6,8

208:4 209:11,15

214:4 219:16

222:21 224:20

225:2,3 228:6

230:11 235:9,22

237:14,22,23

238:9,19 239:15

242:9,23 245:6,19

246:5,14 248:12

250:8,12 252:8,19

253:4,13,23 254:1

254:15,17,19,21

254:23 256:4,13

256:16 257:3,8,17

258:1,15,21 259:5

259:22 263:2,8

265:18 267:12,22

269:2 272:20

274:1,21 275:4,6

276:10 277:19

278:4 279:18,19

279:23,24 280:9

280:15,16,18

281:12 284:11

285:22 286:17,20

287:7,9,15,17

288:5,7,10,12,14

288:16,18 289:2

289:19 290:12,14

290:15,18 291:7

292:2,20,23

293:10,21

answered 136:3

157:11 159:21

186:10 187:3

188:23 189:1

192:18 229:22

290:10 291:24

answering 189:21

190:2 192:15

195:14

answers 5:19 6:4

92:18 97:7 182:20

194:24 196:11,12

198:18 199:12,20

202:8 211:23

226:1

anticipated 30:8

anybody 23:7 38:3

41:8 52:6,9

167:18 173:23

248:5

anyway 237:24

apparently 188:10

194:17 201:24

appear 74:9 75:11

77:5 187:11

188:12

APPEARANCES

2:1 3:1

appeared 96:17

appears 143:9

applicable 46:11

85:2 156:23

application 161:4

apply 113:10

297:19

appreciate 295:17

apprized 112:17

114:20 249:2

appropriate 66:24

137:1,23 170:23

appropriately

137:20

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 301 of 330 PageID:

43890
Page 2

approval 93:23

94:6 97:8,12

136:22 168:9,22

169:8 286:5

approve 108:11

approved 108:13

120:12

April 5:4 6:16,17

61:8,9 74:4 147:3

188:10 204:4

Arch 2:14

area 32:9 33:4 39:8

40:18 161:5 171:9

269:24

arm's 234:11

arrangement

219:10

arrived 156:1

158:4 159:6 163:1

268:4

Arrowood 65:16

Arthur 1:13 2:23

4:4 7:4 10:3,22

104:1 177:3

226:20 298:4,14

299:3,24

arts 11:19

Asbestiform

247:16

asbestos 6:8 15:11

17:10 18:11,17,24

19:8,19 20:3,15

27:4 32:11 33:19

33:23 35:1,22

36:11,22 39:20

40:18 47:4,12

48:15 49:18 54:17

55:15 116:14

117:19 118:9

127:1 129:7

131:20 135:22

136:12,14 142:2,6

149:2 155:4 185:4

188:4 189:10,12

189:19 191:10,24

193:5 203:10

206:17 207:14

228:11 229:6

238:5,15 239:4

240:19 241:5

244:11,22 245:23

246:11 249:16

250:5 251:8 252:1

253:2,11,17

254:11 255:22

256:24 258:9

259:11 260:6

261:12 262:23

264:1 265:7 266:3

274:19 275:2

276:6,15 277:1,15

278:21 279:14

282:22 283:10

284:1,10,19 287:2

290:8 293:7,18

asbestos-related

137:9 183:23

189:11

Ashton 4:15 5:7

208:12,24 209:7

210:22 211:9,14

212:10,18,20

216:21 217:7

220:22

Ashton's 212:24

asked 28:20 36:19

37:10 50:15,16

57:13 80:11

104:18 122:23

126:18 136:3

141:21 157:11

159:21 179:1,15

181:5 201:22

281:2,4 288:3

290:10 291:24

292:19

asking 37:17 45:18

52:17 56:7 62:14

64:17,19 94:18

116:18,22,24

122:6 125:8

129:19,21,23

130:2,3 132:9,10

141:11,13 152:2

162:2,5 165:18

166:11 191:14

196:5 201:18

202:5 205:19,21

206:20 222:9

227:22 228:3

242:13 251:15

252:5 258:1 267:1

267:13 273:6

275:16 287:4,15

290:11 291:15

asks 184:3 192:15

212:6 273:16

assemble 80:23

assert 207:2 290:7

asserted 38:11

54:15 55:24

104:22 125:14

126:6 242:20

286:10,24 294:3

294:10

asserting 39:19

57:11 122:11

289:24

assertion 37:9,18

242:12 253:9

275:1 286:13

assertions 253:1

276:5

assessment 130:14

242:15,19 244:12

244:22 273:7

assigned 86:13

88:21 172:7

assist 219:11

assistance 172:5

assistant 12:7

associate 87:24

192:20 195:17

233:18

associated 244:12

associates 240:14

assume 18:6 77:22

89:13 101:15

137:2 181:19

295:8

assumed 201:19

279:1

assumes 50:2 89:4

134:13 135:10

136:16 148:18

161:13 193:8

199:22 200:23

202:19 203:15

207:17 259:19

260:11 269:10

278:17

assuming 270:23

assumptions 102:5

attach 61:9

attached 25:17

61:7 149:24

200:16 212:10

298:10

attachment 7:11

73:7 218:13 224:9

attachments 7:9

211:8

attend 13:21 87:5

attended 119:23

attention 43:17

110:5 223:9

attorney 42:17

172:7 278:6

attorneys 177:4

209:6 212:16,20

212:23 226:23

243:23

attorney-client

16:11 22:23 36:3

37:12 47:22 76:21

116:8 121:21

207:2 208:3

210:21 228:2

230:9 242:21

250:10 254:24

256:6 257:5

258:17 273:17

286:15

auditor 103:22

130:5

auditors 103:9,14

103:15 104:12,19

105:4,13 114:24

123:20 124:18,20

125:5,20 126:11

126:23 127:6

128:12,19,21

129:5 130:22

131:10

August 219:20

224:5

author 163:21

215:16

authored 48:14

61:5 247:7

authorities 40:17

authorization

105:20 106:4

authorize 94:13

95:1 206:15

288:22 289:20

authorized 96:22

168:21,24 169:3

193:17,24 198:3

209:6 220:8

222:14 262:11

289:10

availability 95:4,14

available 100:10

101:10,18 103:14

171:9 198:16,17

199:1,11,19 200:2

200:13 202:14

203:5,11 221:6

266:3,19

Avenue 2:3

aware 43:3 48:19

58:12 88:9 95:12

96:18 116:14

117:18 118:7

134:15,20 135:4

142:23 152:18

161:14 186:23

193:14 197:20

206:5,11 207:11

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 302 of 330 PageID:

43891
Page 3

213:9,14 219:6

224:15 226:21

228:9 229:2,12

230:6 243:4

247:22 251:22

253:8 255:5,21

256:23 258:7

260:5 262:22

272:13 274:23

287:21 290:5

291:11 292:14

293:6,17 294:2

a.m 1:16 10:10 84:1

84:8 128:1,8

B

B 61:20,22,24

BA 177:2

bachelor 11:19

back 17:4,6 47:15

76:12 84:8 95:20

117:13,15 118:13

128:8 136:24

148:8 153:10,12

166:20 176:3

214:22 217:12

228:1 251:2

259:17 266:24

267:15,18 280:3,6

282:5 287:13

292:6 295:6

ball 196:8

Bank 1:15 2:4

10:12

bar 12:1

Barry 2:13 233:9

based 45:9 102:4

207:13 220:15

222:11 242:20

251:7,23 253:1,9

267:22 282:16

285:24

BASF 1:6 2:11 4:13

4:15 5:19,21 6:21

6:23 7:5 10:5

27:17 28:21 31:9

31:11 37:24 38:1

43:10 44:12,18

70:5 121:2 155:2

155:11 176:9

177:2 197:5

212:16,21 215:7

226:2,3,20 231:12

232:3,15 233:20

236:15 237:2,17

239:11,19,24

241:12,22 242:17

245:11 271:15,23

274:16,23 276:14

276:24 282:8,9

286:10,24 294:4

294:10 295:20

299:2

BASF's 272:6

basically 87:2

138:1 156:18

179:11 265:2

285:2 295:10

basis 17:2 37:8,17

39:11,18 40:6

54:3 79:5 103:15

110:7 112:23

206:16 242:12

251:14 274:11

289:5

Bates 63:2 65:15

began 17:20 231:16

beginning 104:1

105:6

begins 10:2 43:23

164:13

behalf 96:23

141:17 148:11

182:21 193:19

194:24 214:10

220:9 294:10

belief 53:20 54:4

298:9

believe 20:21,21

32:24 41:20 56:1

63:13 100:24

103:17 110:2

154:19 156:12

183:17 197:6

232:20 245:9

253:20 257:12,21

265:3 266:10

277:5 290:13

benefits 140:18

best 181:16 298:8

bid 231:12

big 134:2 156:19

bill 108:1,3,12

billed 111:9,17

billing 107:20

bills 108:4,24

bit 23:2 26:5 42:1

43:20 83:14 91:3

178:14

blame 71:12,12

blessing 93:20

board 13:21 112:16

113:3,11 114:14

116:13,13,19

117:7,18 118:6

119:14 120:10

122:3,5,8 123:6

243:3 284:8,14

Bob 63:6

BOISE 2:13 54:21

65:16 70:15 71:13

101:12,19 105:16

137:16 141:8,12

184:11,16 207:18

209:21 240:8,21

241:6 260:20

262:4 265:12

266:8 285:17

295:24

boiseb@pepperl...

2:16

Bondo 75:5,13

bonus 87:16

books 120:13,16,18

121:2

bottom 71:1

bought 31:22

Boulevard 2:20 3:4

boxes 170:22,23

171:9

Boyle 2:19,20 72:21

143:15 164:6

181:7 246:21,22

285:6,16,19

287:10,14 288:13

291:3,14,19 294:5

294:12

Brazukas 1:17

10:16 297:14

breaching 250:9

break 83:16 230:21

231:4,6 250:15

272:23

brief 84:5 128:5

230:16 250:23

282:2 295:3

briefly 138:10

broad 23:3

Brockman 61:10

64:18,20 65:5

broken 110:3,4

brokers 279:13

brought 252:23

Brush 15:20 16:5

16:24

budget 107:8,14

building 90:19

burden 47:14

business 12:14,15

69:6,20 86:16

89:7 110:9 130:4

172:4 193:12

269:24

Bynoe 66:3

C

Cahill 2:16 4:17

21:12 23:7 26:18

26:20 29:10 38:4

38:13 41:9 50:8

53:19,22 54:7,16

56:14 63:11 65:7

79:1 80:2,22

81:23 84:19,20

85:4 86:24 89:14

91:4 93:13,18

94:6,13 95:2

96:24 97:19 98:18

100:10 101:10

102:1,22 103:1

105:2,13,20 107:7

108:11 111:9,16

133:17 136:20

137:19 151:5

156:21 177:4

199:18 205:13

206:6,16 207:12

211:1 212:16,23

213:1 216:7

226:23 228:19

233:11 240:3,5,18

241:2,11 252:11

262:21 263:5,12

263:22 265:20

273:14 274:5

285:1 286:3

287:23 288:23

291:1 294:4

call 17:15 30:13

109:21 172:6

Callahan 3:9

140:22 164:19,22

called 58:20 65:6

74:5 77:1 82:20

126:1 159:12

225:7

calling 190:19

calls 75:18 78:6

115:2 116:17

168:14 170:2

198:20 199:3

205:17 221:14

222:16 231:4

239:13 248:10

249:4 261:17

264:8 265:11

266:7 267:8 270:7

270:18 277:18

286:7

candor 264:13,22

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 303 of 330 PageID:

43892
Page 4

capable 30:15 38:9

capacity 13:9 21:16

57:10 190:16

caption 188:5

299:2

captioned 226:5

carrier 67:10,19

69:14 281:11

carriers 63:8 66:19

103:2 255:13

279:12 280:21

292:14 293:6,16

Carter 5:8 183:5,13

219:21,22 220:8

224:10

Carter's 224:1

case 5:13 29:18

32:6 43:10 58:20

58:23 62:12 67:2

70:5 74:4 76:4

77:1,8,19 78:2,3

91:23 92:19 97:13

99:9 102:10,12

105:19 138:10,12

138:17,23 141:5

142:16 146:9

147:4,9 148:15

149:8,12 151:16

153:24 155:2,5,6

156:2,7 157:9

165:14 166:16

185:4 199:1 201:6

212:23 224:17

225:7 226:2,22,23

226:24 227:5,15

227:18 228:21

229:3 230:6 243:5

247:9 248:6

249:15 257:10,22

258:7 263:12

268:22 285:13

286:12 294:4,11

299:2

cases 58:19 59:2

75:12 79:22 80:13

81:15 83:7 84:12

91:18 96:16

105:11 113:18

130:21 149:12

153:24 160:1,12

174:18,23 204:13

207:13 209:8

213:24 214:9

251:7,22 252:23

253:8 257:12,23

260:19 261:23

262:14 273:10

274:24 275:12

279:14 291:13

292:13,15 293:16

Catalysts 1:6 2:11

5:19,21 6:21,23

7:5 10:5 299:2

category 84:24

caution 16:9 24:15

113:6 190:8 239:7

254:13 257:2

280:13

cc 66:2

cc'd 204:20

central 172:14,18

181:15,15

certain 12:14 277:5

certainly 54:10

105:5 122:5

142:22 238:13

239:2

CERTIFICATE

297:2 298:1

certification 297:18

certified 1:18 183:5

certify 297:5

certifying 297:22

cetera 44:8,9 184:4

CFO 233:10 244:7

challenging 295:15

change 15:3 120:14

changed 103:24

155:6

charge 14:14 63:19

78:20 80:22 88:24

108:21 120:21

172:18 244:5

260:1

Charles 5:8 183:5

183:13 219:21,22

220:8

Chatham 2:21

check 204:24

checking 169:18,23

checklist 124:13

Chemical 5:16

60:19

chemicals 12:23

13:4,8 156:14

159:3

Chernick 6:12

188:6 201:12

chief 112:9

Chris 11:12 59:24

63:3 70:9,15

76:11 83:13

123:12 143:5

166:24 179:19

186:21 187:16

202:22 208:15

218:1 225:13

237:7 267:2

275:15 281:16

CHRISTOPHER

2:2

chrysotile 142:2,6

144:21 148:1

247:16 249:11,16

250:5

Chuck 170:24

171:3 173:6

circulated 120:10

circumstance

231:19

circumstances

15:16 17:12 23:3

23:24 26:14

138:11 248:14

City 188:4 198:5

202:16 203:12,19

Civil 1:3 10:7 43:1

46:9

claim 66:12 67:2

183:23 294:2,10

claiming 259:12

claims 59:9 291:11

293:5

clarification 255:2

clarify 46:22

186:20 267:13,20

clarifying 123:13

clarity 23:10 205:7

205:19

Clark 4:20 5:5,14

247:10

Class 212:11

clear 102:4 117:17

122:2 125:4,17

168:20 271:12

280:20

clearly 186:7

client 42:18 273:13

close 140:13

code 265:23

Cohen 2:2 10:13

105:8

collected 173:13

270:12

Collection 4:17

column 68:8

come 20:12 45:14

46:18 101:22

131:19 133:16,18

157:7 224:13

230:14 232:14

235:18 246:8

271:8

comes 16:4

coming 132:5

136:23 236:1

commencement

161:1

commencing 1:16

commission 4:11

139:6 298:21

committee 119:16

189:9

committees 119:14

common 219:14

242:10,22 245:4

272:19,23 281:5,9

commun 23:2

communicate 67:9

67:18

communicated

68:23 69:13 126:4

130:22 226:22

communicating

244:23

communication

16:24 73:3 122:12

210:21 228:4

communications

16:10 23:6 38:3

38:12 41:7 42:17

56:13 76:21 79:21

95:24 113:8,10

114:5,8 117:5

122:18 123:5

224:23 229:20

235:11 237:16

242:16 252:10,14

256:6,8 257:5

258:18 263:4

273:12,17 274:4

277:21 280:11

288:7 289:21

company 5:11 6:6

14:5 16:6 31:22

60:6,11 61:11,18

62:5 67:1 79:2

94:23 95:10 104:9

115:24 117:6

119:17 121:19

122:10 123:7

129:24 137:21

156:11 159:14

161:3 190:17

209:4 231:22

234:24 235:7

242:14,18 244:6

248:21 252:16

253:8 275:23

Compensation 59:9

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 304 of 330 PageID:

43893
Page 5

compilation 25:16

compiled 248:15

Complaint 212:12

complete 143:7

245:10 263:13

298:8

completely 22:17

compliance 125:6

complies 204:11

215:3

comply 124:3

194:16

comprehensive

156:9

concept 160:23

concerning 18:11

19:18 33:22 35:22

49:18 58:2 77:8

94:5 95:3,14

101:9 106:20

114:15 116:15

118:8 121:16

123:21 126:11

128:12 151:23

158:5 161:9 189:9

200:17 203:10

230:5 232:16

236:9,21 239:3

240:19 241:3

243:11 244:21

245:23 246:11

259:9,10 260:6,18

264:1 265:7 266:3

266:17 268:6

270:4,24 273:18

274:6 276:15,24

277:24 278:13,22

280:23 284:8,9,19

291:11 292:12

concluded 132:10

149:9

conclude's 296:10

conclusion 131:20

132:5 151:16

205:23 245:22

246:9 247:15

278:21

conduct 87:1

264:13 265:22

conducted 271:15

confer 127:10,20

confidential 37:13

42:16

confirm 254:1

conflict 104:2

confused 234:3

confusing 240:12

Congressional

189:8

conjunction 93:13

213:16

connected 182:1

connection 41:17

56:15 183:22

193:10

consider 94:22

considered 14:10

considering 136:9

consisted 109:21

consistent 55:14

156:15,23

consisting 243:22

constructed 26:10

26:15

construction

275:11

consultants 18:23

183:20

contact 44:18 79:2

103:2,9 104:8

contained 27:3

133:24 134:10

170:14 200:15

253:16 255:22

256:24 258:8

262:23 285:11

297:6 298:6

containing 73:24

76:21 218:13

contaminated 35:1

254:11

contamination

54:17 55:15

content 18:11 23:5

56:12 237:16

245:24 252:9,14

266:3 277:1,15

280:14 282:23

284:20 289:21

contents 24:16

288:7

context 22:13 85:12

133:2 190:21

218:21 227:15

235:24 248:6

281:13 283:3

continue 16:20

continued 3:1 5:1

6:1 7:1 9:1 241:11

continuing 23:11

23:12 42:14

contractors 183:21

contrary 202:6

control 37:23

243:23 275:22

282:21 283:9,16

297:21

controls 37:24 45:8

convention 64:4

conversation 16:4

conversations

48:22 243:10,20

Coopers 104:4

coordinate 91:18

coordinated 63:11

195:19

coordinating 54:8

198:4,11 202:15

203:11

coordination 66:18

copied 205:8,9,10

205:22

copies 85:13,23,24

86:1 150:13,21

171:14 172:12

184:3 228:20

263:14

copy 25:15 29:17

61:8,9 70:16

101:23 102:1

151:6 223:2

Coren 2:3 70:23

71:4,12,21 72:19

72:22

corner 30:11

Corp 7:8 60:19

corporate 13:18,20

28:21 112:14

118:19 119:8,10

125:20 195:13

199:7 234:22

251:5,21 283:7,22

291:20

corporate-wide

172:2

corporation 6:6,10

13:8 14:1,11

59:19 75:5 104:21

119:19 122:7,18

123:5 124:22

125:9,21 131:17

131:22 139:5

141:17 148:11

161:22 182:22

193:18,19 195:1

195:18 199:11

245:14 246:1,12

273:7 291:15

Corporation's 6:7

correct 12:3 29:1

31:2 34:21 40:14

48:6 50:1,4 71:8

76:5 77:10 138:17

141:17 142:3,23

160:13 162:22,23

163:2 170:17

176:8 180:2 183:8

185:5,24 186:4

187:2 188:9

191:11,20,21

192:1,5,8,9,22

193:1 204:20

205:4 213:4

215:19 223:15,19

224:11,12 231:13

238:16 239:5

240:17 241:1,10

254:6 268:1,15,17

268:19 270:16

274:8 275:15

284:22 285:24

286:13 290:22

297:9 298:7

corrected 120:15

CORRECTION

299:5

corrections 298:10

correctly 146:3

correspondence

286:1,3

costs 109:15 110:3

counsel 2:6,11,16

2:23 3:6 10:17

12:9,22 13:4,24

21:16 32:21 34:7

44:21 54:8 56:1

57:10 63:11 88:1

91:6,14 93:16,21

94:14 112:15

118:20 119:9

122:7,17 123:4

125:9 129:24

133:17 150:12

153:22 160:22

190:17 192:21

195:18 213:2

215:24 231:23

233:10,11,12,13

234:22 246:18

248:20 249:6

251:5,21 260:1

273:6 283:7,22

counted 137:22

145:18

countenanced

261:22 262:7

country 209:8

213:17

counts 109:6

145:22

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 305 of 330 PageID:

43894
Page 6

couple 233:23

course 69:6,20

85:19 119:11

151:24 152:22

166:19

court 1:1 10:6,15

10:19 17:5 38:21

95:19 117:14

125:17 153:11

182:23 188:3

194:15 226:6

227:24 259:16

266:23 267:17

280:5 287:12

292:5

coverage 61:12,14

61:15,17

covered 16:11,18

24:22 25:3 51:18

52:1 110:15

273:23 280:17

cplacitella@cprl...

2:5

created 151:24

152:22 245:24

246:11

credentials 33:4

CSR 297:14

culled 70:10

culling 70:18,19

current 15:22

73:24 114:20

153:16

currently 11:15

220:20

custodian 181:18

cut 165:10 296:5

D

D 5:8

Daniel 5:10 28:6,21

Daniels 4:20 5:5,14

247:11

data 18:10,15,16

71:23 81:8 220:21

220:21 221:10,18

222:12

date 1:17 72:20

78:15 147:22

163:7 187:7 210:6

210:6 216:15

217:24 223:14,16

223:24 224:4,11

298:14 299:23

dated 60:6 89:9

David 5:14 7:7 21:8

105:9 204:7 234:6

234:7 244:4

247:10

day 197:13 273:1

298:17

days 109:22

day-to-day 66:22

270:24

dead 48:5 49:17

dealing 130:5 276:1

dealings 21:15,19

Dear 6:16,17 7:7

63:6

Debbie 10:16

Deborah 1:17

297:14

decade 33:14

December 12:5

77:10 231:17

deciding 114:23

decision 132:17,19

133:5,13,21 134:9

135:6,14,19

decisions 114:23

Decof 5:13 247:9

deem 32:7

deemed 249:6

defend 61:19

291:13 292:15

defendant 7:4

183:21

Defendants 1:7

defended 226:23

274:24

defending 65:8

94:22 290:6

defense 53:3,15

54:8,15 87:2

91:18 93:5 107:8

107:8 109:8,14,15

197:16 213:24

214:9,19 219:11

263:23 287:22,23

288:23 292:14

defenses 43:6

104:22

delay 167:4,10

delegated 78:24

demand 294:2,10

Dembrow 2:17

211:1 212:17

217:1

department 32:23

33:1 86:11 88:3

89:16 90:11,15,22

91:24 92:21 98:7

98:11 110:1

141:24 142:5,22

150:13 157:19,20

158:5,17 159:9,19

161:9 167:18

169:4,9,17,19,22

169:23 171:20

172:1 173:4,14

179:3,10 181:16

197:15 199:8

248:19

depend 30:7 101:21

222:22 248:13

depending 16:12

DEPONENT 298:1

299:3

deposed 85:15 86:3

183:22 185:4

186:15 187:1

238:14

deposing 122:16

123:3

deposition 1:12

4:19 5:4,10 7:14

8:2 9:1 10:3,10

23:17 24:10,17

25:2 28:6,12

34:14 85:23 89:14

89:20 90:4 134:17

141:3 146:9 147:3

148:14 166:15

189:8 191:9 192:8

246:9,17 296:11

297:7

depositions 22:18

25:15 85:14 86:2

87:5 185:23

198:23 263:14

Desai 3:8

DESCRIPTION

4:10 5:3 6:3 7:3

destroy 159:18

160:14

destroyed 151:15

159:8

destruction 151:23

152:11 158:15

159:13 162:8

261:22 262:12

detail 51:10 110:7

details 51:8

determination

137:6

determines 197:5

developed 93:4

development 99:17

157:19 159:7

160:15 174:5

176:19 177:20

212:7 266:16

268:5 278:14

Development's

155:7

difference 119:5,7

different 36:8

40:22 91:20 96:6

119:9 130:9

164:24 182:8

187:17 200:11

258:13 292:17

differentiate

284:21

difficult 143:8

dig 164:2

diligence 271:14,22

272:6,16

direct 44:18 45:2

81:3 97:18,20

99:6 102:24 103:2

103:8 173:4 195:5

223:9 297:21

directed 36:2 46:14

57:14 99:3 197:4

direction 8:4 16:16

23:12 35:17 36:6

37:15 45:10 57:12

directive 161:18

162:7

directly 79:7

215:11

directors 112:16

113:3 114:15

116:14,20 117:8

117:18 118:7

122:8 123:7 243:4

discard 170:22

discarded 173:20

174:6 175:2

disclose 16:18,23

37:4,11 42:16

57:6 131:10

132:17,22 133:6,6

135:6,15,22 137:2

234:23 235:6,15

237:15 245:11

260:17 280:13

288:6

disclosed 24:19

37:20 46:2 47:8

47:18 105:12

134:1,10 136:13

137:3,7 146:10

148:14 248:8

255:13 259:11

261:13 263:24

268:7

disclosing 16:21

43:12 235:7,10

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 306 of 330 PageID:

43895
Page 7

253:23

disclosure 16:9

17:16 25:2 36:9

37:21 38:8 42:22

44:13 45:6 125:10

126:23 130:7

136:18 264:14

281:3,4

disclosures 7:4

14:8 32:6,8 44:1,4

46:8 47:17 280:21

281:2

discontinued 5:17

159:14,22 162:21

163:16 172:13

discoverable 32:7

35:21,23 37:20

43:5 46:3

discovery 44:6

47:19 91:22 96:23

97:7,22 98:20

100:11 101:11

137:20 138:3

155:2 183:14

198:5,18 199:9

202:15 203:12

284:24

discuss 108:10

discussed 135:12

135:19

discussing 136:8

discussion 84:4

87:16 106:17

128:4 175:23

231:9 250:22

282:1 295:2 296:8

296:14

disease 183:24

189:11

dismissal 207:13

dismissals 81:17

204:13 206:16

209:7 251:14

dismissed 81:16

83:8 113:21

130:21 251:7,23

253:9

disposed 266:17

279:2

disseminated

212:24 213:17

dissemination

176:20 178:10

212:8

distinguish 118:18

distribution 248:22

District 1:1,1 10:6

10:7 182:22,23

division 5:16 13:6

156:13,14 159:3

275:23

divisions 13:7

156:11

divulging 79:20

doc 163:14

doctrine 16:13

document 4:17

5:17 9:4 28:22

29:17,19 30:2

64:6,7,8,10 73:23

110:15 111:1

122:13 152:3

154:13,15 155:7

155:12,16 156:1

156:10,17,22

157:7,17 158:3

161:4 162:21

163:1,8,12,15

173:20,21 185:9

185:11,13 190:15

192:13 201:8,15

201:23 202:13

203:4 266:14

268:3 269:5 279:3

295:9

documents 4:18

25:18 29:4,8,11

29:15 162:9

171:19 172:12

173:22 174:4,20

174:24 181:10,18

182:12 196:7

246:24 278:15

282:16

doing 85:10 139:1

194:5

dollars 140:18

Dornbusch 1:13

2:23 4:4,14 7:4

10:3,22 11:5 16:1

22:5 24:9 26:4

35:5 36:1 37:21

37:23 38:7 39:5

40:11,13 41:5

43:3 45:7 46:12

47:7,17,21 49:10

53:7 56:11 57:9

64:20,22 78:10

83:15 84:23 95:23

113:7 116:19

117:24 125:19

130:12 136:4

140:4 143:6 144:8

145:14 177:3

179:1,16 181:20

184:18 190:14

191:3 194:23

196:6 209:12

224:21 226:21

228:4 253:21

254:13 256:3

258:18 274:2

280:8 282:7 288:5

289:13,19 295:22

298:4,14 299:3,24

Dornbusch's 29:1

44:3 126:2 201:16

Dornbusch-1 139:3

139:4

Dornbusch-2 69:24

70:3 209:19 210:2

217:13 223:8

Dornbusch-3

140:22 214:23

Dornbusch1 4:11

Dornbusch2 4:13

Dornbusch3 4:15

dozen 233:24

Dr 40:13,14,24

44:13 48:1,4,13

48:23 49:16 50:18

53:2,21 55:13,22

56:13 57:3 68:23

69:13 88:9 99:9

100:9,9,19 101:2

101:8,9 102:11,11

141:4,21,23

144:16,16,22

145:9,10 146:9

148:21 149:2

157:21 158:6,16

159:9,18 161:9

163:20 164:1

165:15 166:16

169:8 174:23

175:7 176:21

178:23 180:6

181:1 186:24,24

186:24 187:10

191:9,19 192:8

220:23 227:17

229:5 247:7

draft 137:22

drafted 179:7,9

212:17 213:15

219:21

drafting 163:10

167:14,23 176:19

177:9 178:2 212:8

213:23 217:7

draw 252:14

273:12 274:3

drawing 43:16

277:20

Drive 11:16

due 165:24 271:14

271:22 272:6,15

Duffy 240:10,12

duly 10:23

duties 118:18,24

duty 57:6 245:11

264:22 265:4

DVD 10:2

Dynatron 75:4,13

Dynatron/Bondo

74:24 75:24

D.C 2:9 4:12

E

earliest 23:15 58:12

early 21:2 58:16,17

62:12 63:20 87:13

273:9

easier 72:22 155:22

Eastern 6:6 62:4

182:23

effect 67:1

effort 172:2

either 48:11 61:11

85:20 99:1 102:11

161:2 165:19,19

197:3 199:18

206:15 269:23

294:4

electron 146:1

147:16

elicit 202:9

ELLIS 2:8

Em 19:6

Emil 99:20

employed 209:4

291:1

employee 66:10

100:5 220:5

239:19,24 255:7

employees 125:20

183:19 188:19

189:7 226:20

255:7,12 290:23

Emtal 14:18 15:11

18:11,17,24 19:8

19:18 20:4,15

22:1 53:3 58:3

67:3,19 76:22

78:16,19 84:21

86:14 88:4 90:6

91:14 93:5,16

94:15 95:4,15

100:12,20 101:10

105:11 109:8,15

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 307 of 330 PageID:

43896
Page 8

112:17 114:15

116:6,15 117:20

118:9 121:6,17

124:20 127:1,6

128:13 129:7

130:21 131:11,20

132:18 133:7

134:3,11 135:7,23

136:12,14 142:1,7

145:20,21 148:1

159:8,19 160:6,14

161:10 170:16,20

174:22 191:24

193:5 197:16

200:18 203:10

206:17 207:15

214:9 235:17

236:9,21 237:4

238:5,15 240:20

241:5,12,22

243:12 244:11

245:24 246:11

251:9 252:1,24

253:2,11 259:1,11

259:13 260:4,7

261:12,23,24

262:14,15 263:24

264:2 265:7 266:4

268:6,22 272:8,14

274:19,23 275:1

275:12 276:5,15

277:1,15 278:1,15

278:22 282:9,23

283:10 284:2,10

284:20 287:2,24

288:23 290:6,7

291:11 292:13

293:4,7,15,18

enforced 156:17

Engel 105:11 232:3

Engelhard 6:6,10

12:4 13:7,18 14:1

14:15 18:24 19:6

19:17 20:1,13

21:20 26:18 31:10

38:4,13 41:8

56:15 57:11 58:2

59:2,10,19 60:11

60:18 61:2,2,18

62:6,11 63:19

65:8 66:9 83:6

85:14,23 86:2,7

86:14 87:12 88:8

88:22 89:1,17

92:1 96:24 97:20

97:22 98:21

102:12 103:9

105:21 107:2

113:3 118:8 121:1

123:21 126:14

129:5 131:10

132:18 137:8

139:5 146:12

149:11 150:7

152:1,23 154:14

155:4,6,12 156:13

157:18 160:14

169:7 182:21

183:8 185:3,23

186:8,14,23

195:18 198:24

213:2 214:10

219:24 220:5,9,20

221:6 222:13

226:20 229:3

231:12 237:17

238:4,14 241:4

243:3,4 245:1

246:10 251:6

252:24 253:7,16

254:10 255:6,20

255:22 256:22

257:20 258:8,24

259:10,12 260:3,6

260:18 262:23

264:3,15 265:4,21

268:21 271:9,16

274:6,17 275:10

278:11 279:11

280:12,22 281:10

291:10 292:11

293:3,15

Engelhard's 57:12

69:14 128:12

195:19 198:4

253:10 255:13

257:11 282:21

283:8,23 287:21

288:21 290:23

Engelhard/BASF

32:12

Engelhard/BASF's

47:5,13

Englehard 7:8

ensued 13:15

ensure 86:24 157:1

260:2

entailed 118:24

Ental 17:10 256:23

enter 219:2 244:22

entering 218:20

entire 14:1 61:12

78:8 291:15 298:5

entirety 122:4

entitled 31:23 63:1

247:7

entity 271:10

entries 4:16 78:11

215:11

entry 70:14 72:15

73:2 74:3,12

76:10 78:1 210:3

216:14,16 217:23

223:10

Eric 3:3 6:13,15 7:7

204:3,5,7

ERRATA 299:1

especially 98:12

Esquire 2:2,3,8,13

2:19,20 3:3,8,8

6:19 195:17

established 64:11

98:12 201:21

247:19

estimate 21:6

et 1:3,6 4:21 5:5,11

5:15,20,21 6:12

6:23,23 7:5,6 10:4

10:5 44:8,8 184:4

247:11 299:2,2

etunis@herold.c...

3:5

evaluation 146:2

event 122:9

events 121:17

eventually 79:3

everybody 25:10

182:20 195:24

233:4

evidence 44:7

54:16 55:15 95:4

95:14 102:9

116:15 117:19

129:6 131:20

132:17 133:6

136:12 151:23

152:11,21 153:23

157:18 161:7

193:1 200:3,17

203:10 224:15

251:24 255:11

262:12,13 264:14

266:16 268:2,14

269:7 274:18

278:21 286:11

287:1 293:6 297:6

Ex 212:10

exact 224:11

exactly 29:14

190:13

EXAMINATION

11:2

examined 10:23

example 80:12

89:13 92:19 96:13

99:7 114:24

exceeding 268:20

exception 79:5

160:10

excerpt 4:13,15 5:9

141:8 143:16

215:7

excerpts 28:5 70:4

141:10,13 209:22

excess 63:8

exchange 4:11

72:12 74:13 77:7

105:4 139:6

210:15,24 215:13

216:24 229:7

excludes 143:16

Excluding 4:17

excuse 26:3 59:24

91:24

executed 208:12

287:23 288:22

execution 176:20

178:18 212:9

executive 183:7

220:1

executives 85:14

97:21 255:18

exercised 245:10

exhibit 7:13 25:15

28:4,5 32:1,5

70:24 71:5 140:21

140:24 141:3

146:6 147:2,2

162:12,16 176:12

177:13 187:14

203:18 204:2,4,5

204:7,24 205:5

208:8,11 211:20

219:18,20 225:10

225:24 247:3,6

exhibits 4:8 5:1 6:1

7:1 149:24 150:22

206:12

existed 18:16

228:12 278:22

existence 126:24

134:16

exists 37:11

expect 96:18

248:20 249:7

263:18

expectation 151:5

151:15 261:10

263:22 264:10

265:19

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 308 of 330 PageID:

43897
Page 9

expenditures 110:2

experience 46:7

129:22

expert 33:2,4

183:20 227:18

228:10 248:24

expires 298:21

explain 40:5 96:9

explained 39:11,23

40:2,8 137:18

exposure 183:24

189:10 252:24

261:24 262:15

264:4 275:12

expressed 97:12

extension 170:24

extent 22:24 25:1

93:10 98:3 102:3

114:4 172:3 190:7

275:9

extracting 270:15

F

faced 271:24

face-to-face 232:15

facilitate 197:7

facility 156:18

facing 234:24 237:3

fact 20:3 24:21

32:24 36:9 37:19

48:4 49:17 64:12

78:8 111:22 195:1

196:9 201:15

235:5 249:15

facts 50:2 54:11

93:22 126:3

134:13 135:10

136:16 148:18

161:13 193:8

198:12,15 199:22

200:23 201:19

202:19 203:15

207:17 259:19

260:11 269:10

278:17 284:8,9,19

294:3,11

factual 93:23 94:5

191:1

factually 57:5

fair 13:1 31:1 52:14

91:6 204:14

285:13 295:12

fairly 92:6,10

fairness 202:23

familiar 25:22,24

63:14

far 79:23 201:4

213:5

Farrell 2:8 13:11

14:19 15:17,24

16:3,8 17:13 18:3

18:18 19:1 20:5

20:17 21:3 22:2

22:14,22 24:7,15

25:6 26:11,22

27:6 28:1,7 29:22

30:4 31:3,14,17

32:3 34:1,16,20

35:2 36:14,19

37:3,17,22 39:2,9

39:15,22 40:1,8

41:2,12,18 42:6,9

44:15 45:16 46:4

46:20 48:7,17,24

49:7,22 50:2,21

51:3,20,24 52:15

53:4,12,23 54:5

54:19,22 55:5,17

56:5,10,19,22

57:18 58:8 59:4

59:11 60:12 62:17

63:2,21 65:1

66:15 67:6,13,20

68:17 69:1,7,15

69:21 70:8 72:5

72:13,17,24 73:20

74:6,15 75:6,17

76:6 77:2,11 78:5

78:22 79:12 80:5

80:15,24 81:18

82:1,5,12 83:1,9

84:14,22 85:16

86:4 87:6 88:10

89:2,22 90:16

91:15 92:2,12,23

93:7,24 94:7,16

95:6,16,21 96:10

97:3,9,14,24 98:8

98:22 99:10

100:13,22 101:3

102:14 103:4,11

104:14 105:14,22

106:6,14,22 107:3

107:10,21 108:15

109:2,9,17 110:12

111:2,11,19 112:6

112:19 113:5

114:2,10,17 115:1

115:9,16 116:1,7

116:16 117:3,10

117:21 118:2,10

118:21 120:7

121:7,12,20 122:4

122:16,23 123:3

123:10,22 124:5

124:23 125:8,14

125:23 126:16

127:2,8,15,19

128:14,23 129:8

129:17,23 130:8

130:12,17,23

131:4,12,23 132:6

132:13,20 133:9

134:4,12 135:1,9

135:17 136:2,15

137:10,14 138:4

138:18 139:11

142:18,24 144:17

145:5 146:13,19

147:10 148:2,17

149:4,13,18 150:2

150:8,15,23 151:8

151:17 152:14

153:3,13 154:2,5

154:17 155:18

156:3 157:10,22

158:7,18,23

159:10,20 160:3,7

160:17 161:11,23

163:3 167:20

168:4,10,13

169:10,24 170:8

171:21 172:20

173:15,24 174:9

175:3,6 177:21

178:3,7,11,19

179:18,21 180:7

180:15,21 182:17

183:9 184:12

185:6,10,14 186:2

186:11,16 187:4

188:15,20,24

189:15,23 190:6,9

190:12 191:12

192:3,10 193:2,6

193:20 194:5,9,13

194:18 195:3

197:17 198:7,19

199:2,13,21 200:8

200:21 201:2

202:2,5,17 203:6

203:14 204:16,21

205:16 206:18

207:1,5,16 208:1

209:9,14 211:16

213:18 214:1,11

215:4 216:1 217:8

217:14,24 218:22

219:5,13 220:2,10

221:3,7,11,13,21

222:2,15 223:4

224:18 225:1,5

227:6,20 228:2,13

228:22 229:10,16

229:23 230:3,8

231:20 232:6,17

232:24 234:14

235:1,8 236:2,10

236:18,23 237:12

238:6,17 239:6,12

239:20 240:6

241:13 242:1,6,13

243:6,13,18

244:14 245:2,17

246:2,13 247:24

248:9 249:3,18,24

250:7,11,14

251:10 252:6,18

253:3,12,18

254:12,19 255:14

255:23 256:3,8,12

257:1,7,14,24

258:10,15,20

259:2,14,18

260:10,21 261:16

262:2,16,24 263:7

263:16 264:6,16

265:9 266:5,21

267:1,6,11,19

268:9,16,23 269:9

270:6,17 271:3,17

272:2,9,17 273:5

273:23 274:10,13

274:20 275:3,13

275:18 276:7,17

277:2,17,24 278:3

278:16,23 279:8

279:16,22 280:7

281:1,13 282:11

282:24 283:3,12

284:3,11 285:4,14

286:6,14 287:6

288:1,15 289:1,6

289:12 290:9

291:4,23 292:16

293:8,19 294:6,13

295:19

Farrell's 17:19

fashion 166:5

fault 226:12

Federal 42:24 46:9

fell 96:20

felt 137:1

fiber 145:22,22

Fiberglas 6:7

fibers 145:18,19

146:1 148:1

Fifteen 181:8

Fifteenth 2:9

fifth 247:14

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 309 of 330 PageID:

43898
Page 10

fifty 182:15

fight 272:24

figure 110:22,24

file 29:1,20 30:3

60:18 82:17,20

90:3,20 138:22

150:14 151:7,15

170:22,23 199:19

201:9

filed 58:22 59:2,10

67:3 82:15 156:2

156:7 226:6

257:13

files 27:18,20 30:10

31:23 50:14 89:1

89:5,7,10 90:22

90:23 158:16

159:13,18 160:15

170:14 172:14,19

173:13 200:4

final 157:8 163:1

finalize 212:19

finalized 155:12

157:4 266:15

269:6

finance 109:20

112:11 119:16

financial 14:8

104:21 112:9

131:16 283:24

find 30:17 39:1

72:1 112:1 164:16

findings 68:23

69:12 88:9

fine 16:22 57:21

250:17

finish 190:2

finished 123:10

221:11

firm 100:10 102:22

228:20 233:14

first 6:11,22 12:6

15:9 17:7,8 18:9

18:14,22 19:5,12

19:21 20:10 37:22

42:21 58:5,11

59:18 71:5 112:8

142:12 145:11

174:20,24 197:13

204:24 206:2

210:16 214:7

216:15 234:5

240:11

firsthand 252:12

Fish 157:1

five 281:19 294:20

five-minute 83:16

flash 208:16 212:1

flesh 39:7,10

Fliegel 87:23

204:20 205:1,14

205:22 206:6

211:4 215:17

flip 182:5 294:17

flipping 182:2

floor 90:19

following 141:22

145:10 181:5

follows 10:24

foregoing 297:18

foremost 40:17

foreseeable 279:13

forget 233:16

forgotten 22:17

55:10

form 13:12 14:20

15:12,18 18:4,19

19:2,10 20:5,17

21:4 22:3,15,22

26:12,23 27:7

28:1 29:22 30:5

31:4,6,17 34:2

35:3 36:15 41:2

41:18 42:10 45:16

46:4,20 48:7,18

48:24 49:7,22

50:22 51:3,20

52:16 53:4,13,24

54:6,20,21,22

55:18 56:4,6 58:9

59:5,12 60:13

62:17 63:22,23

65:1 66:16 67:7

67:14,21 68:17

69:1,7,15 73:21

74:7 75:6,16,18

76:6 77:2,11 78:5

78:23 79:13 80:6

80:15 81:1,19

82:5,13 83:2,10

84:15,23 85:17

86:5 87:7 88:11

89:3,21,22 90:17

91:16 92:3,12,23

93:8,24 94:16

95:6 96:11 97:4,9

97:14 98:1,8,22

99:11 100:13,22

101:12 102:14

103:5,12 104:14

105:14,16,22

106:6,14,22

107:11,16,21

108:15 109:3,10

109:18 110:12

111:3,11,19

112:20 113:6

114:3,17 115:2,10

115:17 116:1,8,16

117:21 118:22

120:7 121:7,21

123:23 124:5,24

127:8 128:14,24

129:8,18 130:23

131:12,24 132:21

133:9 134:4 135:2

135:10 136:3,16

137:11,14 138:5

138:19 139:12

142:17,19,24

144:17 145:5

146:14,20 147:11

148:3,17 149:4,13

149:18 150:15,24

151:1,8,17,19

152:4,14 153:3,14

154:3,18 155:19

156:4 157:11,22

158:8,18,23

159:10,21 160:7

160:16,18 161:12

161:24 163:4,24

167:21 168:5,11

169:10,24 171:22

172:21 173:15

174:1,9,11 175:4

175:5 177:21

180:7,16,22

183:10 184:11,12

185:7 186:3,12,17

186:19 187:4

188:16 191:12

192:3 193:3,7,20

194:9 195:3

196:17 197:3,17

198:7,20 199:14

199:21 200:8,19

200:21 202:18

204:17,22 205:17

206:10,19 207:17

208:2 209:9

211:16 213:12,19

214:2,11 216:1

217:9 218:23

219:14 220:3,10

221:8,14 222:3,16

223:4 224:18

227:6,21 228:13

228:23 229:11

230:9 231:21

232:7,18,24

234:14 235:2,8,19

236:2,10,18

237:12 238:7,17

239:13,21 240:7

240:21 241:6,14

242:2,7 243:6,13

244:14 245:3,16

245:17 246:3

248:1,9 249:18

251:10 253:18

255:15,23 257:15

258:23 259:3,19

260:9,11,20,21

261:15,16 262:1,2

262:16,18 263:1

263:17 264:7,16

265:10 266:6,20

268:8,9,23 269:9

270:6,18 271:17

272:9,18 275:13

276:8,17 277:2,18

278:16,20,23

279:9,16 282:11

282:24 283:12

284:3 285:5,14

286:7,15 288:2

290:10 291:2,3,4

291:23 292:17

293:8,19 294:6,14

format 115:7

former 100:5

122:17 123:4

125:9 190:16

198:24

Formerly 6:5

formulate 156:9

forth 43:2,4 47:15

found 18:24 27:18

28:23,24 34:24

39:20 72:3 142:6

144:22 149:2

191:24 200:4

229:6 249:11

foundation 18:19

20:6,18 22:23

28:2 29:23 30:5

31:18 35:3 36:15

41:3,19 42:10

45:17 46:5,21

48:8 49:1,8,23

51:4 53:5,13

54:23 55:18 56:6

59:5 62:18 65:2

68:18 69:2,8,16

75:7,18 76:7 77:3

77:12 78:6 80:16

81:19 82:6 84:15

89:3,23 92:3,13

92:24 94:1,17

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 310 of 330 PageID:

43899
Page 11

95:7 97:10,15

98:1,9,23 100:14

100:23 101:13

102:15 104:15

105:15,23 106:7

106:15,23 107:22

108:16 109:10

110:13 111:12,20

113:6 114:3,18

115:2 116:2,8,17

117:22 120:8

121:8,21 124:6,24

127:9 128:15,24

129:9,18 130:24

131:13,24 132:21

133:10 134:5

135:10 136:3,16

137:15 143:1

144:18 145:6

146:20 147:11

148:3,18 149:5,14

149:19 150:16

151:9,18 152:5,15

153:4,14 154:6

155:19 157:11,23

158:8,19,24

159:11,21 160:8

160:18 161:12

163:4 168:13

169:11 170:1

172:21 173:16

174:1,10 175:6

177:22 180:8

184:13 185:7

186:17 187:5

188:16 191:13

192:4 193:3,7,21

194:10,13,19,22

195:4 197:18

198:8,20 199:22

200:9,22 201:11

201:21 202:18

205:17 206:19

207:17 208:2

209:10 211:17

214:2,12 216:2

217:9 219:14

220:11 221:14

222:3,16 223:5

224:19 227:7,21

228:14,23 229:11

230:9 233:1

234:15 235:9,20

236:3,11,19

237:13 238:7,18

239:13 240:8,22

241:7 242:7 243:7

243:14 244:15

245:3,18 246:3

248:10 249:19

251:11 253:19

255:15,24 257:15

259:3,19 260:11

260:22 261:17

262:3,17 263:1,17

264:7,17 265:10

266:6 268:10,24

269:10 270:7,18

271:18 272:10,18

275:14 276:8,18

277:3,18 278:17

278:24 279:17

282:12 283:1,13

284:4 285:15

286:7,15 288:2

290:10 291:5,24

292:17 293:9,20

foundational 19:12

founded 32:24

fourth 68:2 216:14

216:14

frame 55:1 153:1,6

154:8 227:17

228:10

Francis 6:18

frankly 126:18

229:22

free 103:16 206:17

275:2 276:6 290:8

293:18

frequently 21:22

124:12

Friedman 74:14,14

74:16,18,21

front 1:15 10:11

25:13 59:17

143:12,14,22

155:1 162:15

176:12 200:12

209:19 210:1

211:21

full 27:17 28:8

87:21 141:10

145:11 195:11

263:13

fully 297:6

furiously 182:2,5

further 33:18 52:3

212:21 250:12

255:2

future 105:11

257:13,22

G

G 63:14 65:6

gaining 196:5

Gale 5:4 100:2

147:3,8,15 186:24

191:23 263:15

gathered 171:19

general 12:9,13,22

13:4,24 21:16

54:9 57:10 84:11

86:16 87:24 94:19

94:21 95:2,9

108:5 112:15

118:19 119:8

122:7,17 123:4

125:9 129:24

131:14 153:22

154:13 160:10,22

173:7 190:17

192:21 195:17

251:5,21 260:1

269:19 271:5

273:6 283:7,22

generally 51:12

65:8 80:8 84:21

91:13 104:11,19

162:7 291:17

generated 269:8

generic 95:22

geology 32:23

40:18

Georgia 32:24

57:23 147:17

Germany 233:22

getting 22:21 41:6

130:14 224:21

263:3 284:14

286:5

give 24:6 28:3

30:14 32:1 34:7

59:15 65:10 69:23

72:14 82:19 87:18

96:13 98:13 102:1

112:12 113:12

139:2 140:20

146:6 154:21

162:12 165:1,2

196:15 203:21,22

210:5 214:3

219:17 233:6

237:23 247:3

274:8

given 37:19 87:21

136:23 141:4

182:19 191:23

228:3 246:10

gives 63:12

giving 32:5 147:8

157:2 190:14

Glassley 148:22

149:2 227:17

229:5 247:7

glean 74:3

Glen 176:21 177:3

Glenn 4:19 141:4

168:15,20

Global 6:12

go 25:7 28:18 38:20

42:20,21 59:22

62:23 70:7 76:10

85:9 98:6,11

108:14 121:12

124:10 127:21

136:4 139:15

141:19 145:1

147:14 148:8

164:2 165:22

166:20 168:9

174:20 175:15,17

176:11,14 177:17

181:12 183:16

188:8 189:20

192:12 214:22

216:13 217:12,18

223:8 225:10,11

226:18 247:14

goes 28:15

going 15:21 28:11

30:16 65:14 70:2

83:14 84:1 102:2

112:17 127:20

128:1 147:1

165:20,21 175:20

187:13 196:2,3

203:24 205:15

206:7 207:7 208:7

208:16 209:18

210:1 213:10

234:12 237:21

250:19 281:22

283:14 294:19,23

295:9 296:11

golf 234:4

good 11:5,7,11

28:17 71:12 87:18

104:5 133:2

187:22 234:9

294:17

good-looking

246:19

Gordon 2:16 21:13

26:18,20 53:19,22

54:16 63:12 65:7

79:1 80:2,22

81:23 85:4 93:18

94:6,13 95:2 97:1

97:19 98:18

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 311 of 330 PageID:

43900
Page 12

100:10 101:10

102:22 103:1

105:2,20 107:7

111:9,17 136:21

151:5 177:4

199:18 205:13

206:6,16 207:12

211:2 228:20

233:11 240:3,5,18

241:2,11 252:11

262:22 263:5,13

263:22 273:14

287:23 288:23

291:1

gotten 120:15

great 144:10

156:18

Grimm 5:13 247:9

ground 25:11

grounds 23:9 25:19

36:3 41:14 44:7

56:24 117:11

118:4 127:17

132:7 252:20

256:14 263:9

267:23 278:4

group 12:18 172:8

173:8 243:21,23

275:22

groups 12:15,19

172:4

guess 33:18 93:11

108:18 133:11

157:15 239:24

guessed 216:7

guessing 33:16

G.A 162:17

H

H 5:6,14 212:10,20

247:10

Hachat 170:24

171:3,4,5 173:7

Halket 3:6 73:4

86:17 87:11 88:8

89:6 99:1 141:16

141:21 143:2

144:16 150:21

177:3 218:16

260:17 294:4

296:3

Halket's 261:7

halls 90:24

HAMILTON 2:13

hand 204:1

handful 92:15

handle 175:14

handling 81:8

289:23

happen 120:4

169:16 180:20

279:5

happened 108:24

115:22 121:17

149:9,23 278:14

happening 171:18

happy 165:3,7

166:7,22 201:2

Harbor 11:16

harder 277:8

Harriet 7:10 65:20

Hassett 88:14

192:20,24 193:10

193:17,22 195:1,7

195:17 197:11,14

199:20 200:3,14

201:6 202:14

203:11 205:2

226:21 227:15

228:5 282:18

head 32:22 99:16

169:17,22 179:2

209:3

headed 157:21

158:5 161:9

heading 16:16

hear 99:13 256:20

held 1:13 84:4

128:4 175:23

231:9 250:22

282:1 295:2 296:8

296:14

help 172:5,7

helping 199:8

Hem 199:19

Hemstock 4:19

90:4 99:9 100:9

100:19 101:8

102:11 141:4,23

144:16,22 145:9

145:10 157:21

158:6 159:9 161:9

162:17 163:20

164:1 165:15

166:16 168:15,20

169:8 176:22

177:3 178:23

179:21 180:6

181:1 186:24

187:10 191:9,19

263:14

Hemstock's 146:9

158:16 159:18

174:23 175:7

herewith 298:11

HEROLD 3:3

he'll 197:1,3

high 51:6 85:1

145:21

highlight 47:9

highlighted 43:18

68:2 147:20 165:9

hired 18:23 91:5

historic 244:10

historical 238:13

239:2 240:19

241:2 244:20

Hobson 6:14 204:3

hold 51:22 160:23

160:24 161:7,18

162:7 164:14

174:15,16 179:16

179:17

honest 266:2

honesty 265:2,5

hope 25:7 94:11

hostile 231:12

hour 83:14 295:8

hours 194:6 196:6

Howard 63:14,18

64:1,15,16,19,21

65:6 148:10

269:14 271:2

how's 37:8

HR 90:20

hundreds 96:16

Hurst 32:9,19,21

32:22 34:23 35:20

36:10 38:7,24

39:20 40:13,14,24

41:8,9,10 44:13

45:14 46:2 47:3,8

47:20,24 48:1,4

48:13,23 49:16

50:18 53:2,21

55:13,22 56:12

57:3 68:23 69:13

88:9

Hurst's 36:20 38:2

38:12 56:13

Hyde 21:8 23:6

25:17 105:9

134:21 135:5

200:5,17 218:16

hygiene 189:12

hypothetical 56:8

166:4 262:5

265:13 266:9

H.A 61:5

I

IBM 109:21

idea 169:21 170:7

216:3 217:5

identified 134:16

143:10 176:10

identifies 177:2

identify 176:18

183:18 187:19

204:1 212:6

225:14,16 226:3

identity 42:23

45:19 102:10

II's 7:4

Ike 105:8

imagine 82:15 90:2

immediately 43:24

impact 104:21

122:10 124:21

131:16,21 244:11

impede 197:8

implement 172:2

implementation

163:7

implementing

290:24

implicates 44:13

51:8 190:22

229:18

implicating 56:12

implicitly 237:15

important 39:8

126:12

imposed 102:22

impressions 126:2

improper 35:11

123:13 237:7

inaccurate 187:11

inadvertent 25:8

include 14:7,17

126:23 266:1

276:5

included 79:20

170:16

including 117:7

212:16 229:16

incomplete 262:4

265:12 266:8

inconsistent 55:23

57:4

incorporate 121:5

121:16

Independence 3:4

independent

183:20 205:20

254:4 282:16

295:11

INDEX 4:1 8:2 9:1

indicate 30:12

76:24 78:1 195:1

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 312 of 330 PageID:

43901
Page 13

205:13

indicated 52:1

229:5 263:23

289:14

indicates 141:16

147:24 195:7

223:17 226:3

indicating 15:10

17:9 18:16 20:3

20:15 25:1 129:6

261:11 274:18

287:1 288:6 293:6

individuals 43:4

industrial 189:11

industry's 156:13

information 16:10

16:18,22 18:1

32:7 35:21,23

37:11,18,20 43:5

43:12,18,23 44:17

44:20 45:6,13

46:3,13,18,23

47:2,18,22 48:6

49:17,21 53:1

55:11,23 56:2

57:3 61:15 70:22

80:3,23 81:15,23

93:23 94:5 98:14

98:19 100:11,20

101:7,18 102:17

104:10 111:10,18

113:2 114:22

115:5 121:5,16

123:19,20 124:2

124:20 125:4,11

125:18 126:10,11

126:24 128:11,19

129:14 130:6

131:9 133:6,24

134:9 135:7,15

136:23,24 137:7

148:13 159:7

170:13 190:11,18

191:1 195:2,8

198:17 199:10

200:14 216:4

230:5 236:8,15

237:19 238:4

239:3 244:10,20

245:23 249:21

252:23 253:24

254:3,6 255:1

259:9 260:5,17

261:11,14 264:1

265:6 266:2,18

267:9 268:5,12

269:2 272:7,14

276:14 277:14

280:15 285:11

289:10

informed 206:7

274:16 275:21

279:12

initial 38:8 44:3

46:8

initially 98:24

injuries 137:9

injury 213:2

259:13 260:4

264:3

inquiry 45:11

inside 88:21

inspection 33:8

48:15

inspections 32:10

33:6,19 47:3,11

instance 112:8

institute 161:1

institution 57:24

instruct 16:17 17:1

35:5 41:12 42:12

52:2 55:19 56:22

114:10 116:10

117:10 118:2

121:23 125:1

127:16 130:17

132:1 146:22

191:2 207:3 208:4

219:15 228:6

230:11 237:21

238:9 239:15

242:9 245:6 246:5

250:11 252:19

256:12 257:7,17

258:20 259:5

263:7 267:12,21

272:20 276:10

278:3 280:18

286:17 288:9

instructed 35:12

36:23 37:5 38:14

57:19 122:13

126:7,19 132:14

207:6 242:23

288:14,16 290:15

instruction 35:9

36:15 42:15

118:11 126:17

127:3 132:7

156:20 206:22

246:14 253:4,13

258:11 274:14

275:4 287:7 288:4

288:4,19

instructions 104:17

156:21 274:21

289:2

insurance 60:6,10

61:17 66:19,24

67:10,19 69:14

103:2 255:13

279:12,13 280:21

281:11 292:13

293:5,16

insured 61:19

insured's 63:11

insurer 280:12

intellectual 157:3

intend 60:1

intended 30:13

intent 31:21 171:14

172:11

interact 103:22

interacted 52:8

interaction 84:20

269:21

interest 15:22

57:13 219:15

242:10,22 245:4

272:19,24 281:6,9

interested 104:19

intermingled

247:17

interpretation

267:8

Interrogatories

5:19 6:7,11 92:18

182:21 186:9

187:3,17 188:2

192:16,19 193:19

195:6,14 198:13

211:24

Interrogatory

188:11,13 191:19

194:23 196:10

201:12 211:24

226:1,2

interrupt 16:14

190:1,4

interrupted 190:23

interruption

230:17

Inter-Department

5:16

invade 46:13

investigation

199:10 271:15,22

278:13

involved 62:10 65:8

75:3 79:7 86:17

86:20 119:19

138:16 174:16

176:19 177:9,17

193:10,13,23

197:15,23 201:6

212:7,21 213:23

214:9,19 226:4

240:14 260:19

271:14 275:10

289:15 290:23

291:10 292:12

293:4

involvement 58:6

involving 62:11

102:12 136:14

245:1 261:24

in-house 91:24

92:20,21 105:21

150:12

Ira 2:17 212:17

Island 58:13 155:5

226:7

issue 38:18 136:9

153:20 161:6

168:16 169:22

261:19 273:22

276:15 283:10

284:1

issued 139:9 162:24

169:8 174:19

issues 130:15

229:19 273:8

295:16

issuing 162:6

items 15:21

J

J 74:16,18,20

192:20 195:16

January 6:14 7:11

65:19 87:14 204:2

204:6

jboyle@khmarin...

2:22

Jersey 1:1,16,19

2:4,21 3:4 10:7,12

11:17 12:1,18

Jesse 66:8,9 68:16

68:24 276:23

277:14

Jim 6:16 204:5

job 12:6,12 67:11

277:16

Joe 15:20

JOHN 2:20

Johnson 32:11 33:7

33:9,22 34:24

39:21 40:24 47:4

47:12 48:15 49:18

50:17 51:2 52:6,9

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 313 of 330 PageID:

43902
Page 14

52:12 54:17 55:16

58:7 149:3 209:4

209:4 212:20,21

213:16,16,22,22

214:8,8,16,17

215:24,24 219:4,4

219:10,10 228:12

247:18 249:11,16

250:6 253:15

254:10 255:8,12

255:21 256:24

258:8 262:22

269:18 270:1,5

271:1,9

join 78:7 202:20

214:13 285:6,16

285:19

Joyce 1:14

July 5:10 7:7 60:7

June 274:18

junior 105:7

jurisdiction 298:18

K

Kangas 61:20 68:3

keep 14:23 26:4

30:3,9 80:2 81:23

83:6 112:16

114:19 128:21

171:8

keeping 120:22

151:6 205:14

206:6 209:20

Kelly 1:14

Kenneth 61:10

kept 80:8 89:6

106:19 120:19

128:18

Kevin 2:19 176:5

181:2 182:3 247:4

key 169:12

khmarino@khm...

2:22

Kimberlee 1:3 10:4

kind 44:14 80:3,23

81:22 100:1

104:10 219:9

254:7

KIRKLAND 2:8

knew 18:7 33:3,3,3

55:8 116:22

186:14 197:22

214:15 222:11,23

237:8 276:24

277:14

know 11:12 12:16

15:6 19:23 21:8

26:9,17,24 27:2,8

27:10 29:3,14,18

30:22 33:16,21,24

34:3,19,21,23

40:19 42:5 43:9

45:24 46:1 47:16

47:24 48:2,10,13

49:4,9,11 50:10

50:16,19 51:1,10

51:12,14,15 52:5

52:7,8,11 53:9,11

54:12 57:23 58:1

58:4,24 59:8,13

60:9,11,15,21

61:4 65:4,6,21,24

66:6 67:15,17,23

68:12,20,22 69:3

69:12,17,22 73:19

76:8 77:19,21

79:15 80:4,7

86:16,17,19 87:15

88:7,12 90:1,23

99:19 100:3,4,5,6

101:21 104:16

105:3,7,17 106:1

107:24 108:22,23

109:11 111:8,16

111:22 112:21

115:4 116:22

117:1,18 118:6,14

118:17 119:5

123:8 124:7,16

126:12 129:15

130:20 131:4

133:23 134:6

142:14,20 145:22

146:15,16 148:19

148:21 149:10,15

149:17,21,23

150:5,9,11,17,19

151:2,12,20

155:17 156:5,7

158:20,22 163:6

168:6 172:1

175:12 179:6,9

181:16 182:4

183:15 184:22

185:1 193:24

197:1,11 198:15

198:21 199:4,17

199:24 201:1

203:7,17 206:5

208:23,24 209:14

213:9,22 215:1,20

215:23 216:9,12

220:7 221:16,20

221:23 222:10

234:2 235:12

240:2,13 241:15

241:19 243:8

251:6 253:7,15

254:4,9,17,20

255:6,10,11 256:2

257:20 258:4

262:21 269:12,14

270:9,11,13,14

272:7 275:6,8

276:13,19,22

277:13 279:11,19

279:22 280:9

282:14,19,20

289:18 290:4,12

290:14,18 292:20

292:23 293:5,10

293:12,14,21,23

knowledge 32:10

33:9 36:13,20

45:23 46:19 47:8

100:21 107:5

116:23 202:8

205:20 220:16

221:5 227:4

237:11 238:13

239:3,11 240:19

241:3,19 252:12

254:4 270:24

287:20 291:16

298:8

knowledgeable

33:6 36:10 47:9

47:10 226:4 270:4

known 6:5 102:12

143:3 155:5 186:8

211:14

knows 47:3 117:1

258:1 291:22

Kohn 218:16

L

L 62:1 74:14,14

labeled 90:4 201:8

lack 127:1

Lacks 194:13

LaFevor 204:5

laid 201:10

large 243:20

late 21:2 77:23

law 1:13 3:3 11:22

laws 156:23

lawsuit 43:6 161:2

183:23 269:8

lawsuits 58:6 67:18

lawyer 16:6 88:2

99:2 117:6 119:3

119:18 199:7

216:7 234:8

240:10 242:14

lawyers 56:14 85:7

86:10,12 148:9

206:15 207:11

229:17 252:15

253:10 256:10

261:10 265:4,20

265:21 286:4

294:16

lawyer's 190:20

lay 194:19

layer 201:18,18

Lea 3:9

learn 19:17 20:1

44:17 250:5

271:23

learned 15:10 17:9

18:10,15,23 19:6

19:22 20:13 44:20

138:11 142:13,15

197:14 214:8

227:14

learning 149:2

leave 34:5 197:24

lecture 122:20,20

ledger 109:7

ledgers 110:24

left 49:20 87:11

120:24 121:1

139:2,10,20

140:10,16 278:11

legal 1:23 10:15,17

12:14 13:6 14:4

86:11 88:3 89:16

90:11,14,22 91:24

92:21 98:6,11

109:14 110:1

119:18 130:15

169:3,9,18,23

173:10,23 174:8

174:15,20 175:1

179:2,10 180:5,5

181:16 197:15

216:20 218:13

231:23 248:19

273:8 284:8,20

length 234:11

Leroy 61:20 68:3

Les 87:24 215:17

Lester 87:23

letter 6:13,15,17,18

7:7,10 60:5 61:4,5

61:8,9 65:19

75:23 76:20 204:3

204:4,6,8 210:20

218:12 224:9

letters 94:14 95:2

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 314 of 330 PageID:

43903
Page 15

204:12,20,22

205:12,21

let's 28:18 89:13

122:22 144:5,9

166:13

level 51:6 66:24

85:1

Liability 6:9,11

License 1:19

297:14

life 140:15

lifting 174:16

light 267:19 288:5

likelihood 104:23

105:10

limitations 43:2

limited 6:5 84:24

line 8:5,5,5,5 9:5,9

9:13 78:9 164:12

164:13 181:7

299:5

lines 164:12

lining 90:24

Lipton's 233:14

list 32:8 124:16

298:9

listed 35:20 36:9

38:7 45:14 47:2

215:17

literally 96:15

litigant 146:10

148:15 268:7

litigants 134:11

135:7,23 259:12

260:3 261:13

264:2,14 266:19

293:17

litigating 265:6

293:15

litigation 6:9 13:10

13:14 14:14,18

15:7 21:22 33:2

41:17 53:3 54:9

56:16 57:5 58:13

62:11 63:7,15,19

65:9 67:4 73:9,16

74:24 75:3,14

76:22 78:16,19,21

79:8 82:21 84:21

85:6,13 86:12,14

86:15,22 88:5,21

89:1 90:6 91:14

93:6,17,22 94:5

94:15 95:5,15

97:23 98:20

100:12 102:23

103:3,10 104:13

104:20 107:2,9,20

108:7 109:8,16

110:3 112:18

113:4 114:16

115:22 116:6

121:6,18 122:9

123:6,21 124:13

124:21 125:11

126:3,15 127:7

128:13 131:11

132:19 133:7,8

134:3,11 135:8,23

136:13 152:1,23

157:14 160:5,10

160:23,24 161:6

161:18 162:7,10

174:7,14,22 188:4

190:21 193:11,15

193:23 194:1

197:16 198:6

202:16 203:13,20

205:15 206:8

211:15 213:3

218:15,21 234:23

235:6,18 236:9,22

237:4,17 238:3

241:12,23 242:16

242:19 243:11,24

244:12,13,24

245:12 249:1

259:1 260:2

263:24 271:24

272:8,15 273:18

274:7 275:11,24

276:1 278:1 282:9

287:22,24 288:22

288:24 289:23

290:7,24 291:10

291:12 292:12

293:4

litigations 53:16

76:1 88:18 89:5

little 26:5 34:6

41:24 43:20 80:18

83:14 91:3 143:8

178:14 196:21

Littleton 1:14

LLC 1:6 2:11 5:19

5:21 6:23 7:5 10:5

299:2

LLC's 6:21

LLP 2:8,13

local 93:16,21

located 12:18 29:4

90:9

locating 228:20

Lockman 60:5,22

log 4:14,15 38:24

39:3 70:5,17

77:14 78:11,12

209:21 210:3,15

215:8 217:15

223:10

Logan 2:14

long 269:7

longer 278:22

look 25:20,22 144:6

154:24 155:3

159:2 182:8 183:3

187:15 204:10

215:2 294:20

looked 26:19

looking 164:11

210:3 215:5

looks 25:24 74:19

210:4

loss 284:1

lost 290:20

lot 11:9 81:7 233:2

248:13 281:17

lots 162:12

Lummus 6:12

lunch 175:14,24

lunchtime 164:3

166:21

lungs 255:8

Lybrand 104:5

M

M 2:2

Magna 1:23 10:15

10:16

Magnesia 6:6

Magnesium 62:5

maintain 153:23

maintained 150:13

maintaining 119:12

making 95:3,13

100:9 114:23

137:6 140:17

252:2

man 172:24 240:10

management 66:11

231:24 233:9

255:20 256:9,10

256:22 257:11,21

275:10,22 277:16

282:21,22 283:8

283:23 287:21

288:21 289:9,13

289:18,22 290:5

manager 171:7

269:19 271:6

managing 78:21

Maple 2:3

March 4:19 5:18

141:4 162:16

167:15 171:10

176:21 177:9,20

180:14 181:11

182:13

margins 109:24

Marino 2:19,19

15:12 17:3,14,18

18:5 19:9 22:4,7

23:10 24:23 27:21

31:5,12 32:2 34:4

34:9,12 35:11,17

36:1 37:10 41:24

42:3,14 43:14,22

44:16,24 45:5

46:6,22 47:7 48:9

49:13 51:22 52:17

52:20,22 54:24

56:3,17 57:7

61:22 62:14,19

63:24 64:3,17

65:3,12 71:6,9,17

73:10,15 75:15,22

77:13 78:7 83:13

83:19,23 94:18

116:18,24 118:23

119:2 122:22

123:12 127:21

143:5,19,23 144:5

144:9 152:2,7,10

152:24 163:12,17

163:23 164:4,8,11

164:17 165:4,9,16

165:19 166:2,9,12

166:22 167:3,7,9

170:2 175:15

176:6,8 178:13,24

180:2 181:3 182:4

182:7,16 184:17

184:21 185:8,12

186:18 190:4,7,10

191:14 195:5,10

195:15,21,24

196:4,18,23 200:6

200:19 202:20

203:2 205:7,18

206:3 207:9 208:9

210:5,10,13

213:11 214:13

218:7 222:5,18

226:10 230:1,20

230:24 231:2

234:13 235:19

236:5 237:6

245:15 246:19

251:12,17 252:2

260:8 265:15

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 315 of 330 PageID:

43904
Page 16

281:16,19 295:21

Marino's 294:18

marked 7:13 9:12

25:14 59:18 65:15

70:3 147:2 177:12

187:14 208:8

Martin 225:8 226:5

226:22,24 227:5

229:3

Marty 233:13

material 131:16,21

147:20 245:24

246:12 272:7,14

materially 245:13

245:13

materials 25:3

120:11 180:13

212:23 246:24

math 140:9

matter 10:4 23:4,18

24:10,20 41:9

51:6 63:9,10 74:1

84:24 85:19 94:19

98:15 108:4,7

110:4 134:18

150:20 169:6,13

193:14 226:5

248:7 280:11,23

284:13 285:1,10

286:2 297:8

matters 21:21 85:5

119:18 157:3

mcoren@cprlaw....

2:5

mean 16:14 24:2

29:7 46:23 71:9

75:20 79:2,11

89:16 91:10 96:5

96:8,24 97:19

103:1 113:16

119:21 150:12

153:18 198:10

205:8 236:3

283:15

means 297:20

measures 283:9,16

283:18

meet 101:22 124:12

246:16

meeting 85:8

119:22 120:11

232:15 236:4

243:22 244:1

269:23,24

meetings 13:21

119:13,13 232:20

232:23 276:23

member 244:2

members 289:17

memo 22:1,8,13,21

23:1,8 24:1 25:17

26:9,21 27:3,11

27:18,20 31:1,8

73:7 134:21

162:16 163:11,15

163:22 167:15,23

168:1,3,8,17,21

169:2,6,22 171:20

174:19,24 175:7

177:10,20 179:7

179:11 180:6,14

181:11 182:13

200:5,15,16 211:8

216:20

memorandum 5:16

73:23 108:5

145:12 176:21

memory 62:10

144:15 182:11

227:4

Menlo 179:4

mental 126:2

mention 185:22

191:8,18,22 192:7

mentioned 38:24

138:9 243:21

mergers 244:5

mesothelioma

155:5

met 269:22

Michael 2:3 81:12

192:20 195:16

201:5 226:21

microscope 146:1

147:16

mid 58:17,17

middle 189:2 190:1

190:5

Mike 112:8 193:10

205:2 233:9

282:18

million 140:11,17

mine 28:15,15

32:11 33:7,9,22

34:24 39:21 41:1

47:4,11 48:15

49:19 50:18 51:2

52:6,9,13 54:18

55:16 58:7 142:1

142:8 149:3

166:21 214:16

228:12 247:18

249:11,17 250:6

253:16 254:10

255:8,12,21

256:24 258:8

262:22 270:5

271:1,10

Mineral 13:4

minerals 5:16

12:23 13:7 60:19

156:14 159:3

minimizing 283:24

minus 25:18

minute 120:13,16

120:18 121:1

minutes 119:12,13

119:21,22 120:5

121:5,15 122:3,5

253:21 258:12

281:20

mischaracterizes

137:17 170:4

285:17

misleading 200:20

202:6

misstates 145:6

148:3 163:4 166:5

170:8 175:7

185:10 193:7

197:18 199:22

200:7,9,22 202:18

204:22 207:18

214:12 222:3,6,17

222:19 229:11

245:3 251:11

259:20 260:12

264:7 265:10

266:6 269:10

moment 16:3 72:14

127:22 144:6,10

Monday 1:9 298:6

money 113:19,22

month 239:23

monthly 108:2

110:7

Moore 3:9 10:14

morning 11:5,7

177:10

mother 230:19

231:3

move 38:17

N

name 30:19,20

100:4 103:21

195:12 205:1

233:16,18 234:3,5

240:11 244:2

named 172:24

205:5,8 240:10

names 61:20 68:3

70:21 104:5 205:1

233:22 234:1,10

Nancy 7:10 65:23

national 91:6,13

213:2

nature 21:18 236:3

Neave 157:1

necessarily 156:15

273:15

need 30:9,16 37:4

38:20 122:19,20

127:10,15 136:21

164:5 172:15

207:1 252:18

255:1 267:11,21

274:2 288:6

needed 54:12 82:4

87:1,4 98:3

119:19

negatively 124:22

negotiation 234:12

negotiations 240:5

never 49:6 55:8

111:24,24 135:24

151:11 190:16

201:9,23 268:20

270:1,1

nevertheless

145:19

new 1:1,16,19 2:4

2:21 3:4 10:7,12

11:16 12:1,18

155:12 156:1

159:5 161:4 172:3

172:6 188:3,4

198:5 202:15

203:12,19

Newell 6:19 204:9

NJ 297:14

non-lawyers

276:14

normal 69:5,20

Notary 1:20 298:21

note 63:10 71:17

noted 10:17 297:6

notes 50:13 128:22

297:7

notice 67:4

notified 44:12

November 6:19

204:8

Now's 250:17

number 21:21

60:18 71:16 85:5

109:20 145:18

195:12 223:10

233:21

numbered 71:7,10

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 316 of 330 PageID:

43905
Page 17

numbers 70:24

72:18 143:9

N.W 2:9

O

oath 19:7,18 20:2

20:14 118:8 187:1

241:4 243:5

246:10

object 17:2 19:9

23:8 28:1 34:10

44:5 101:12 102:2

128:23 186:19

220:2 221:13

240:21 241:6

objected 197:2,2

281:7

objection 13:11

14:19 15:12,17

17:20 18:3,5,18

19:1 20:5,17 21:3

22:2,14,22 23:11

26:11,22 27:6,21

29:22 30:4 31:3,5

31:12,14,17 34:1

34:2 35:2 36:14

39:12 41:2,18

42:6,9 44:15

45:16 46:4,20

48:7,9,17,24 49:7

49:22 50:21 51:3

51:20 52:15 53:4

53:12,23 54:5,19

54:21,22 55:17

56:3,5 58:8 59:4

59:11 60:12 62:17

63:21,23 65:1,3

66:15 67:6,13,20

68:17 69:1,7,15

73:20 74:6 75:6

75:15,17,18 76:6

77:2,11 78:5,22

79:12 80:5,15,24

81:18 82:1,5,12

83:1,9 84:14,22

85:16 86:4 87:6

88:10 89:2,21,22

90:16 91:15 92:2

92:12,23 93:7,24

94:16 95:6 96:10

97:3,9,14,24 98:8

98:22 99:10

100:13,22 102:14

103:4,11 104:14

105:14,16,22

106:6,14,22

107:10,15,21

108:15 109:2,9,17

110:12 111:2,11

111:19 112:19

113:5 114:2,17

115:1,9,10,16

116:1,7,16 117:21

118:21 120:7

121:7,20 123:22

124:5,23 125:15

126:7 127:8

128:14,24 129:8

129:17 130:23

131:12,23 132:20

133:9 134:4 135:1

135:9 136:2,15

137:10,14 138:4

138:18 139:11

142:17,18,24

144:17 145:5

146:13,19 147:10

148:2,17 149:4,13

149:18 150:15,23

151:1,8,10,17,19

152:14 153:3,5,13

154:2,4,17 155:18

156:3 157:10,22

158:18,23 159:10

159:20 160:3,7,16

160:17 161:11,19

161:23 163:3,23

167:20 168:4,10

168:12 169:10,24

171:21 172:20

173:15,24 174:9

174:11 175:3,5

177:2,21 180:7,15

180:21 183:9

184:11,12 185:6

186:2,11,16 187:4

188:15 189:2,15

191:12 192:2,3

193:2,6,20 194:3

194:9 195:3

196:14,17 197:17

198:7,19 199:13

199:21 200:6,8,19

200:21 202:17

204:16,21 205:16

206:9,18 207:16

208:1 209:9

211:16 213:11,18

214:1,11,14 216:1

217:8 218:22

219:5,13 220:10

221:3,7,14 222:2

222:15,18 223:4

224:18 226:19

227:6,20 228:13

228:22 229:10

230:8 231:20

232:6,17,24

234:13,14 235:1,8

235:19 236:2,10

236:18 237:12

238:6,17 239:12

239:20 240:6

241:13 242:1,6

243:6,13 244:14

245:2,15,17 246:2

246:13 247:24

248:9 249:18

251:10 253:3,12

253:18 254:12

255:14,23 257:1

257:14 259:2,18

260:8,10,20,21

261:15,16 262:1,2

262:16,18,24

263:16 264:5,6,16

265:9 266:5,20,21

268:8,9,23 269:9

270:6,17 271:17

272:2,9,17 274:14

275:13 276:7,17

277:2,17 278:16

278:23 279:8,16

282:11,24 283:12

284:3 285:4,7,14

286:6,14 288:1

290:9 291:2,3,23

292:16 293:8,19

294:5,6,12,13

objectionable

123:16

objections 6:4,21

55:5 69:21 78:8

94:7 95:16 101:3

101:19 107:3

112:6 118:10

126:16 127:2

132:6 134:12

135:17 150:2,8

155:11 158:7

178:3,7,11,19

184:16 192:10

199:2 202:21

203:6,14 212:15

236:23 239:6

242:20 243:18

249:3,24 250:7

252:7 258:10

268:16 271:3

274:20 275:3

285:20 287:6

289:1

obligation 56:1

199:9 234:22

260:16

obligations 261:8

observe 64:4

observed 146:1

obtained 29:11

53:2 55:13 170:23

obviates 293:1

Obviously 197:21

occasion 112:1

occasional 112:23

occur 107:20

occurred 236:15

243:11

occurs 247:16

offer 139:22 190:24

191:3

office 30:10 90:18

171:6,9 173:7

officer 14:10

112:10 195:13

officers 125:21

183:18 188:19

189:7

offices 1:13 89:15

89:16

official 163:7

off-site 89:10 90:12

oh 26:6 32:17,19

60:2 68:9 70:13

88:16 134:2,23

141:1 170:10

214:23 226:13

233:12 237:6

294:18

okay 12:3,11,21

13:9,17,23 14:3,7

14:17,23 15:2,6

18:1,9,14,22

19:24 21:8,23

22:12,20 23:13,20

23:23 24:5 25:21

26:2 27:2,10,16

30:2,22 31:24

32:20 33:5,11,17

34:19 35:15 40:16

40:20 41:22 42:20

44:11 45:4,13

46:1 49:4,16

50:11,15 51:1

52:22 53:20 54:3

58:1,5,15 59:1,8

59:14,22 60:17,21

60:24 61:4,7

62:23 63:5 65:10

66:2,21 68:6,12

68:22 69:23 70:21

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 317 of 330 PageID:

43906
Page 18

72:4,24 74:11,23

76:20 77:18,22,23

77:24 78:18 79:18

80:11,21 81:5,14

81:22 82:9,17,23

83:6,12 84:18

85:12,22 86:9

87:10,23 88:7,14

88:17,20 90:8,14

91:2,9 93:4,15,19

93:21 94:10 95:1

95:12 96:19 97:6

98:5,17 99:6,19

100:2,8,17 101:7

102:19 103:8

105:10 106:3,11

106:19 107:7,19

108:12,20,23

111:7,15,23

112:14 113:1,24

115:13,21 119:20

120:21 121:4,15

122:15 123:1

124:2,19 125:13

127:18 128:11,21

132:16 133:14

134:24 138:9,16

139:15,19 140:2

140:16,20 141:15

142:12 143:4

144:5,12 145:1

146:5 147:14,21

148:8,13,24 149:8

150:5,11,19 151:4

151:14 154:12,24

155:23 157:6

162:11,11,15,20

162:24 163:20

164:10,18,23

165:13 166:1,12

166:18,20 167:8

167:13,17 168:1

169:1,5 170:12,19

171:8,13,17

172:10 173:3,19

174:4 175:10,13

176:8 178:2,14,15

178:22 180:11

181:1,5 182:6,10

182:15 183:3,7,16

185:20 187:6,13

192:12 194:11,11

194:15,17 195:10

197:24 199:17

202:1,4,10,24

203:9 204:11,12

204:19 205:12

206:14 208:18

209:18 211:4,20

213:7 214:22

215:23 216:5,9,12

216:19,24 217:12

218:10 219:2,9,17

220:7,14,18

221:23 222:11

223:1,8 225:1,5

225:10,24 226:18

227:10 228:18

229:2 230:2,14

231:15,18 232:3

232:10 233:15

234:1,11,17 235:5

235:24 236:14

238:22 239:1,10

240:2,17 241:21

243:2,10 245:9

246:23 247:2,14

248:5,17,23

249:10 250:4,13

251:4,20 252:22

254:9 255:18

256:19,22 258:6

259:24 260:15

261:9,21 262:21

263:21 264:21

265:3 266:13

267:10 268:1,14

269:5,20 271:8,12

271:21 272:5

273:20 274:12

275:9 276:4,13,22

277:11,13 278:7

278:20 280:2

281:15 282:20

283:18 284:7,22

285:10,24 286:10

286:24 288:21

289:4 290:16,22

291:9 293:1 294:9

294:19,21 295:14

295:23

old 159:2

older 90:12

once 79:14 98:12

115:18 135:4

ones 12:16

one's 64:5

ongoing 30:9 156:8

open 124:17

operation 159:23

170:17

operations 5:17

159:14 162:21

163:16 170:16

172:13 269:19

271:1

opinion 125:10

126:3 129:20

130:2 190:15,20

190:24 273:16

opinions 191:3

opportunity 34:10

184:18

opposed 190:24

254:3

oral 115:8,11

order 24:12,22 25:4

25:5 97:21 101:11

124:3 138:2

198:18 246:17

ordinary 96:7,9

ore 142:1,7

organization

112:11

original 28:24 29:4

29:17,17 70:21

150:6

originally 24:2

40:22

outside 133:17

233:10 248:19

outsourced 138:1

263:23

overall 54:11 93:10

247:18

overseeing 78:21

overview 113:13,15

Owens-Corning

6:7

owned 139:20

253:16 254:10

255:21 258:8

262:22

ownership 139:16

O'Brien 6:19

o'clock 128:1

296:10

O'Shaughnessy

4:15 215:14,15,21

217:2,6

P

P 25:13

page 4:3,10 5:3 6:3

7:3 8:5,5,5,5 9:5,9

9:13 28:12,16,19

28:20 32:16 42:21

42:22 45:15 59:18

59:23 60:4 62:24

63:2 68:2 70:7,13

70:13,17,17,24

71:3,5 139:15

141:15,19 143:8

143:10,16 144:14

145:2,11 147:14

147:15,23 148:9

164:12 165:3

176:15 178:24

179:24 181:2

183:4,17 192:13

195:6,9 210:9

215:11 218:8

226:19 247:15

299:5

pages 71:7 143:11

182:2 294:17

298:7

Pagonis 66:8,9

68:16,24 276:23

277:14,22 278:5

paper 78:14 101:23

109:23 129:2

241:17

papers 138:15

paragraph 43:24

145:11 170:13

220:19

paralegal 81:7

88:20

Park 1:14 179:4

part 25:9 50:13

54:10,14 67:10

94:22 95:8 126:13

173:7,10 234:21

244:23 272:15

275:1

participants 176:18

212:7

particular 91:23

106:13

partner 21:12

233:17

patent 33:2

Patrick 6:18 204:8

pattern 96:21

Paulette 66:2

pay 110:5

payable 108:18

109:7,13 110:22

110:23

payment 108:11,13

229:8

penalty 220:16

pendency 258:6

263:12

pending 74:5 75:12

77:1 78:2 84:13

142:16 154:1

160:2,6,10,12

174:6,14,18,23

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 318 of 330 PageID:

43907
Page 19

227:16 242:15

257:11,22 261:24

262:15 273:8,11

273:18 274:7

Pennsylvania 2:15

11:22 182:24

people 50:7 53:14

53:19,21 90:20

98:13 105:7

109:20 137:8

168:17 192:15

233:3,6,21,24

243:23 265:5

275:18

PEPPER 2:13

perforations

109:23

performed 147:16

period 16:13 61:12

105:6 113:18

239:23 268:20

271:5

perjury 220:16

permanent 110:9

110:17 120:19

151:6

permit 158:15

159:6,17

permitted 97:6

160:14 194:3

Perry 233:9

person 15:19 45:19

48:5 49:20 63:14

64:6 80:22 99:3

101:22 103:21

104:6 105:3 106:3

108:20 270:22

personal 45:23

46:17,18 50:12

130:14 202:8

213:2 220:16

259:13 260:4

personally 123:19

personnel 162:17

226:3

persons 176:18

212:6

pertaining 170:15

pertinent 133:7

Peter 2:8,16 5:4

6:17 50:10 65:7

81:3 85:8 100:2

105:5 147:3,8,15

149:20 191:23

205:2 212:17

215:17

peter.farrell@ki...

2:10

Phil 240:11

Philadelphia 2:15

physical 149:10

physically 50:17

82:11 88:24 90:9

90:15 108:13

120:1 149:9 179:6

179:9 181:12

pick 171:10

piece 78:14

Pita 6:5

place 24:24 30:17

270:10

placed 29:20

170:22

Placitella 2:2,2 4:5

10:13 11:4,13

13:16 14:22 15:13

17:7,24 18:8,21

19:4,13 20:9,19

21:5 22:6,9,11,19

23:13,19 24:5,8

25:12 26:8,13

27:1,9,24 28:3,9

28:10 30:1,18

31:7,15,24 32:4

34:18,22 35:7,14

35:19 36:7,17

37:1,7,16 38:19

38:22 39:3,6,13

39:17,24 40:4,12

41:15,21 42:4,7

42:19 43:21 44:10

44:22 45:4,12,20

45:21 46:7,16

47:1,23 48:12,21

49:3,15,24 50:5

50:24 51:11 52:4

52:19,24 53:10,17

54:2,13 55:3,7,21

56:9 57:1,16,21

57:22 58:14 59:7

59:14,16 60:2,3

60:16 61:23 62:16

62:22 63:4 64:2

64:14,23 65:10,13

65:17,18 66:20

67:8,16,24 68:21

69:4,11,18,23

70:1,10,12,19

71:8,11,14,19,24

72:7,16 73:1,12

73:17 74:2,10,18

74:22 75:10 76:2

76:9,13,16 77:6

77:15 78:17 79:9

79:17 80:10,20

81:5,11,21 82:2,8

82:16 83:5,12,17

83:21 84:10,17

85:11,18 86:8

87:9 88:13 89:12

90:7 91:1,21 92:8

92:16 93:3,14

94:3,10,12,20,24

95:11 96:3,12

97:5,11,17 98:4

98:16 99:5,15

100:16 101:1,6,16

102:8,18 103:7,20

105:1,18,24

106:10,18,24

107:6,13,15,18,23

108:19 109:5,12

110:8,20 111:6,14

111:23 112:2,13

112:24 113:14

114:12,21 115:6

115:12,20 116:4

116:12,21 117:2

117:12,16 118:5

118:16 119:1,4,6

120:17 121:14

122:1,15,19 123:1

123:8,11,17 124:1

124:9 125:3,13,16

125:24 126:9,20

127:4,13,18,23

128:10,17 129:3

129:13,21 130:3

130:10,19 131:7

131:18 132:3,8,15

132:24 133:14,20

134:7,19 135:3,13

135:20 136:6

137:4,12,24 138:8

138:21 139:14

140:8,23 141:2,9

141:14 142:21

143:4,13,21,24

144:3,7,13,24

145:7 146:5,7,17

146:24 147:13

148:7,20 149:7,16

149:22 150:4,10

150:18 151:3,13

151:21 152:6,9,13

152:19 153:2,9,17

154:9,21,23

155:20 157:5,16

158:2,13,21 159:4

159:15,24 160:4

160:11,20 161:16

161:20 162:4,11

162:14 163:9,14

163:19 164:2,10

164:14,18,21,23

165:6,10,12,17,23

166:7,10,14 167:1

167:5,8,12,22

168:7,18 169:20

170:6,11 172:9

173:2,18 174:3,17

175:10,13,17

176:4,7 178:1,5,9

178:17,21 179:20

179:23 180:1,10

180:18,24 181:4,8

181:9,23 182:6,9

182:18 183:12

184:14,20,23

185:18,21 186:6

186:13,22 187:8

187:12,18,22,24

188:17,22 189:3,5

189:17,21,24

191:6,17 192:6,11

193:4,16 194:2,7

194:11,14,21

195:9,11,16,22

196:2,16,22

197:10 198:1,14

198:22 199:5,16

200:1,10,24 202:1

202:4,10,12,24

203:3,8,21,23

204:18 205:3,11

206:1,4,13,23

207:10,22 208:6

208:10,18,19

209:17,23,24

210:7,12,14

211:19 212:3,5

213:13,21 214:6

214:21 215:6,9

216:5,8 217:11,16

217:17,21,22

218:2,3,9,11

219:1,8,17,19

220:6,13 221:4,9

221:12,17,22

222:8,20 223:7

225:6,15,18,23

226:11,14,17

227:10,13 228:8

228:17 229:1,14

229:21 230:2,4,13

230:18,22 231:1,5

231:10 232:2,10

232:13,21 233:5

234:17,19 235:4

235:14,21 236:7

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 319 of 330 PageID:

43908
Page 20

236:13,20 237:1

237:10 238:1,11

238:22,24 239:9

239:17 240:1,16

240:24 241:9,20

242:3,11 243:1,9

243:15 244:9,18

245:8,21 246:7,15

247:2,5 248:4,16

249:9,22 250:3,16

251:3,15,19 252:4

252:21 253:6,14

254:8,16 255:4,17

256:1,15 257:9,19

258:3,5,13,22

259:7,21 260:14

261:2,20 262:8,10

262:20 263:10,20

264:11,20 265:17

266:12 267:4,10

267:14,24 268:13

268:18 269:4,13

270:8,21 271:7,20

272:4,12,22

273:20 274:12,15

274:22 275:5,17

275:20 276:3,12

276:21 277:7

278:7,9,19 279:4

279:10 280:2,19

281:8,15,18 282:6

282:13 283:5,17

284:6,17 285:9,21

286:9,19 287:8,16

287:19 288:11,17

289:4,8 290:3,17

291:6,17,21 292:1

292:7,10,24

293:13,24 294:8

294:16 295:7,14

295:23 296:4

Placitella's 34:6

plaintiffs 1:4 2:6

5:20 6:10,22

94:14 212:11

286:4

plaintiff's 61:20

227:18 248:24

267:20

played 91:11

player 234:4

please 10:19 17:4

19:12 27:23 42:1

43:14 46:24 51:23

55:2 61:16 63:6

72:14,15 95:18

117:13 143:11

146:6 153:1,10

154:22 164:17

166:9 171:8

172:10 178:13

185:12,15 186:21

187:21 194:8,8

195:8 206:3

208:17 210:6

212:2 217:13

223:9 227:23

236:6 259:15

266:22 267:16

287:11 292:4

point 13:14 14:11

19:24 29:20 55:3

80:12 86:13 87:11

89:8 92:6,9,17

104:7 105:3

148:15 149:1

154:10 187:23

201:9,17 219:3

228:19 230:14

231:11 247:23

249:23 250:4,15

259:8,24 271:9

278:10

points 213:1

policies 156:15,16

policy 110:16 111:1

124:17 150:20

151:22 152:3,11

152:18 154:13,15

155:8,13,17 156:1

156:10,22 157:8

157:18 158:4,10

158:15 159:2,5

161:5,21 162:3

163:1,8,13 169:7

169:13,15 172:3,6

173:21 266:15,18

268:3 269:6,11

279:3

Pooley 220:23

position 15:20

43:11 55:14 57:4

93:22 94:4 99:24

122:2 125:4,18

195:13 280:20

281:9

positions 55:24

119:9

possess 220:20

possession 18:2

101:8 129:6

132:18 161:8

182:11 201:16

221:19 222:13,24

236:16 260:6

264:15

possible 169:16

193:12

possibly 105:8

potential 115:23

121:18

practical 98:15

practice 169:7,13

248:7

practices 130:4

Pratter 3:8

preceded 15:20

preceding 43:24

predecessor 17:23

Prefix 65:16

prep 246:17

preparation 216:21

246:24

prepared 27:11

91:23 92:18

156:21 228:10

presence 142:2

present 3:7 30:24

103:18 143:3

145:19 183:18

201:5,7 232:22

243:12 244:1

presently 43:3

preserve 113:9

preserved 172:12

preserving 85:1

president 12:22

13:3,24

pretty 58:16 140:13

277:4 285:12

prevent 162:8

previous 22:17

23:17 25:14,14

34:14 87:17

156:12 188:13

193:15,15

previously 26:1

pre-marked 70:3

price 140:1,7

Pricewaterhouse

104:4

primary 61:11

principal 240:9

printouts 109:22

prior 7:13 24:21

59:3 120:11

154:14 157:21

158:14 162:24

237:4 274:17

286:5,12 287:2

priv 72:15,18

217:15

privilege 4:13,15

16:12,19 22:23

23:9 25:19 34:15

35:3 36:4,16

37:24,24 38:1,9

38:10,11,24 39:3

39:11,19 40:7

41:14 42:10 44:8

44:14 45:8,10

46:14 51:8,19

52:2 55:18 56:24

57:11 70:5 71:16

72:8 74:12 77:14

78:10,12 114:3

116:9 117:11

118:4 121:22

122:11 124:24

127:17 132:7

146:21 191:5

207:2 208:3 210:2

215:8 219:14,15

223:10 228:3

229:18 230:10

238:7 239:14

242:7,10,21,22

245:5 246:3

250:10 252:20

256:14,17 257:15

259:4 263:9

267:23 272:19

273:4,22 276:8

278:4 280:22

281:5,6,10 286:16

288:4 289:6 290:1

295:15

privileged 4:18

36:18 37:2,19

43:13 47:22 79:20

122:3 125:7,12,22

126:6 190:10

237:18 245:4

253:24 254:2,7,24

267:8 272:18

280:14 289:9,11

privileges 44:2

46:11 85:2 113:9

280:17

probably 15:15

30:10 50:7,10

58:17 81:3,9

82:20 83:3 88:1

92:4 96:1 98:15

99:4 101:5,22

103:19 110:2,4,17

149:21 172:24

173:6 197:22

269:22 270:11

probe 47:21

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 320 of 330 PageID:

43909
Page 21

Probing 46:11

problem 34:17

procedure 43:1

46:9 150:20

proceedings 297:5

processed 141:24

142:7

product 16:13,19

35:4 36:16 42:11

44:8 55:19 75:5

113:9 125:12

126:5 131:24

146:20 190:12,22

191:5 208:2

230:10 238:8

239:14 242:8,12

242:21 245:4

246:4 257:16

259:3 267:9,23

272:19 273:2,5,16

276:9 280:14

281:6 286:16

289:7 290:1

Production 6:8 9:4

products 6:8

256:23

professional 1:18

264:13 265:24

prognosis 104:24

program 255:6

promise 11:8

proper 194:19

property 157:3

proposal 232:1

Propounded 5:20

protected 24:11

191:5 280:22

281:5

protection 157:2

protections 44:3

provide 22:5

100:11 104:11

106:11 109:13

123:18,20 124:19

126:10,21 128:12

145:9 198:18

236:8 265:5 284:7

provided 49:17

52:13 53:21 55:22

57:3 125:5,19

128:19 129:15

196:11,12 220:21

231:23 241:3

276:14 284:19,24

providing 195:8

199:12 216:20

Public 1:20 298:21

pull 80:18 164:16

166:21 167:10,11

pulling 24:8 198:11

pulmonary 189:10

purchased 214:16

purpose 40:23

47:16 114:13,14

161:18 162:6

purposes 125:6

270:15

pursuant 42:23

46:8 171:20

173:21 180:13

181:11 182:12

purview 66:13

put 25:13 29:13

30:17 32:18 55:1

62:24 76:12 90:3

112:10 120:13,16

136:20 145:2

182:19 210:1

225:20

P-1 24:6 133:24

134:10,17 200:12

200:15 201:8

295:9

P-15 29:5

P-214 59:18

P.A 3:3

P.C 2:2,19

p.m 175:20 176:3

250:19 251:2

281:22 282:5

294:23 295:6

296:10

Q

quantities 144:23

145:4

question 9:12 17:2

17:4,8,11,13,15

19:10,11,12,14

20:8,11 22:4 23:2

27:22 31:6,13

34:7 35:6,8,12,13

35:16,18 36:2,8

36:22 37:5,15

38:15,16,17 39:4

39:16,18 40:3,9

40:11 41:5,13

42:13 43:15 44:11

44:23 45:1,3,5

49:10 52:3 55:2

55:20 56:4,11,20

56:23 57:8,14,17

57:19 62:20 75:16

95:17,22 101:13

114:6,11 116:11

117:4,13 118:3,13

118:14,23 121:24

122:6,14,24 125:2

126:1,8,18,22

127:12,17 130:13

130:18 131:5

132:2,14 133:2

135:14 141:22

145:10 146:23

152:8,12 153:8

155:21 156:12

159:17 162:10

163:24 164:12

165:24 168:2

174:21 179:15

181:6,14,17

185:15,17 186:20

188:21 189:1,4,16

189:19,22,22

190:3 191:7,9

192:14 196:4,24

197:13 200:7,11

201:22 206:2,23

207:6 208:5

209:15 213:12

219:16 222:5

225:11,21 227:23

228:7 229:18

230:12 236:6

237:7,15,20,22

238:10 239:16

242:10,24 244:17

245:7,16 246:6

248:13 250:9

251:16 252:5

253:5,22,23 254:2

254:18 255:3

256:4,13,17,20

257:8,18 258:2,12

258:14,16 259:6

259:15 260:9

263:2,8 266:22

267:5,7,13,15,21

267:22 272:21

273:15 275:7

276:11 277:19

279:20 280:3,9,16

281:12 286:18,20

287:9,11 288:8,12

288:19 289:3,16

290:2,2,12,14,19

290:21 292:4,18

292:21 293:11,22

questioning 78:9

questions 15:8

16:17 42:15 70:6

86:10 102:20,20

103:16 104:18

108:10 130:9

141:11 194:20

202:6 213:7 252:8

252:13,19 274:1

293:2 295:17,19

295:22,24 296:2

quoted 32:14

R

R 158:15

ran 33:21 269:18

raw 142:1,7

Ray 3:9 10:14

reach 245:22

read 17:6 68:20

72:23 75:21 82:11

95:20 117:12,15

143:17 144:8

145:8 146:3 153:9

153:12 165:3,5,7

165:8 166:8 167:2

167:6 181:24

191:15 205:21

213:4 228:1

259:17 266:24

267:15,18 280:3,6

287:13 292:6

298:4

reading 64:10

78:11 144:14

179:19

ready 176:4,5,6

really 33:15 39:14

84:16 138:20

Realty 6:5

reason 31:20 81:16

87:15 106:12

196:19 257:12,21

reasonable 199:10

reasons 106:20

114:1 130:20

recall 12:15 15:22

18:13,20 19:3

20:24 21:23 23:20

27:14,15 29:19

33:12 41:23 42:2

50:14 55:10 58:6

59:1,6 60:24

74:20 88:15 111:5

135:11 136:5,7,8

138:13 139:1,23

139:24 140:7,9

147:6,7 153:19

158:1,9 163:18

166:17 173:19

177:24 178:16

183:15 193:9,22

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 321 of 330 PageID:

43910
Page 22

203:18 207:21

214:20 223:1

225:7 228:16,18

232:11 233:19

240:15 244:3,4,8

248:3 260:24

261:3,6,19 264:9

264:18

receive 67:4 79:4

81:15 85:13,22

86:1 108:1

received 23:24 27:3

31:1 63:7 82:9

109:19 135:5

140:10,14 150:21

263:13

receiving 84:18

223:1

recess 84:5 128:5

175:24 250:23

282:2 295:3

recipients 215:16

recognize 238:2

recollection 22:20

23:14,15 27:19

30:24 58:12 62:15

64:5,9,13 75:4,9

84:12 88:6 99:8

99:13 100:8 102:6

127:7 129:4,11

132:4,11 144:20

149:1 155:24

157:6 163:22

167:14,18 169:5

171:18,24 173:12

177:8 180:4,12

201:5,7 209:5

211:13 218:19

227:12 254:6

282:16,19 295:12

298:9

recommend 156:17

recommendation

106:12

recommendations

98:18

record 10:2,18 17:6

23:11 24:24 42:21

47:15 64:11 81:24

83:7 84:2,4,9

95:20 117:15

123:14 127:22

128:2,4,9,18

153:12 175:21,23

176:3 187:19

193:7 199:23

200:7,9,22 201:1

201:3,3 202:3,7

202:18 203:24

207:19 214:12

222:6,17,19 228:1

229:11 231:2,7,9

245:3 250:20,22

251:2,11 259:17

259:20 260:12

264:7 265:10

266:6,24 267:18

280:6 281:23

282:1,5 285:18

287:13 292:6

294:24 295:2,6

296:6,8,12,14

records 26:19,20

27:4,5 50:13

106:19 110:10,22

120:19

Red 1:15 2:4 10:12

reduced 49:6

refer 28:11 30:9

63:6 215:10

reference 62:4

referred 64:22

referring 35:24

64:18,21 65:5

110:10 145:23

225:22 289:17

refers 78:15

reflecting 73:2

reframe 185:19

refresh 62:9 64:12

144:15,20 163:22

177:7 182:10

211:12 227:3,11

refreshes 62:15

64:9

refreshing 64:5

refusal 267:20

regard 222:7

regarding 36:21

38:4 54:11 73:8

73:15 75:24 76:22

125:10 210:22

216:20 218:14

Registered 1:18

regular 103:15

regulations 156:24

Reindel 21:13

63:12

relate 14:14 74:5

related 5:13 14:15

22:1 33:22 40:24

48:14 58:7 59:3

59:10 67:3,19

75:13 84:20 86:21

89:7 94:15 103:3

103:10 104:12

117:19 121:6

124:20 125:11

126:3,14 131:10

132:18 157:20

159:7,13,19 160:6

161:7 174:4

213:23 224:17

237:3 241:22

243:12 244:24

247:8 262:12

272:7,14 277:15

278:15 279:15

284:1

relates 102:23

107:1 178:22

relating 73:8

189:12 238:4

262:13 282:22

294:3,11

relationship 37:13

37:14 60:10 61:1

relatively 145:21

relevant 63:9

100:20 136:11

162:9

relied 137:19

relying 254:24

remember 21:1

22:12 23:23 33:13

58:20 87:10,13,15

104:6 108:21

128:16 140:19

154:16 180:20,23

197:21 213:20

233:7,22 234:1,2

234:9

remind 24:9,20

25:10

Remundo 7:11

65:23

rendered 5:13

247:9

repeat 259:14

287:10

repeatedly 259:1

rephrase 133:4

174:21 229:19

236:5 283:20

replacement 71:22

report 49:5 52:13

73:8,18,22 79:6

79:11,16,19

114:24 115:24

116:6 139:4,9

168:16 220:23

227:17 229:4

247:6,15,23 248:5

248:15

reporter 1:18,19

10:16,19 17:5

95:19 117:14

153:11 227:24

259:16 266:23

267:17 280:5

287:12 292:5

297:22

reporting 102:21

113:2 114:14

119:12 126:13

reports 15:10 17:9

48:14 53:21 79:4

81:15 82:10,21

84:19 110:10

115:8,15

repository 181:15

represent 70:4

75:11 241:12

representation

77:18 95:3,9

166:4 185:2

207:14,24 222:7

232:4 251:8,24

252:3

representations

95:13

representative

27:17 28:21

291:20

representatives

183:19

represented 21:20

25:16 27:16 85:4

representing

251:13 287:3

represents 74:13

reproduction

297:19

request 6:8,22 9:4

10:12 44:6 63:8

81:3 103:18 112:5

155:3,3 248:18

requested 17:6

27:11,13 95:20

117:15 153:12

228:1 259:17

265:8 266:24

267:18,21 280:6

287:13 292:6

requesting 204:13

261:14

requests 101:11

137:20 190:19,21

require 124:8

273:11

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 322 of 330 PageID:

43911
Page 23

required 98:14,19

104:11 105:12

110:18 112:16,22

124:3 129:15

130:1,6 131:9

138:2 172:4 229:4

229:7 264:13

271:23 272:6

requirements

102:21 126:13

research 97:21

99:4,17,24 142:6

155:7 157:19

159:7 160:15

174:5 266:16

268:5 278:14

reservation 44:2

reserved 138:14,15

reside 11:15

respect 46:12 47:19

122:6 156:6 161:5

162:2 165:24

respecting 36:5

respectively 210:8

respond 97:22

100:11 101:11

127:11 130:13

137:19 138:3

158:12 199:8

237:19

responding 125:24

199:20 231:24

response 52:20

137:23 145:9

176:14 177:1

188:12 191:8,18

207:9 253:21

290:2

responses 6:5,10,21

91:22 96:23 155:1

183:14 188:1

190:20 195:19

198:4 201:13

202:15 203:12

284:24 285:3

responsibilities

12:12 13:3 15:3

66:22 78:19 86:23

91:3,13

responsibility

67:18 79:1 136:10

152:21 153:23

265:24

responsible 12:13

13:5 14:4 53:15

66:10,18,23

119:11

responsive 190:19

rest 120:10

results 20:2,14

145:16 284:9

retain 152:21

171:14 172:11

269:7

retained 33:1 40:21

41:16 42:8 110:19

233:12 265:21

retainer 40:24

retention 110:16

111:1 152:3

154:13,15 155:7

155:12,16 156:1

156:10,18,22

157:8,17 158:4

161:4 163:1,8,13

173:21 266:15

268:3 269:6 279:3

retired 14:24 15:4

224:14 230:7

277:6

retrieval 5:17

162:21 163:16

retrieved 180:13

181:11 182:12

returned 52:12

150:6 229:7

reveal 56:2 113:7

237:18

revealed 22:18

revealing 114:7

117:5 254:2 256:5

257:4 258:16

289:20

review 64:7 108:9

184:19 185:9,13

246:23

reviewed 91:24

92:20 110:6 157:1

173:22 174:7

reviewing 14:7

180:12

revised 212:18

revising 176:20

178:6 212:8

Rhode 58:13 155:5

226:7

Rhule 61:5

Richards 30:21

right 11:24 13:20

21:14 22:6 26:17

28:18 34:8,12

44:5 49:14 58:21

62:9 70:20 75:22

76:3 77:16 98:13

99:3,16 101:17

117:2 125:16

145:14 147:23

159:16 163:15

164:6,8,22 167:7

170:15 176:16

177:7,15 179:12

181:23 186:7

187:8 189:14

195:15,21 196:22

205:8 217:5 227:3

230:23 232:22

254:14 261:4

280:4 290:4 292:8

risk 66:10 238:3

244:12,22 245:24

246:12 277:16

282:21 283:9,15

283:24

risks 234:23 235:6

237:2 241:22

243:11 244:24

245:12 271:24

road 25:8

Robert 3:8

Robin 104:7

role 91:10 119:2

137:5 163:10

167:14,19 177:19

198:3,3 217:6

231:18

roles 275:16,18

room 90:20 233:24

Roth 2:2 10:13

routine 79:6,10

81:8 92:7,10

285:1,11 286:3

Royal 60:6,10

61:17

RPR 297:14

Rudberg 6:19

204:9

Rule 7:4 36:9 37:21

42:24 47:16

rules 25:11 42:24

46:9 124:4 194:4

194:16 264:12

Rumson 11:16

running 80:3 285:3

R&D 158:5,16

159:18 161:8

162:17 170:15

171:19,24 173:13

S

S 6:13,15 7:7

Salling 7:9 59:19

62:1 68:3

sample 145:20

samples 145:21

146:2 229:6

261:22 270:11,16

Sampson 5:11

165:14 166:16

179:19,22

Sarner 6:13,15,17

7:7 204:3,5,7

217:2

savings 140:15

saw 26:1 129:1

206:12 286:2

saying 15:23 92:22

137:13

says 33:18 42:23

59:18 60:17 61:7

61:16 63:6,13

71:15 72:8 73:7

75:23 76:17,20

77:14,17 139:21

140:6 155:11

170:13,20 171:8

172:10 176:17

183:17 188:18

189:6,13 191:16

196:10,11 212:15

220:15,19 223:20

247:15

Schedule 4:12

School 11:22

Schwartz 73:8,15

scientist 145:13

scientists 19:6,17

20:1,13 86:2

97:21 118:8

149:11 185:24

198:24 238:14

241:4 243:5

246:10 259:10

260:19

scratch 99:7 133:22

278:11

screen 43:19 60:1

76:12 208:16

212:2 217:20

225:21

scroll 43:19

se 86:16

seal 24:18

sealing 24:12,22

25:4,5

SEC 124:3 125:6

126:14

second 17:11 25:20

51:22 148:9

164:15 165:1

170:12 179:16

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 323 of 330 PageID:

43912
Page 24

183:4 192:13

210:11 212:11

215:2 218:7 231:6

296:4,5

seconds 36:24

secretary 13:18,21

30:12,15 82:19

112:15 118:19

119:8,11,15

120:23 251:5,21

283:8,22

secure 111:18

209:7

Securities 4:11

139:5

see 31:19 32:13,14

32:19 43:7 59:20

60:7,17 62:2,7

63:16 66:4 68:1,4

68:6,8 71:15

72:10 73:5,13

75:1 76:17,20

139:7,17 140:1,5

141:6 142:10

143:8 147:18,19

147:19 148:5

155:8,14 162:18

168:2 171:1,11,15

172:16,17 176:17

176:23 177:1,5

181:21,22 182:1

182:20 183:1,4

184:1,2,5,7 188:7

188:11 189:13

192:14 195:23

205:22 208:20

209:3 210:18,23

211:6,10 212:13

215:12 216:17,22

217:3 218:17

220:14,15,18,24

223:12 224:1

226:8,15 227:1

247:12,20 249:12

seeing 23:16

seek 206:16 255:2

seeking 207:13

seeks 45:6

seen 23:21 147:5

165:13 166:11,15

190:16 201:10,12

201:24 208:13,22

211:13 241:16

282:17

sees 195:24

selected 183:13

selection 93:15

send 94:14 168:21

179:11 180:5,6

286:3

senior 21:12 88:2

99:23 233:8,21

275:22

sense 72:23

sent 26:20 71:21

95:2 134:21

170:14 175:1

181:14 223:2

sentence 145:23

separate 108:4

109:7 298:11

September 187:7

series 108:3

serpentine 247:17

servants 183:19

serve 96:22 97:7

served 119:15

182:21 213:1

283:7

service 138:15

services 1:23 10:15

10:17 33:1 231:23

247:8

serving 189:2

Servives 5:13

set 6:11 43:2,4

187:17 195:20

settled 77:20,23

78:3 80:13 83:7

105:19 113:19,19

157:14 229:3

253:1

settlement 106:13

settlements 80:1

106:20,21

Shafer 269:14

271:2

share 139:23

shared 61:13,13

90:20

shares 139:16,20

sheet 298:11 299:1

shorter 11:9 165:11

Shorthand 1:19

shortly 224:14

230:6

show 27:22 38:23

43:22 60:1 64:6

65:14 70:2 143:6

143:11 147:1

163:24 187:13

208:7 209:18

showed 23:16

145:16,21 148:1

203:18

showing 78:10

shown 241:17

Shroyer 204:7

sic 36:23 204:6

side 133:1,8 135:16

233:19,20 248:24

sifted 70:20

sign 212:19 220:8

signature 224:2

299:23

Signe 6:19

signed 85:23

219:22 223:15,16

223:18,21,23

224:10

significance 249:6

265:16

significant 104:20

115:22 234:23

235:6 238:3

271:23

similar 90:3 105:11

153:24 188:12

253:22 257:12,23

simply 64:10

single 201:21 268:7

sir 35:9,16,20 39:10

56:9

sit 11:24 30:23

177:15 268:2

294:1

site 270:1,10,15

Six 11:16

Sixty-three 189:17

Sloane 2:17 50:10

63:14,18 64:1,16

64:19,21 65:6

73:3 77:9 81:4

85:9 105:5 141:16

148:10 149:20

205:2 210:17

211:5 212:17

215:18 217:1

218:15

smaller 243:22

Smith 61:21,22,24

76:22 77:1,8

78:16

Sneha 3:8

sold 271:9

somebody 35:21

46:2 85:8 105:21

112:11 126:5

169:3 248:19

270:3

soon 51:7

sorry 26:6 34:5,11

50:15 60:2 68:10

70:13 71:2 82:23

92:14 115:13

124:10 140:3

141:22 148:10

212:3 214:24

223:22 225:11

230:18 261:5

sort 47:15 73:24

80:1 81:8 104:24

113:1,20 171:6

sorted 72:18,19

sounded 16:15

source 29:3,6,14

45:22 46:12 49:20

50:6 98:19 229:14

229:17

sources 198:16

Southern 2:20

space 34:6

speak 38:6 41:24

51:6 178:13 203:1

speaking 24:16

194:3 196:14

291:18,21

special 233:13

specific 85:4 95:23

95:24 97:13 126:1

129:11 158:11

162:2 171:24

206:21 267:2

281:3,3

specifically 12:16

66:21 107:1 127:5

157:20 177:18

210:3 243:24

specified 43:17

specify 229:12

speculate 49:12,13

speculating 56:18

speculation 75:19

78:6 115:2 116:17

168:14 170:3

198:20 199:3

201:18 205:17

221:15 222:16

239:13 248:10

249:4 261:17

264:8 265:11

266:7 270:7,19

277:18 286:7

speculative 237:24

speed 205:14

spent 295:8

Sperduto 112:9

233:9

spoke 17:22

spring 273:10

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 324 of 330 PageID:

43913
Page 25

274:7

Square 2:14

staff 85:21 244:2,3

stages 92:5

standard 6:11

195:20 198:5

stands 68:13 153:8

206:24 267:5,15

start 7:13 11:9

started 12:4

state 23:17 24:10

134:17 188:3

195:11 201:1,3

226:6

statement 24:24

123:14 145:12

221:2,24

statements 17:16

states 1:1 4:11 10:6

91:20 144:21

182:22 212:16,22

215:12 226:19,20

247:16

status 63:9 73:8,11

73:18,22,24 79:16

79:19,23 82:10,21

84:19 114:20

242:18 274:6

stayed 282:9

Steinmetz 5:10

28:6,22

stenographic 10:18

step 118:13

steps 282:22 283:23

Steve 234:4

Steven 188:5

Stipulations 9:8

stood 113:13

stop 165:16

stopped 31:10

storage 89:11 90:13

181:15,15

straight 209:20

strategies 275:11

287:22 288:22

289:11 290:24

291:12 292:14

strategy 93:5,11

218:13 276:1,4

289:15,23 290:6

streamline 196:20

Street 1:15 2:9

10:11

Streets 2:14

strictly 265:23

strike 85:24 100:18

255:19

Stryker 234:2,4,6,7

244:1

studies 32:12 33:20

47:5,13

sub 12:15

subfile 90:5

subject 23:4 25:4

26:21 43:1 44:1

46:10 51:6 63:7,9

79:19 84:24

135:21 143:7

161:5 174:6,14,15

200:5 216:19

235:17 280:11,23

284:13 295:16

subjects 191:4

subject-matter-t...

95:22

submit 285:2

submitted 43:9

109:1 188:2

194:24 226:1

SUBSCRIBED

298:16

subsidiary 62:5

substance 16:23

23:1,1,7 24:17

38:2,11 41:6

113:8 114:4,7

117:5 224:22

235:10 256:5

257:4 258:17

263:3 273:12

274:3 277:20

280:10 284:15

substantive 280:16

success 104:24

successor 57:12

sue 219:12

sued 138:14 155:4

259:1,12 268:21

279:14

suggest 241:17

suggested 205:24

suing 137:8 147:7

260:3 264:3

Suite 1:15

Sullivan 81:12

205:2 228:19

summaries 109:14

summarize 108:6

Summary 5:12

247:8

Superior 226:6

supervising 14:14

79:8

supervision 297:21

supplied 21:24

32:20

supplying 195:2

support 8:2 9:1

12:14 21:21 43:6

Supreme 188:2

sure 12:20 13:14

19:15 27:24 50:16

58:10 66:23 69:10

82:15 87:3 96:8

103:6 104:8

110:16 111:13

136:11 172:23

187:22 225:15

230:24 232:8

240:13 244:19

250:16 254:22

256:18 259:9

280:4 283:15

surfaced 227:19

surprised 99:13

214:17

suspend 161:3

Swartz 74:5

swear 10:20

sworn 10:23 198:18

199:12 298:16

systems 12:17,17

T

tab 164:19,20

tad 72:22

take 47:19 93:22

94:4 118:13 144:6

144:9 185:8,12

187:14,15 194:14

204:9 215:2,2

230:21 231:4,6

237:5 250:14

273:9 274:2,8

281:19 283:8,23

294:20

taken 10:11 61:19

84:6 128:6 147:3

176:1 185:23

186:8 250:24

282:3 283:18

295:4 298:5

takeover 231:12

232:16 234:21

236:14,17 238:12

239:2,10,18 240:3

240:18 241:2,11

241:24 243:17

244:23 245:10

271:16 272:1

282:8,10

talc 6:6 13:10,14

14:18 15:7,11

17:10 18:12,17,24

19:8,19 20:4,16

22:1 32:12 36:21

47:6,13 53:3,15

54:9,11 56:15

58:3,7 59:3,10

62:5,11 65:9 67:3

67:19 74:24 75:13

75:24 82:20 85:12

86:11,14,16,22

88:4,18,21 89:1,5

90:6 91:14 93:5

93:16 94:15 95:4

95:15 97:22 98:20

100:12,21 101:10

102:13,23 103:3

103:10 104:12

107:2,9,20 108:7

108:7 109:8,15

112:18 113:3

114:15 116:6,15

117:20 118:9

121:6,17 123:21

124:21 126:14

127:1,6 128:13

129:7 131:11,21

132:19 133:7

134:3,11 135:8,23

136:12,14 141:24

142:1,7 148:1

152:1,23 159:8,19

160:6,14 161:10

170:16 191:24

193:5,11,11

197:16 200:18

203:11 206:17

207:13,15 214:9

235:18 236:9,21

237:4 238:5,15

240:20 241:5,12

241:23 243:12

244:11 245:24

246:11 247:17

251:9 252:1,24

253:2,11 259:1,11

259:13 260:4,7

261:12,23,24

262:14,15 264:2

265:8 266:4 268:6

268:22 269:18

272:8,15 274:19

274:24 275:1,12

275:24 276:5,16

277:1,15 278:1,15

278:22 279:15

282:9,23 283:10

284:2,10,20 287:2

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 325 of 330 PageID:

43914
Page 26

287:24 288:24

290:6,7 291:11

292:13 293:7,15

293:18

talk 15:7 91:2

101:23 124:12,14

133:18 154:12

204:13 242:14

243:24

talked 21:22

145:14 191:10

talking 27:23

223:22 243:16

talks 68:6 74:23

139:16 147:15

162:20 171:13

189:19 210:20

218:6,12 249:10

tank 235:17

team 85:6

tease 38:20

Tech 57:23 147:17

technical 248:12

telephone 3:8

195:12

tell 15:23 29:16

30:15 38:8 80:12

80:12,14 89:24

113:17,22,24

124:16 127:5

138:10 165:7

179:8 196:6 233:3

233:4

telling 15:23 129:5

180:5,6 278:8

tempted 282:18

tender 139:22

140:1

tenth 90:19

tenure 104:2

terminated 157:9

terms 78:18 107:19

110:21 130:4

161:21 205:15

221:10 269:5

280:10 283:19,24

Terry 30:20,20

tested 141:24

145:20 229:6

270:12

testified 10:24 19:7

19:17 20:1,13

63:20 64:16 99:9

141:23 144:16

149:11 163:21

183:22 188:19

189:7 193:22

198:24 201:4

268:4 290:13

testify 145:3 228:11

testimony 4:3

11:14 17:21 24:21

28:8 118:7 137:17

142:13,23 143:7

145:6 147:8 148:4

148:6 163:5 164:1

165:14 166:6

168:19 170:5,9

177:16 187:1,9

191:20,23 197:18

202:22 203:1

222:4 238:15

241:3 243:4 246:9

259:10 260:18

284:23 286:1

298:5

testing 4:17 18:10

18:15,16 19:7,18

20:2,14 22:1 27:4

36:11,21 40:18

47:3 48:16 49:18

56:13 58:3 100:1

100:20 101:9

116:14 117:19

118:9 135:22

136:12 147:24

161:7 191:10,24

193:1 200:3,17

203:10 220:21

221:10,18 222:12

239:4 240:20

241:5 244:21

260:5 261:23

262:13 264:2

265:7 268:6 270:4

270:10 278:21

284:10

tests 32:10,11 33:6

33:18,19,22 35:22

47:5,11,12 147:15

thank 32:2,3 42:3

65:12 72:24 83:19

83:23 123:11

144:11 163:17

182:16,17 184:21

202:10 208:9

225:22 251:17

278:8 295:18

thereof 127:1

they'd 101:24

104:23 106:8

124:13

thing 28:19 80:1

100:1 104:24

113:20 144:2,4

things 51:15 109:20

109:23 124:14

165:11 196:20

think 17:19 24:12

38:18 44:18,19

47:16 50:3 53:6

57:16 58:21 67:22

74:15,17,19 83:11

83:15 84:23 87:8

88:1,19 91:7 92:7

94:8 99:23 100:5

101:4 104:3

111:21 119:14,15

127:13 157:12

166:5 169:2,12

172:22 178:23

179:14 229:21

231:16 235:12

248:12 269:22

270:20 271:11

280:15 288:2

289:12 294:20

thinking 261:19

third 59:22 60:4

68:2 216:13,14

220:18

Thirteen 226:10,11

Thomas 3:6 260:16

thought 25:9

124:15,21 126:12

151:11 212:4

245:12 267:3

threatens 46:13

three 13:7 83:4

194:6 268:20

time 10:10 11:10

12:11,20 15:9

16:12 17:8 18:9

18:14,22 19:5,21

20:12,22 21:24

29:21 30:16,16

31:9 55:1,4 80:12

83:18,21,24 84:7

84:13 85:10 87:11

90:11 103:24,24

127:24 128:7

134:5 136:17

139:10,10,19,20

140:16 142:12,16

146:11 148:16

149:1 152:24

153:2,5 154:8,10

156:9,24 160:2,6

161:12 172:23

174:23 175:19

176:2 179:3 185:9

185:13 186:9

187:2,15 193:13

197:21 201:9,17

213:1 214:7 219:3

222:23,24 224:13

227:16 228:10,19

230:15 231:11

232:14 234:24

235:7 238:2,12,18

239:1 240:3,18

241:1,23 243:2,16

247:23 249:23

250:4,18 251:1,4

251:20 259:8,24

261:8 262:14

264:19 265:22,22

271:5,9 273:9,19

278:10 281:21

282:4,7 283:4,6

283:21 291:9

292:11 293:3,14

294:22 295:5,9,17

295:20,22 296:1,9

times 79:15 83:4

title 14:23 91:7

today 10:9 11:14

30:23 39:3 43:11

44:12 58:13

177:16 197:20

241:17 268:2

282:17 284:23

286:2 294:1

today's 197:12,13

246:17 296:11

told 82:23 128:22

129:11 157:13

179:11 241:21

249:8 293:17

tolling 218:14,20

219:3

Tom 86:17,19,19

86:19 87:11 88:7

90:2 99:1 177:3

ton 5:19

top 80:8 209:2

210:9

TORTORELLA

2:19

touch 112:10

Township 2:21

trace 144:22 145:4

track 290:20

transaction 232:5

transcript 4:19 5:4

5:9 297:9,19

298:5

transcripts 149:10

150:1,6,22 184:4

228:21

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 326 of 330 PageID:

43915
Page 27

transferred 31:9

89:14 173:14

transition 239:23

transmitted 239:4

transmitting 73:10

73:13 210:21

211:9 223:21

224:9

trial 189:7

Triglia 99:20 100:9

101:2,9 102:11

145:13,23 186:24

187:10 192:8

263:15

true 102:7 160:15

160:19 298:7

truthful 184:10

try 104:23

trying 196:15,18

197:7 202:9 267:6

TUNIS 3:3 26:3

59:24 63:23 71:2

76:11 89:21 102:2

140:3 142:17

151:1,10,19 152:4

152:16 153:5

154:4,7 160:16

161:19 162:1

168:12 170:4

174:11 175:5

187:16,20 192:2

206:9 208:15

212:1 217:19

225:13,16,20

261:15 262:1,18

264:5 266:20

268:8 291:2 296:2

turn 121:1

twice 115:19

two 2:14 83:3 111:9

119:9 130:8

145:11 148:9

215:11 293:2

type 131:9

typically 46:10

89:19

U

Ughetta 1:14

Uh-huh 24:14 51:9

76:13 85:3 89:18

96:1 127:23 133:3

141:7 164:21

176:13,24 180:3

217:16 275:17,20

287:16

ultimately 79:3

108:24 120:24

133:12 134:9

umbrella 61:13

unaware 286:11

287:1

uncommon 85:7

underlying 262:13

underneath 74:11

155:10 184:7

188:5

understand 16:5

24:13 37:14 54:14

57:9 153:21

172:11 196:19

197:8 198:2 199:6

234:20 237:2

244:17 264:12

267:7 271:21

272:5,23

understanding

57:2 131:8,15

152:20 153:16

160:22 161:17

162:6 172:5

249:14 258:24

260:16 261:7

264:22 266:14

understood 237:9

264:19 280:8

289:16

undertake 278:12

undertaking 156:8

Union 12:18

unique 93:2 96:2,4

Uniroyal 226:5

unit 99:24

United 1:1 4:11

10:6 182:22

University 11:21

32:23

unlimited 107:14

update 79:6

updated 79:16

updates 123:6

upper 30:11

use 43:5 114:22

189:12 209:7

useful 25:10

V

vague 132:21 134:5

135:10 136:16

153:14 154:7

155:19 160:18

161:12 238:18

value 253:1

variability 145:17

various 60:18

212:22 213:1

vary 212:23

Vasilopoulos 7:10

65:20

vehicle 136:19

verbal 48:23 49:6

verify 183:14

Vermont 32:11

33:7,9 47:4,12

269:18 270:2

Vernon 32:8,19,21

32:22 34:23 36:10

36:20 45:14 47:2

version 28:24 29:5

157:8

versus 10:5 60:18

76:22 78:16

118:19 119:3

247:10 284:20

vice 12:22 13:3,24

videographer 3:9

10:1,14 83:24

84:7 127:24 128:7

175:19 176:2

250:18 251:1

281:21 282:4

294:22 295:5

296:9

Videotaped 1:12

Viner 172:24

virtue 37:12

visited 270:1,15

voice 26:4

volunteer 17:21

vs 1:5 4:20 5:5,11

5:14,20 6:12,23

7:5 226:5 299:2

V-I-N-E-R 173:1

W

wait 184:17 283:19

296:4,5

waive 38:10 190:9

waived 38:1

waiving 38:9 43:2

44:5

wall 90:23

Walter 61:20

want 15:8 38:19

39:6 47:14 70:5

72:1 83:18,22

86:9 91:2 102:19

119:4 154:12

165:8 166:3 167:3

167:9 175:14,15

177:17 181:24

196:13 216:13

229:19 230:20

231:3 240:11

253:24 271:12

280:3,12

wanted 103:17

111:8,16 124:14

168:17

wants 190:8

Warren 3:4

Washington 2:9

4:12

wasn't 49:19 76:4

124:16 135:19

140:12 234:4

wastebasket 156:19

water 12:18

way 44:4 60:5 68:7

74:9 144:15 146:8

191:7 200:12

220:22 229:20

237:14 240:4

254:20

weather 206:21

week 145:18,18

Weldon 61:22,24

went 11:18 31:10

50:17 52:5 92:1

168:3 177:10

242:4 270:5

280:24,24

weren't 134:22

186:10

West 1:15 10:11

Westfall 4:20 5:5

5:14 58:20 59:3

62:12 76:4 77:19

78:3 84:13 99:9

102:10 138:10,12

141:5 146:9 147:4

147:9 148:15

149:8 150:14

151:6,16 155:6

156:2,7 157:9,13

199:1,19 218:14

218:21 224:17

227:18 228:21

230:6 243:5

247:10 257:10,22

258:7 263:12

286:12

Wexler 244:4

We'll 71:17

we're 15:6 84:1

122:2 125:3,17

128:1 175:20

176:4 223:22

250:19 273:9

280:19 281:22

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 327 of 330 PageID:

43916
Page 28

294:23 296:11

we've 63:7 64:11

83:13 194:5

201:14

whatever's 295:10

whatsoever 137:5

Whittaker 4:20

5:14 247:10

Willia 68:3

William 5:6 7:8

59:19 61:24

148:21 208:12,24

212:10,18,20

247:7

Williams 1:3 5:20

6:22 7:5 10:4

294:11 299:2

wish 24:23 47:20

withdraw 189:3

withdrawing

188:21

withdrawn 170:21

withheld 25:19

witness 8:4 10:20

13:13 14:21 15:19

16:2,7 17:17,22

18:6,20 19:3 20:7

22:10,16 23:14

24:14 26:6,24

27:8 29:24 30:6

31:19 33:2 34:8

34:11,13 36:20

38:14,16 39:16

40:3,10,10 41:11

41:20 42:2 48:10

48:19 49:2,11,14

50:3,23 51:9,24

52:21,23 53:8,14

54:1,7 55:6 56:21

57:20 58:10 59:6

59:13 60:14 62:21

65:4 66:17 67:15

67:22 68:19 69:3

69:9,17,22 73:22

74:8,17,19 75:8

75:20,23 76:8,15

77:4 78:13,24

79:14 80:7,17

81:2,6,20 82:7,14

83:3,11 84:16

85:3 86:6 87:8

88:12 89:4,24

90:18 91:17 92:4

92:14 93:1,9 94:2

94:8,11,21 95:8

96:1 97:16 98:2

98:10,24 99:12

100:15,24 101:4

101:14,20 102:7

102:16 103:6,13

104:16 105:17

106:8,16 107:4,12

107:17 108:17

109:4,11,19

110:14 111:4,13

111:21,24 112:7

112:21 113:12

114:9,19 115:3,11

115:18 116:3

117:9 118:1,15

120:9 121:11,13

123:24 124:7

126:8 127:11

128:16 129:1,10

130:16 131:3,6,14

132:14,22 133:11

133:15 134:6,14

135:11,18 136:5

136:18 137:18

138:6,20 139:13

140:5 141:1

142:20 143:2

144:1,12,19

146:15 147:12

148:5,19 149:6,15

149:20 150:3,9,17

151:2,11,20

152:17 153:7,15

154:19 156:5

157:12,24 158:9

158:20 159:1,12

159:22 160:9,19

161:14 163:6,18

168:6,15 169:12

170:10 171:23

172:22 173:17

174:2,13 175:8,11

177:23 178:4,8,12

178:15,20 180:9

180:17,23 183:11

184:22 185:16,20

186:4 187:6,9

189:18 192:5

193:9,21 196:9

197:19 198:9,21

199:4,15,24 201:4

201:11,19,23

202:7 203:7,16

204:11,23 205:9

206:11 207:4,7,20

209:13,16 211:18

213:20 214:5,15

215:3 216:3,6

217:10 218:10,24

219:6 220:4,12

221:16 223:6

224:24 225:3,14

226:13,15 227:8

227:11 228:15,24

229:24 231:22

232:8,11,19 233:2

234:16,18 235:3

235:13 236:12,24

238:21,23 239:8

239:22 240:9,23

241:8,15 243:8,19

244:16 245:20

248:2,11 249:5,20

250:1,8,13 251:18

252:17 254:5,14

254:22 255:16

256:7,11 257:6

258:4,19 260:13

260:23 261:18

262:6,9,19 263:6

263:18 264:9,18

265:14 266:10

268:11,17 269:1

269:12 270:20

271:4,19 272:3,11

274:9 275:21

276:19 277:4,23

278:2,5,18 279:1

279:21,24 283:2

283:14 284:5,16

285:8 286:8

287:17 290:16

292:3,22 293:12

293:23 294:7,15

295:18

witnesses 42:23

183:20

witness's 43:17

102:4 222:3

Wittacker 5:5

words 47:10 252:11

work 13:10 16:13

16:19 31:11 35:3

36:16 38:2,12

42:10 44:8 55:18

58:2 80:18 81:10

88:4,17 93:16

108:6 113:9

125:12 126:5

131:24 146:20

173:3 190:12,22

191:5 208:2

230:10 238:7

239:14 242:4,7,12

242:20 245:4

246:3 257:15

259:3 267:9,23

272:18 273:2,3,5

273:16 276:8

280:14 281:6

286:16 289:7

290:1

worked 86:11,12

87:21 88:8 146:11

173:6 179:4

192:22 197:14

207:12 211:1

212:18 243:3

Workers 59:9

working 31:10

93:12 199:7

214:20 233:17

261:11 282:8

world 40:17

wouldn't 31:20

79:7 96:21 98:10

110:18 209:2

277:9

write 30:11 61:14

120:1

writing 49:6,19

129:2

written 96:23 97:7

115:8 200:16

wrong 120:15

225:12

www.MagnaLS.c...

1:24

X

X 196:11,12

XI 1:20 297:14

x-raying 255:7

x-rays 255:8,12

Y

Yale 11:18

yeah 17:17 22:9

28:14 52:19 56:19

62:16 64:2 65:17

66:14,17 74:17

92:14 115:3 119:4

129:2 138:6 140:5

140:14 143:20

144:2,9 152:13

157:24 164:17

175:17 178:15

179:20,23 185:16

187:20 205:9

221:12 225:15,18

226:14,15 231:1,5

234:7 249:5

250:16 258:3

260:24 286:22

year 68:7 79:15

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 328 of 330 PageID:

43917
Page 29

83:4 87:14,14,17

87:22 110:18

115:19 140:18

years 29:13 105:6

268:21

Yep 217:21

York 188:3,4 198:5

202:16 203:12,19

YR 68:10

$

$33 140:11

$400,000 229:4,8

$45 139:23

0

01938 1:20 297:14

07059 3:4

07701 2:4

07928 2:21

1

1 4:17 8:8,10,13,16

8:17 10:2 25:15

61:8 70:24 71:3

298:7

1:07 176:3

10 8:10,19,20,21,22

176:15

10:12 84:1

10:20 84:8

103 145:2

108 6:13 204:2

205:10

11 4:5 8:8,12,21

61:9 70:13,13,17

70:17 71:1,10

128:1 176:15

183:17 211:24

11:10 128:8

114 8:20

116 8:21

117 8:22

118 8:6

12 8:12,13,15,16

183:16 187:7

226:3,9

12/13/1985 76:18

12/13/85 78:15

12:01 175:20

120 1:15

121 6:15 8:7 204:4

205:10

123 6:17 205:6

125 8:8

126 8:9

127 2:3 8:10,11

13 5:9 8:11,19 28:4

28:5 226:13

130 8:12 28:12,13

132 8:13,14

14 1:9 5:12 8:6,11

8:14 225:11 247:3

247:6 298:6

14A 4:12

14th 10:9

141 1:15 10:11

146 8:15

1472 223:11

148 6:18 204:7

205:1

15 5:16 8:7,11

162:12,16 177:13

15th 60:7

1516 74:12

1561 76:10

16 4:19 7:7 8:6,9

16th 141:4 171:10

204:6

17 8:9,12,13,18,18

139:15 141:19

143:10,11

176 6:21 154:21,22

18 5:10 6:20 8:13

143:11,16,22

144:14 224:5

18th 2:14 204:8

219:20

19 8:6 147:14,15

191 8:16

19103 2:15

195 210:4

1976 12:4

1979 147:17

1980 12:21

1980s 62:13 63:20

1981 15:15

1982 134:21 135:5

250:2

1983 4:20 5:4 77:23

141:4 147:4

1984 5:18 13:17,23

14:3,13 15:3 74:4

75:4,12 154:14

155:13 157:4,21

158:6,14 159:6

160:13 162:2,16

167:15 171:10

173:13 176:21

177:10,20 180:14

181:11 182:13

187:10 266:15

267:3 268:4,19

269:6 279:3,6

1985 7:11 60:7,11

61:8,9 63:1 65:19

77:1,10 160:13

1987 78:3

1989 212:9,19,24

213:3 219:20

221:20 224:6

1990 6:14,16,17

204:3,4

1991 7:7 204:6

1995 187:7

2

2 8:6,10,15,16

42:22 195:9

2:11-cv-1754 1:7

10:8

2:31 250:19

2:53 251:2

20 8:7,8,20

20th 63:1

2000 111:17 250:1

2000s 213:3

20005 2:9

2002 188:9,11

2003 6:20 111:10

204:8

2004 227:16 228:9

2005 111:8,10,16

111:17 227:16

228:9 231:17

2006 14:24 15:4

139:13 268:20

273:10 274:8,18

2009 286:12 287:2

2017 5:10

2018 1:9 10:9 298:6

298:17

202.879.5959 2:10

203 7:4 32:1,5

207 8:17

208 8:18

21 8:22 155:3

210 7:7 204:5 205:5

214 7:8 59:15

215 7:10 59:15

65:11,15

215.981.4591 2:15

219 8:19

22 6:14 8:15,19

22nd 204:2

228 8:20

23 6:16 8:7

23rd 204:4

230 8:21

237 8:22

238 8:6

239 8:7

24 6:17 7:11 8:17

65:19

242 8:8

245 8:9

246 8:10,11

25 3:4

250 8:12

252 8:13

253 8:14,15

256 8:16

257 8:17,18

258 8:19,20

259 8:21

26 5:4 36:9 37:21

47:17

26th 147:3

26(a)(1) 7:5

26(a)(1)(A)(i) 42:24

263 8:22

267 8:6

272 8:7

274 8:8

275 8:9

276 8:10

278 8:11

280 8:12

286 8:13

287 8:14

288 8:15

289 8:16

296 298:7

3

3 4:19 8:9,11,14

140:21,24 141:3

3M 5:11

3:27 281:22

3:42 282:5

3:56 294:23

3:59 295:6

30 36:23

30th 74:4

3000 2:14

34 164:12

35 8:7,8,9 178:24

36 8:10,11

4

4 5:4 8:18 146:6

147:2,2 212:10

296:10

4/28 210:10

4/28/89 210:7

4/30/1984 72:9

4/30/84 72:21

4/4/1989 216:15

4/4/89 216:16

40 29:13

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 329 of 330 PageID:

43918
Page 30

41 5:19 8:12 176:12

211:20 225:10,16

225:24

42 8:13 145:20,21

43 8:14

437 2:20

45 8:15

46 8:16

49428 63:5

5

5 5:6 8:7,10,21

208:8,11

5/18 210:12

5/18/89 210:8

50 6:4

5072 170:24

50872 65:15

51 8:17

55 8:18

56 8:19

57 6:10 182:15

187:14 203:19

572 210:4,24

6

6 5:8 8:9,14,14,16

8:20 164:13

219:18,20

62 181:2

624-6221 1:23

63 188:8,11

655 2:9

7

7 5:18 8:12,17,22

176:21 180:14

181:11 182:13

7th 162:16 167:15

177:9,20

7/1/83 217:23

7/18/1995 215:12

732.747.9003 2:4

754,787 139:20

76 12:8

8

8 32:16 45:15

212:19,24

8th 212:9

8/18/89 223:11,18

80s 21:2,2 33:14

58:17,18

82 28:19,20

83 157:14

84 157:15

866 1:23

873 71:16,19 72:8

72:16

9

9 8:6,8,15

9:06 1:16 10:10

90s 21:2 33:14

908.484.1153 3:5

93 28:16

96 12:5

973.824.9300 2:21

99 96:17

Case 2:11-cv-01754-BRM-AME Document 600-14 Filed 06/25/18 Page 330 of 330 PageID:

43919